id	sid	tid	token	lemma	pos
dpc-2620	1	1	dermatology	dermatology	NOUN
dpc-2620	1	2	:	:	PUNCT
dpc-2620	1	3	practical	practical	ADJ
dpc-2620	1	4	and	and	CCONJ
dpc-2620	1	5	conceptual	conceptual	ADJ
dpc-2620	1	6	original	original	ADJ
dpc-2620	1	7	article	article	NOUN
dpc-2620	1	8	|	|	ADV
dpc-2620	1	9	dermatol	dermatol	ADJ
dpc-2620	1	10	pract	pract	NOUN
dpc-2620	1	11	concept	concept	NOUN
dpc-2620	1	12	.	.	PUNCT
dpc-2620	2	1	2023;13(2):e2023077	2023;13(2):e2023077	NUM
dpc-2620	2	2	1	1	NUM
dpc-2620	2	3	lenalidomide	lenalidomide	NOUN
dpc-2620	2	4	augments	augment	VERB
dpc-2620	2	5	differentiation	differentiation	NOUN
dpc-2620	2	6	of	of	ADP
dpc-2620	2	7	cultured	cultured	ADJ
dpc-2620	2	8	hair	hair	NOUN
dpc-2620	2	9	follicle	follicle	NOUN
dpc-2620	2	10	derived	derive	VERB
dpc-2620	2	11	melanocyte	melanocyte	NOUN
dpc-2620	2	12	stem	stem	NOUN
dpc-2620	2	13	cells	cell	NOUN
dpc-2620	2	14	into	into	ADP
dpc-2620	2	15	functional	functional	ADJ
dpc-2620	2	16	melanocytes	melanocyte	NOUN
dpc-2620	2	17	uma	uma	PROPN
dpc-2620	2	18	kumari1	kumari1	PROPN
dpc-2620	2	19	,	,	PUNCT
dpc-2620	2	20	naveed	naveed	PROPN
dpc-2620	2	21	pervaiz1	pervaiz1	PROPN
dpc-2620	2	22	,	,	PUNCT
dpc-2620	2	23	harjot	harjot	PROPN
dpc-2620	2	24	kaur1	kaur1	PROPN
dpc-2620	2	25	,	,	PUNCT
dpc-2620	2	26	himani	himani	PROPN
dpc-2620	2	27	sharma1	sharma1	PROPN
dpc-2620	2	28	,	,	PUNCT
dpc-2620	2	29	davinder	davinder	PROPN
dpc-2620	2	30	parsad2	parsad2	PROPN
dpc-2620	2	31	,	,	PUNCT
dpc-2620	2	32	ravinder	ravinder	PROPN
dpc-2620	2	33	kumar1	kumar1	PROPN
dpc-2620	3	1	1	1	NUM
dpc-2620	3	2	department	department	NOUN
dpc-2620	3	3	of	of	ADP
dpc-2620	3	4	zoology	zoology	NOUN
dpc-2620	3	5	,	,	PUNCT
dpc-2620	3	6	panjab	panjab	PROPN
dpc-2620	3	7	university	university	PROPN
dpc-2620	3	8	,	,	PUNCT
dpc-2620	3	9	chandigarh	chandigarh	PROPN
dpc-2620	3	10	,	,	PUNCT
dpc-2620	3	11	india	india	PROPN
dpc-2620	3	12	2	2	NUM
dpc-2620	3	13	department	department	NOUN
dpc-2620	3	14	of	of	ADP
dpc-2620	3	15	dermatology	dermatology	NOUN
dpc-2620	3	16	,	,	PUNCT
dpc-2620	3	17	postgraduate	postgraduate	PROPN
dpc-2620	3	18	institute	institute	PROPN
dpc-2620	3	19	of	of	ADP
dpc-2620	3	20	medical	medical	ADJ
dpc-2620	3	21	education	education	NOUN
dpc-2620	3	22	and	and	CCONJ
dpc-2620	3	23	research	research	NOUN
dpc-2620	3	24	,	,	PUNCT
dpc-2620	3	25	chandigarh	chandigarh	PROPN
dpc-2620	3	26	,	,	PUNCT
dpc-2620	3	27	india	india	PROPN
dpc-2620	3	28	key	key	ADJ
dpc-2620	3	29	words	word	NOUN
dpc-2620	3	30	:	:	PUNCT
dpc-2620	3	31	lenalidomide	lenalidomide	NOUN
dpc-2620	3	32	,	,	PUNCT
dpc-2620	3	33	melanocyte	melanocyte	NOUN
dpc-2620	3	34	stem	stem	NOUN
dpc-2620	3	35	cells	cell	NOUN
dpc-2620	3	36	,	,	PUNCT
dpc-2620	3	37	melanocyte	melanocyte	NOUN
dpc-2620	3	38	,	,	PUNCT
dpc-2620	3	39	differentiation	differentiation	NOUN
dpc-2620	3	40	citation	citation	NOUN
dpc-2620	3	41	:	:	PUNCT
dpc-2620	3	42	kumari	kumari	PROPN
dpc-2620	3	43	u	u	PROPN
dpc-2620	3	44	,	,	PUNCT
dpc-2620	3	45	pervaiz	pervaiz	ADJ
dpc-2620	3	46	n	n	CCONJ
dpc-2620	3	47	,	,	PUNCT
dpc-2620	3	48	kaur	kaur	PROPN
dpc-2620	3	49	h	h	PROPN
dpc-2620	3	50	,	,	PUNCT
dpc-2620	3	51	sharma	sharma	PROPN
dpc-2620	3	52	h	h	PROPN
dpc-2620	3	53	,	,	PUNCT
dpc-2620	3	54	parsad	parsad	PROPN
dpc-2620	3	55	d	d	PROPN
dpc-2620	3	56	,	,	PUNCT
dpc-2620	3	57	kumar	kumar	PROPN
dpc-2620	3	58	r.	r.	PROPN
dpc-2620	3	59	lenalidomide	lenalidomide	PROPN
dpc-2620	3	60	augments	augment	VERB
dpc-2620	3	61	differentiation	differentiation	NOUN
dpc-2620	3	62	of	of	ADP
dpc-2620	3	63	cultured	cultured	ADJ
dpc-2620	3	64	hair	hair	NOUN
dpc-2620	3	65	follicle	follicle	NOUN
dpc-2620	3	66	derived	derive	VERB
dpc-2620	3	67	melanocyte	melanocyte	NOUN
dpc-2620	3	68	stem	stem	NOUN
dpc-2620	3	69	cells	cell	NOUN
dpc-2620	3	70	into	into	ADP
dpc-2620	3	71	functional	functional	ADJ
dpc-2620	3	72	melanocytes	melanocyte	NOUN
dpc-2620	3	73	.	.	PUNCT
dpc-2620	4	1	dermatol	dermatol	NOUN
dpc-2620	4	2	pract	pract	PROPN
dpc-2620	4	3	concept	concept	NOUN
dpc-2620	4	4	.	.	PUNCT
dpc-2620	5	1	2023;13(2):e2023077	2023;13(2):e2023077	NUM
dpc-2620	5	2	.	.	PUNCT
dpc-2620	5	3	doi	doi	PROPN
dpc-2620	5	4	:	:	PUNCT
dpc-2620	5	5	https://doi.org/10.5826/dpc.1302a77	https://doi.org/10.5826/dpc.1302a77	PROPN
dpc-2620	5	6	accepted	accept	VERB
dpc-2620	5	7	:	:	PUNCT
dpc-2620	5	8	september	september	PROPN
dpc-2620	5	9	3	3	NUM
dpc-2620	5	10	,	,	PUNCT
dpc-2620	5	11	2022	2022	NUM
dpc-2620	5	12	;	;	PUNCT
dpc-2620	5	13	published	publish	VERB
dpc-2620	5	14	:	:	PUNCT
dpc-2620	6	1	april	april	PROPN
dpc-2620	6	2	2023	2023	NUM
dpc-2620	6	3	copyright	copyright	NOUN
dpc-2620	6	4	:	:	PUNCT
dpc-2620	6	5	©	©	PROPN
dpc-2620	6	6	2023	2023	NUM
dpc-2620	6	7	kumari	kumari	PROPN
dpc-2620	6	8	et	et	PROPN
dpc-2620	6	9	al	al	PROPN
dpc-2620	6	10	.	.	PUNCT
dpc-2620	7	1	this	this	PRON
dpc-2620	7	2	is	be	AUX
dpc-2620	7	3	an	an	DET
dpc-2620	7	4	open	open	ADJ
dpc-2620	7	5	-	-	PUNCT
dpc-2620	7	6	access	access	NOUN
dpc-2620	7	7	article	article	NOUN
dpc-2620	7	8	distributed	distribute	VERB
dpc-2620	7	9	under	under	ADP
dpc-2620	7	10	the	the	DET
dpc-2620	7	11	terms	term	NOUN
dpc-2620	7	12	of	of	ADP
dpc-2620	7	13	the	the	DET
dpc-2620	7	14	creative	creative	ADJ
dpc-2620	7	15	commons	common	NOUN
dpc-2620	7	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-2620	7	17	license	license	NOUN
dpc-2620	7	18	(	(	PUNCT
dpc-2620	7	19	by	by	ADP
dpc-2620	7	20	-	-	PUNCT
dpc-2620	7	21	nc-4.0	nc-4.0	NOUN
dpc-2620	7	22	)	)	PUNCT
dpc-2620	7	23	,	,	PUNCT
dpc-2620	7	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-2620	7	25	,	,	PUNCT
dpc-2620	7	26	which	which	PRON
dpc-2620	7	27	permits	permit	VERB
dpc-2620	7	28	unrestricted	unrestricted	ADJ
dpc-2620	7	29	noncommercial	noncommercial	ADJ
dpc-2620	7	30	use	use	NOUN
dpc-2620	7	31	,	,	PUNCT
dpc-2620	7	32	distribution	distribution	NOUN
dpc-2620	7	33	,	,	PUNCT
dpc-2620	7	34	and	and	CCONJ
dpc-2620	7	35	reproduction	reproduction	NOUN
dpc-2620	7	36	in	in	ADP
dpc-2620	7	37	any	any	DET
dpc-2620	7	38	medium	medium	NOUN
dpc-2620	7	39	,	,	PUNCT
dpc-2620	7	40	provided	provide	VERB
dpc-2620	7	41	the	the	DET
dpc-2620	7	42	original	original	ADJ
dpc-2620	7	43	authors	author	NOUN
dpc-2620	7	44	and	and	CCONJ
dpc-2620	7	45	source	source	NOUN
dpc-2620	7	46	are	be	AUX
dpc-2620	7	47	credited	credit	VERB
dpc-2620	7	48	.	.	PUNCT
dpc-2620	8	1	funding	funding	NOUN
dpc-2620	8	2	:	:	PUNCT
dpc-2620	8	3	none	none	NOUN
dpc-2620	8	4	.	.	PUNCT
dpc-2620	9	1	competing	compete	VERB
dpc-2620	9	2	interests	interest	NOUN
dpc-2620	9	3	:	:	PUNCT
dpc-2620	9	4	none	none	NOUN
dpc-2620	9	5	.	.	PUNCT
dpc-2620	10	1	authorship	authorship	NOUN
dpc-2620	10	2	:	:	PUNCT
dpc-2620	10	3	all	all	DET
dpc-2620	10	4	authors	author	NOUN
dpc-2620	10	5	have	have	AUX
dpc-2620	10	6	contributed	contribute	VERB
dpc-2620	10	7	significantly	significantly	ADV
dpc-2620	10	8	to	to	ADP
dpc-2620	10	9	this	this	DET
dpc-2620	10	10	publication	publication	NOUN
dpc-2620	10	11	.	.	PUNCT
dpc-2620	11	1	corresponding	correspond	VERB
dpc-2620	11	2	author	author	NOUN
dpc-2620	11	3	:	:	PUNCT
dpc-2620	11	4	ravinder	ravinder	PROPN
dpc-2620	11	5	kumar	kumar	PROPN
dpc-2620	11	6	,	,	PUNCT
dpc-2620	11	7	department	department	PROPN
dpc-2620	11	8	of	of	ADP
dpc-2620	11	9	zoology	zoology	PROPN
dpc-2620	11	10	,	,	PUNCT
dpc-2620	11	11	panjab	panjab	PROPN
dpc-2620	11	12	university	university	PROPN
dpc-2620	11	13	,	,	PUNCT
dpc-2620	11	14	chandigarh	chandigarh	NOUN
dpc-2620	11	15	,	,	PUNCT
dpc-2620	11	16	india-160014	india-160014	NOUN
dpc-2620	11	17	.	.	PUNCT
dpc-2620	12	1	e	e	X
dpc-2620	12	2	-	-	NOUN
dpc-2620	12	3	mail	mail	NOUN
dpc-2620	12	4	:	:	PUNCT
dpc-2620	12	5	ravinder03@gmail.com/ravinder@pu.ac.in	ravinder03@gmail.com/ravinder@pu.ac.in	NOUN
dpc-2620	12	6	introduction	introduction	NOUN
dpc-2620	12	7	:	:	PUNCT
dpc-2620	12	8	melanocyte	melanocyte	NOUN
dpc-2620	12	9	progenitors	progenitor	NOUN
dpc-2620	12	10	are	be	AUX
dpc-2620	12	11	embryonically	embryonically	ADV
dpc-2620	12	12	derived	derive	VERB
dpc-2620	12	13	from	from	ADP
dpc-2620	12	14	the	the	DET
dpc-2620	12	15	neural	neural	ADJ
dpc-2620	12	16	crest	crest	NOUN
dpc-2620	12	17	and	and	CCONJ
dpc-2620	12	18	subsequently	subsequently	ADV
dpc-2620	12	19	get	get	AUX
dpc-2620	12	20	localized	localize	VERB
dpc-2620	12	21	in	in	ADP
dpc-2620	12	22	hair	hair	NOUN
dpc-2620	12	23	follicles	follicle	NOUN
dpc-2620	12	24	and	and	CCONJ
dpc-2620	12	25	epidermis	epidermis	NOUN
dpc-2620	12	26	to	to	PART
dpc-2620	12	27	provide	provide	VERB
dpc-2620	12	28	hair	hair	NOUN
dpc-2620	12	29	and	and	CCONJ
dpc-2620	12	30	skin	skin	NOUN
dpc-2620	12	31	pigmentation	pigmentation	NOUN
dpc-2620	12	32	.	.	PUNCT
dpc-2620	13	1	these	these	DET
dpc-2620	13	2	progenitor	progenitor	NOUN
dpc-2620	13	3	cells	cell	NOUN
dpc-2620	13	4	in	in	ADP
dpc-2620	13	5	hair	hair	NOUN
dpc-2620	13	6	follicles	follicle	VERB
dpc-2620	13	7	repeatedly	repeatedly	ADV
dpc-2620	13	8	proliferate	proliferate	VERB
dpc-2620	13	9	and	and	CCONJ
dpc-2620	13	10	differentiate	differentiate	VERB
dpc-2620	13	11	to	to	PART
dpc-2620	13	12	maintain	maintain	VERB
dpc-2620	13	13	pigmentation	pigmentation	NOUN
dpc-2620	13	14	.	.	PUNCT
dpc-2620	14	1	vitiligo	vitiligo	VERB
dpc-2620	14	2	,	,	PUNCT
dpc-2620	14	3	a	a	DET
dpc-2620	14	4	pigmentary	pigmentary	ADJ
dpc-2620	14	5	disorder	disorder	NOUN
dpc-2620	14	6	,	,	PUNCT
dpc-2620	14	7	is	be	AUX
dpc-2620	14	8	associated	associate	VERB
dpc-2620	14	9	with	with	ADP
dpc-2620	14	10	loss	loss	NOUN
dpc-2620	14	11	of	of	ADP
dpc-2620	14	12	melanocytes	melanocyte	NOUN
dpc-2620	14	13	.	.	PUNCT
dpc-2620	15	1	repigmentation	repigmentation	NOUN
dpc-2620	15	2	of	of	ADP
dpc-2620	15	3	vitiligo	vitiligo	ADJ
dpc-2620	15	4	lesions	lesion	NOUN
dpc-2620	15	5	mainly	mainly	ADV
dpc-2620	15	6	depends	depend	VERB
dpc-2620	15	7	upon	upon	SCONJ
dpc-2620	15	8	the	the	DET
dpc-2620	15	9	proliferation	proliferation	NOUN
dpc-2620	15	10	,	,	PUNCT
dpc-2620	15	11	migration	migration	NOUN
dpc-2620	15	12	and	and	CCONJ
dpc-2620	15	13	differentiation	differentiation	NOUN
dpc-2620	15	14	of	of	ADP
dpc-2620	15	15	melanocyte	melanocyte	NOUN
dpc-2620	15	16	stem	stem	NOUN
dpc-2620	15	17	cells	cell	NOUN
dpc-2620	15	18	(	(	PUNCT
dpc-2620	15	19	melscs	melsc	NOUN
dpc-2620	15	20	)	)	PUNCT
dpc-2620	15	21	into	into	ADP
dpc-2620	15	22	functional	functional	ADJ
dpc-2620	15	23	melanocytes	melanocyte	NOUN
dpc-2620	15	24	.	.	PUNCT
dpc-2620	16	1	the	the	DET
dpc-2620	16	2	current	current	ADJ
dpc-2620	16	3	study	study	NOUN
dpc-2620	16	4	is	be	AUX
dpc-2620	16	5	designed	design	VERB
dpc-2620	16	6	to	to	PART
dpc-2620	16	7	check	check	VERB
dpc-2620	16	8	the	the	DET
dpc-2620	16	9	efficacy	efficacy	NOUN
dpc-2620	16	10	of	of	ADP
dpc-2620	16	11	lenalidomide	lenalidomide	NOUN
dpc-2620	16	12	,	,	PUNCT
dpc-2620	16	13	an	an	DET
dpc-2620	16	14	imide	imide	ADJ
dpc-2620	16	15	drug	drug	NOUN
dpc-2620	16	16	in	in	ADP
dpc-2620	16	17	the	the	DET
dpc-2620	16	18	differentiation	differentiation	NOUN
dpc-2620	16	19	of	of	ADP
dpc-2620	16	20	melscs	melsc	NOUN
dpc-2620	16	21	into	into	ADP
dpc-2620	16	22	functional	functional	ADJ
dpc-2620	16	23	melanocytes	melanocyte	NOUN
dpc-2620	16	24	.	.	PUNCT
dpc-2620	17	1	objectives	objective	NOUN
dpc-2620	17	2	:	:	PUNCT
dpc-2620	17	3	the	the	DET
dpc-2620	17	4	aim	aim	NOUN
dpc-2620	17	5	of	of	ADP
dpc-2620	17	6	the	the	DET
dpc-2620	17	7	study	study	NOUN
dpc-2620	17	8	is	be	AUX
dpc-2620	17	9	to	to	PART
dpc-2620	17	10	check	check	VERB
dpc-2620	17	11	the	the	DET
dpc-2620	17	12	effect	effect	NOUN
dpc-2620	17	13	of	of	ADP
dpc-2620	17	14	lenalidomide	lenalidomide	NOUN
dpc-2620	17	15	in	in	ADP
dpc-2620	17	16	the	the	DET
dpc-2620	17	17	proliferation	proliferation	NOUN
dpc-2620	17	18	,	,	PUNCT
dpc-2620	17	19	migration	migration	NOUN
dpc-2620	17	20	of	of	ADP
dpc-2620	17	21	cultured	cultured	ADJ
dpc-2620	17	22	hair	hair	NOUN
dpc-2620	17	23	follicle	follicle	NOUN
dpc-2620	17	24	derived	derive	VERB
dpc-2620	17	25	melanocyte	melanocyte	NOUN
dpc-2620	17	26	stem	stem	NOUN
dpc-2620	17	27	cells	cell	NOUN
dpc-2620	17	28	and	and	CCONJ
dpc-2620	17	29	their	their	PRON
dpc-2620	17	30	differentiation	differentiation	NOUN
dpc-2620	17	31	into	into	ADP
dpc-2620	17	32	functional	functional	ADJ
dpc-2620	17	33	melanocytes	melanocyte	NOUN
dpc-2620	17	34	.	.	PUNCT
dpc-2620	18	1	methods	method	NOUN
dpc-2620	18	2	:	:	PUNCT
dpc-2620	18	3	primary	primary	ADJ
dpc-2620	18	4	culture	culture	NOUN
dpc-2620	18	5	of	of	ADP
dpc-2620	18	6	melscs	melsc	NOUN
dpc-2620	18	7	was	be	AUX
dpc-2620	18	8	established	establish	VERB
dpc-2620	18	9	from	from	ADP
dpc-2620	18	10	whisker	whisker	NOUN
dpc-2620	18	11	hair	hair	NOUN
dpc-2620	18	12	of	of	ADP
dpc-2620	18	13	c57bl/6	c57bl/6	NOUN
dpc-2620	18	14	mice	mouse	NOUN
dpc-2620	18	15	.	.	PUNCT
dpc-2620	19	1	proliferation	proliferation	NOUN
dpc-2620	19	2	and	and	CCONJ
dpc-2620	19	3	migration	migration	NOUN
dpc-2620	19	4	of	of	ADP
dpc-2620	19	5	cultured	cultured	ADJ
dpc-2620	19	6	cells	cell	NOUN
dpc-2620	19	7	were	be	AUX
dpc-2620	19	8	done	do	VERB
dpc-2620	19	9	by	by	ADP
dpc-2620	19	10	mtt	mtt	NOUN
dpc-2620	19	11	assay	assay	NOUN
dpc-2620	19	12	and	and	CCONJ
dpc-2620	19	13	boyden	boyden	PROPN
dpc-2620	19	14	’s	’s	PROPN
dpc-2620	19	15	chamber	chamber	PROPN
dpc-2620	19	16	migration	migration	NOUN
dpc-2620	19	17	assay	assay	NOUN
dpc-2620	19	18	,	,	PUNCT
dpc-2620	19	19	respectively	respectively	ADV
dpc-2620	19	20	.	.	PUNCT
dpc-2620	20	1	effect	effect	NOUN
dpc-2620	20	2	of	of	ADP
dpc-2620	20	3	lenalidomide	lenalidomide	NOUN
dpc-2620	20	4	on	on	ADP
dpc-2620	20	5	the	the	DET
dpc-2620	20	6	melscs	melscs	ADJ
dpc-2620	20	7	differentiation	differentiation	NOUN
dpc-2620	20	8	was	be	AUX
dpc-2620	20	9	checked	check	VERB
dpc-2620	20	10	at	at	ADP
dpc-2620	20	11	gene	gene	NOUN
dpc-2620	20	12	level	level	NOUN
dpc-2620	20	13	by	by	ADP
dpc-2620	20	14	qpcr	qpcr	ADJ
dpc-2620	20	15	and	and	CCONJ
dpc-2620	20	16	protein	protein	NOUN
dpc-2620	20	17	expression	expression	NOUN
dpc-2620	20	18	was	be	AUX
dpc-2620	20	19	checked	check	VERB
dpc-2620	20	20	by	by	ADP
dpc-2620	20	21	immunocytochemistry	immunocytochemistry	PROPN
dpc-2620	20	22	.	.	PUNCT
dpc-2620	21	1	results	result	VERB
dpc-2620	21	2	:	:	PUNCT
dpc-2620	21	3	a	a	DET
dpc-2620	21	4	significant	significant	ADJ
dpc-2620	21	5	increase	increase	NOUN
dpc-2620	21	6	in	in	ADP
dpc-2620	21	7	the	the	DET
dpc-2620	21	8	migration	migration	NOUN
dpc-2620	21	9	of	of	ADP
dpc-2620	21	10	melscs	melsc	NOUN
dpc-2620	21	11	in	in	ADP
dpc-2620	21	12	comparison	comparison	NOUN
dpc-2620	21	13	to	to	ADP
dpc-2620	21	14	control	control	NOUN
dpc-2620	21	15	was	be	AUX
dpc-2620	21	16	also	also	ADV
dpc-2620	21	17	observed	observe	VERB
dpc-2620	21	18	.	.	PUNCT
dpc-2620	22	1	lenalidomide	lenalidomide	NOUN
dpc-2620	22	2	treatment	treatment	NOUN
dpc-2620	22	3	significantly	significantly	ADV
dpc-2620	22	4	increased	increase	VERB
dpc-2620	22	5	the	the	DET
dpc-2620	22	6	expression	expression	NOUN
dpc-2620	22	7	of	of	ADP
dpc-2620	22	8	melanocyte	melanocyte	ADJ
dpc-2620	22	9	specific	specific	ADJ
dpc-2620	22	10	genes	gene	NOUN
dpc-2620	22	11	in	in	ADP
dpc-2620	22	12	cultured	cultured	ADJ
dpc-2620	22	13	melscs	melsc	NOUN
dpc-2620	22	14	as	as	SCONJ
dpc-2620	22	15	compared	compare	VERB
dpc-2620	22	16	to	to	ADP
dpc-2620	22	17	control	control	NOUN
dpc-2620	22	18	.	.	PUNCT
dpc-2620	23	1	conclusions	conclusion	NOUN
dpc-2620	23	2	:	:	PUNCT
dpc-2620	23	3	from	from	ADP
dpc-2620	23	4	the	the	DET
dpc-2620	23	5	results	result	NOUN
dpc-2620	23	6	we	we	PRON
dpc-2620	23	7	concluded	conclude	VERB
dpc-2620	23	8	that	that	SCONJ
dpc-2620	23	9	lenalidomide	lenalidomide	AUX
dpc-2620	23	10	induce	induce	VERB
dpc-2620	23	11	the	the	DET
dpc-2620	23	12	proliferation	proliferation	NOUN
dpc-2620	23	13	and	and	CCONJ
dpc-2620	23	14	migration	migration	NOUN
dpc-2620	23	15	of	of	ADP
dpc-2620	23	16	melscs	melsc	NOUN
dpc-2620	23	17	and	and	CCONJ
dpc-2620	23	18	accelerate	accelerate	VERB
dpc-2620	23	19	the	the	DET
dpc-2620	23	20	differentiation	differentiation	NOUN
dpc-2620	23	21	of	of	ADP
dpc-2620	23	22	melscs	melsc	NOUN
dpc-2620	23	23	into	into	ADP
dpc-2620	23	24	functional	functional	ADJ
dpc-2620	23	25	melanocytes	melanocyte	NOUN
dpc-2620	23	26	.	.	PUNCT
dpc-2620	24	1	abstract	abstract	ADJ
dpc-2620	24	2	2	2	NUM
dpc-2620	24	3	original	original	ADJ
dpc-2620	24	4	article	article	NOUN
dpc-2620	24	5	|	|	ADV
dpc-2620	24	6	dermatol	dermatol	ADJ
dpc-2620	24	7	pract	pract	NOUN
dpc-2620	24	8	concept	concept	NOUN
dpc-2620	24	9	.	.	PUNCT
dpc-2620	25	1	2023;13(2):e2023077	2023;13(2):e2023077	NUM
dpc-2620	25	2	introduction	introduction	NOUN
dpc-2620	25	3	hair	hair	NOUN
dpc-2620	25	4	follicle	follicle	NOUN
dpc-2620	25	5	melanocyte	melanocyte	NOUN
dpc-2620	25	6	stem	stem	NOUN
dpc-2620	25	7	cells	cell	NOUN
dpc-2620	25	8	(	(	PUNCT
dpc-2620	25	9	melscs	melsc	NOUN
dpc-2620	25	10	)	)	PUNCT
dpc-2620	25	11	are	be	AUX
dpc-2620	25	12	present	present	ADJ
dpc-2620	25	13	in	in	ADP
dpc-2620	25	14	bulge	bulge	PROPN
dpc-2620	25	15	or	or	CCONJ
dpc-2620	25	16	sub	sub	ADJ
dpc-2620	25	17	-	-	ADJ
dpc-2620	25	18	bulge	bulge	NOUN
dpc-2620	25	19	regions	region	NOUN
dpc-2620	25	20	of	of	ADP
dpc-2620	25	21	hair	hair	NOUN
dpc-2620	25	22	and	and	CCONJ
dpc-2620	25	23	are	be	AUX
dpc-2620	25	24	important	important	ADJ
dpc-2620	25	25	reservoirs	reservoir	NOUN
dpc-2620	25	26	of	of	ADP
dpc-2620	25	27	melanocytes	melanocyte	NOUN
dpc-2620	25	28	.	.	PUNCT
dpc-2620	26	1	they	they	PRON
dpc-2620	26	2	persist	persist	VERB
dpc-2620	26	3	as	as	ADP
dpc-2620	26	4	self	self	NOUN
dpc-2620	26	5	-	-	PUNCT
dpc-2620	26	6	renewing	renew	VERB
dpc-2620	26	7	cells	cell	NOUN
dpc-2620	26	8	and	and	CCONJ
dpc-2620	26	9	play	play	VERB
dpc-2620	26	10	a	a	DET
dpc-2620	26	11	very	very	ADV
dpc-2620	26	12	significant	significant	ADJ
dpc-2620	26	13	role	role	NOUN
dpc-2620	26	14	in	in	ADP
dpc-2620	26	15	the	the	DET
dpc-2620	26	16	pigmentation	pigmentation	NOUN
dpc-2620	26	17	of	of	ADP
dpc-2620	26	18	hair	hair	NOUN
dpc-2620	26	19	and	and	CCONJ
dpc-2620	26	20	skin	skin	NOUN
dpc-2620	26	21	[	[	X
dpc-2620	26	22	1	1	NUM
dpc-2620	26	23	]	]	PUNCT
dpc-2620	26	24	.	.	PUNCT
dpc-2620	27	1	they	they	PRON
dpc-2620	27	2	regenerate	regenerate	VERB
dpc-2620	27	3	mature	mature	ADJ
dpc-2620	27	4	melanocytes	melanocyte	NOUN
dpc-2620	27	5	for	for	ADP
dpc-2620	27	6	hair	hair	NOUN
dpc-2620	27	7	and	and	CCONJ
dpc-2620	27	8	skin	skin	NOUN
dpc-2620	27	9	in	in	ADP
dpc-2620	27	10	response	response	NOUN
dpc-2620	27	11	to	to	ADP
dpc-2620	27	12	some	some	DET
dpc-2620	27	13	kind	kind	NOUN
dpc-2620	27	14	of	of	ADP
dpc-2620	27	15	melanocyte	melanocyte	ADJ
dpc-2620	27	16	loss	loss	NOUN
dpc-2620	27	17	under	under	ADP
dpc-2620	27	18	normal	normal	ADJ
dpc-2620	27	19	conditions	condition	NOUN
dpc-2620	27	20	and	and	CCONJ
dpc-2620	27	21	ultimately	ultimately	ADV
dpc-2620	27	22	maintain	maintain	VERB
dpc-2620	27	23	the	the	DET
dpc-2620	27	24	pigmentation	pigmentation	NOUN
dpc-2620	27	25	 	 	SPACE
dpc-2620	28	1	[	[	X
dpc-2620	28	2	2	2	NUM
dpc-2620	28	3	]	]	PUNCT
dpc-2620	28	4	.	.	PUNCT
dpc-2620	29	1	the	the	DET
dpc-2620	29	2	regeneration	regeneration	NOUN
dpc-2620	29	3	of	of	ADP
dpc-2620	29	4	functional	functional	ADJ
dpc-2620	29	5	melanocytes	melanocyte	NOUN
dpc-2620	29	6	is	be	AUX
dpc-2620	29	7	influenced	influence	VERB
dpc-2620	29	8	by	by	ADP
dpc-2620	29	9	activation	activation	NOUN
dpc-2620	29	10	,	,	PUNCT
dpc-2620	29	11	proliferation	proliferation	NOUN
dpc-2620	29	12	and	and	CCONJ
dpc-2620	29	13	differentiation	differentiation	NOUN
dpc-2620	29	14	of	of	ADP
dpc-2620	29	15	these	these	DET
dpc-2620	29	16	melscs	melsc	NOUN
dpc-2620	29	17	 	 	SPACE
dpc-2620	30	1	[	[	X
dpc-2620	30	2	3	3	NUM
dpc-2620	30	3	]	]	PUNCT
dpc-2620	30	4	.	.	PUNCT
dpc-2620	31	1	loss	loss	NOUN
dpc-2620	31	2	of	of	ADP
dpc-2620	31	3	functional	functional	ADJ
dpc-2620	31	4	melanocytes	melanocyte	NOUN
dpc-2620	31	5	causes	cause	VERB
dpc-2620	31	6	skin	skin	NOUN
dpc-2620	31	7	depigmentation	depigmentation	NOUN
dpc-2620	31	8	and	and	CCONJ
dpc-2620	31	9	thus	thus	ADV
dpc-2620	31	10	leads	lead	VERB
dpc-2620	31	11	to	to	ADP
dpc-2620	31	12	depigmentory	depigmentory	ADJ
dpc-2620	31	13	disorders	disorder	NOUN
dpc-2620	31	14	like	like	ADP
dpc-2620	31	15	vitiligo	vitiligo	NOUN
dpc-2620	31	16	[	[	X
dpc-2620	31	17	4,5	4,5	NUM
dpc-2620	31	18	]	]	PUNCT
dpc-2620	31	19	.	.	PUNCT
dpc-2620	32	1	vitiligo	vitiligo	PROPN
dpc-2620	32	2	is	be	AUX
dpc-2620	32	3	an	an	DET
dpc-2620	32	4	autoimmune	autoimmune	ADJ
dpc-2620	32	5	cutaneous	cutaneous	ADJ
dpc-2620	32	6	disorder	disorder	NOUN
dpc-2620	32	7	that	that	PRON
dpc-2620	32	8	has	have	VERB
dpc-2620	32	9	grave	grave	ADJ
dpc-2620	32	10	psychosocial	psychosocial	ADJ
dpc-2620	32	11	impact	impact	NOUN
dpc-2620	32	12	on	on	ADP
dpc-2620	32	13	the	the	DET
dpc-2620	32	14	patient	patient	NOUN
dpc-2620	32	15	’s	’s	PART
dpc-2620	32	16	quality	quality	NOUN
dpc-2620	32	17	of	of	ADP
dpc-2620	32	18	life	life	NOUN
dpc-2620	32	19	[	[	X
dpc-2620	32	20	6	6	NUM
dpc-2620	32	21	]	]	PUNCT
dpc-2620	32	22	.	.	PUNCT
dpc-2620	33	1	the	the	DET
dpc-2620	33	2	mechanism	mechanism	NOUN
dpc-2620	33	3	of	of	ADP
dpc-2620	33	4	melanocyte	melanocyte	NOUN
dpc-2620	33	5	disappearance	disappearance	NOUN
dpc-2620	33	6	in	in	ADP
dpc-2620	33	7	this	this	DET
dpc-2620	33	8	disease	disease	NOUN
dpc-2620	33	9	still	still	ADV
dpc-2620	33	10	remains	remain	VERB
dpc-2620	33	11	unclear	unclear	ADJ
dpc-2620	33	12	[	[	X
dpc-2620	33	13	7	7	NUM
dpc-2620	33	14	]	]	PUNCT
dpc-2620	33	15	.	.	PUNCT
dpc-2620	34	1	several	several	ADJ
dpc-2620	34	2	treatment	treatment	NOUN
dpc-2620	34	3	modalities	modality	NOUN
dpc-2620	34	4	are	be	AUX
dpc-2620	34	5	available	available	ADJ
dpc-2620	34	6	like	like	ADP
dpc-2620	34	7	the	the	DET
dpc-2620	34	8	conventional	conventional	ADJ
dpc-2620	34	9	medical	medical	ADJ
dpc-2620	34	10	,	,	PUNCT
dpc-2620	34	11	surgical	surgical	ADJ
dpc-2620	34	12	and	and	CCONJ
dpc-2620	34	13	physical	physical	ADJ
dpc-2620	34	14	means	mean	NOUN
dpc-2620	34	15	but	but	CCONJ
dpc-2620	34	16	none	none	NOUN
dpc-2620	34	17	are	be	AUX
dpc-2620	34	18	completely	completely	ADV
dpc-2620	34	19	satisfactory	satisfactory	ADJ
dpc-2620	34	20	.	.	PUNCT
dpc-2620	35	1	in	in	ADP
dpc-2620	35	2	the	the	DET
dpc-2620	35	3	depigmented	depigmented	ADJ
dpc-2620	35	4	patches	patch	NOUN
dpc-2620	35	5	there	there	PRON
dpc-2620	35	6	is	be	VERB
dpc-2620	35	7	a	a	DET
dpc-2620	35	8	loss	loss	NOUN
dpc-2620	35	9	of	of	ADP
dpc-2620	35	10	functional	functional	ADJ
dpc-2620	35	11	melanocytes	melanocyte	NOUN
dpc-2620	35	12	but	but	CCONJ
dpc-2620	35	13	hair	hair	NOUN
dpc-2620	35	14	follicle	follicle	NOUN
dpc-2620	35	15	melscs	melsc	NOUN
dpc-2620	35	16	are	be	AUX
dpc-2620	35	17	preserved	preserve	VERB
dpc-2620	35	18	.	.	PUNCT
dpc-2620	36	1	therefore	therefore	ADV
dpc-2620	36	2	this	this	DET
dpc-2620	36	3	original	original	ADJ
dpc-2620	36	4	source	source	NOUN
dpc-2620	36	5	of	of	ADP
dpc-2620	36	6	regeneration	regeneration	NOUN
dpc-2620	36	7	in	in	ADP
dpc-2620	36	8	the	the	DET
dpc-2620	36	9	hair	hair	NOUN
dpc-2620	36	10	follicle	follicle	NOUN
dpc-2620	36	11	bulge	bulge	PROPN
dpc-2620	36	12	is	be	AUX
dpc-2620	36	13	being	be	AUX
dpc-2620	36	14	targeted	target	VERB
dpc-2620	36	15	to	to	ADP
dpc-2620	36	16	repopulates	repopulate	VERB
dpc-2620	36	17	the	the	DET
dpc-2620	36	18	vitiligo	vitiligo	NOUN
dpc-2620	36	19	-	-	PUNCT
dpc-2620	36	20	depigmented	depigmente	VERB
dpc-2620	36	21	epidermis	epidermis	NOUN
dpc-2620	36	22	with	with	ADP
dpc-2620	36	23	melanocytes	melanocyte	NOUN
dpc-2620	36	24	[	[	X
dpc-2620	36	25	8	8	NUM
dpc-2620	36	26	]	]	PUNCT
dpc-2620	36	27	.	.	PUNCT
dpc-2620	37	1	various	various	ADJ
dpc-2620	37	2	studies	study	NOUN
dpc-2620	37	3	have	have	AUX
dpc-2620	37	4	shown	show	VERB
dpc-2620	37	5	that	that	SCONJ
dpc-2620	37	6	melscs	melscs	NOUN
dpc-2620	37	7	in	in	ADP
dpc-2620	37	8	the	the	DET
dpc-2620	37	9	outer	outer	ADJ
dpc-2620	37	10	root	root	NOUN
dpc-2620	37	11	sheath	sheath	NOUN
dpc-2620	37	12	played	play	VERB
dpc-2620	37	13	important	important	ADJ
dpc-2620	37	14	part	part	NOUN
dpc-2620	37	15	in	in	ADP
dpc-2620	37	16	the	the	DET
dpc-2620	37	17	epidermal	epidermal	ADJ
dpc-2620	37	18	follicular	follicular	ADJ
dpc-2620	37	19	repigmentation	repigmentation	NOUN
dpc-2620	37	20	.	.	PUNCT
dpc-2620	38	1	however	however	ADV
dpc-2620	38	2	the	the	DET
dpc-2620	38	3	activation	activation	NOUN
dpc-2620	38	4	,	,	PUNCT
dpc-2620	38	5	proliferation	proliferation	NOUN
dpc-2620	38	6	,	,	PUNCT
dpc-2620	38	7	migration	migration	NOUN
dpc-2620	38	8	and	and	CCONJ
dpc-2620	38	9	differentiation	differentiation	NOUN
dpc-2620	38	10	of	of	ADP
dpc-2620	38	11	melscs	melsc	NOUN
dpc-2620	38	12	from	from	ADP
dpc-2620	38	13	the	the	DET
dpc-2620	38	14	outer	outer	ADJ
dpc-2620	38	15	root	root	NOUN
dpc-2620	38	16	sheath	sheath	NOUN
dpc-2620	38	17	of	of	ADP
dpc-2620	38	18	the	the	DET
dpc-2620	38	19	hair	hair	NOUN
dpc-2620	38	20	follicle	follicle	NOUN
dpc-2620	38	21	require	require	VERB
dpc-2620	38	22	more	more	ADV
dpc-2620	38	23	novel	novel	ADJ
dpc-2620	38	24	and	and	CCONJ
dpc-2620	38	25	effective	effective	ADJ
dpc-2620	38	26	strategies	strategy	NOUN
dpc-2620	38	27	.	.	PUNCT
dpc-2620	39	1	here	here	ADV
dpc-2620	39	2	we	we	PRON
dpc-2620	39	3	aimed	aim	VERB
dpc-2620	39	4	at	at	ADP
dpc-2620	39	5	investigating	investigate	VERB
dpc-2620	39	6	the	the	DET
dpc-2620	39	7	potential	potential	ADJ
dpc-2620	39	8	therapeutic	therapeutic	ADJ
dpc-2620	39	9	efficacy	efficacy	NOUN
dpc-2620	39	10	of	of	ADP
dpc-2620	39	11	lenalidomide	lenalidomide	NOUN
dpc-2620	39	12	as	as	ADP
dpc-2620	39	13	the	the	DET
dpc-2620	39	14	possible	possible	ADJ
dpc-2620	39	15	repigmentation	repigmentation	NOUN
dpc-2620	39	16	strategy	strategy	NOUN
dpc-2620	39	17	.	.	PUNCT
dpc-2620	40	1	lenalidomide	lenalidomide	PROPN
dpc-2620	40	2	is	be	AUX
dpc-2620	40	3	an	an	DET
dpc-2620	40	4	immunomodulatory	immunomodulatory	ADJ
dpc-2620	40	5	drug	drug	NOUN
dpc-2620	40	6	that	that	PRON
dpc-2620	40	7	has	have	AUX
dpc-2620	40	8	shown	show	VERB
dpc-2620	40	9	a	a	DET
dpc-2620	40	10	clinical	clinical	ADJ
dpc-2620	40	11	effect	effect	NOUN
dpc-2620	40	12	in	in	ADP
dpc-2620	40	13	several	several	ADJ
dpc-2620	40	14	autoimmune	autoimmune	ADJ
dpc-2620	40	15	and	and	CCONJ
dpc-2620	40	16	inflammatory	inflammatory	ADJ
dpc-2620	40	17	disorders	disorder	NOUN
dpc-2620	40	18	.	.	PUNCT
dpc-2620	41	1	recently	recently	ADV
dpc-2620	41	2	,	,	PUNCT
dpc-2620	41	3	its	its	PRON
dpc-2620	41	4	effect	effect	NOUN
dpc-2620	41	5	was	be	AUX
dpc-2620	41	6	observed	observe	VERB
dpc-2620	41	7	as	as	ADP
dpc-2620	41	8	the	the	DET
dpc-2620	41	9	hyperpigmentation	hyperpigmentation	NOUN
dpc-2620	41	10	of	of	ADP
dpc-2620	41	11	skin	skin	NOUN
dpc-2620	41	12	in	in	ADP
dpc-2620	41	13	black	black	ADJ
dpc-2620	41	14	/	/	SYM
dpc-2620	41	15	african	african	ADJ
dpc-2620	41	16	-	-	PUNCT
dpc-2620	41	17	american	american	ADJ
dpc-2620	41	18	patients	patient	NOUN
dpc-2620	41	19	suffering	suffer	VERB
dpc-2620	41	20	from	from	ADP
dpc-2620	41	21	multiple	multiple	ADJ
dpc-2620	41	22	myeloma	myeloma	NOUN
dpc-2620	41	23	[	[	X
dpc-2620	41	24	9	9	NUM
dpc-2620	41	25	]	]	PUNCT
dpc-2620	41	26	.	.	PUNCT
dpc-2620	42	1	interestingly	interestingly	ADV
dpc-2620	42	2	,	,	PUNCT
dpc-2620	42	3	in	in	ADP
dpc-2620	42	4	a	a	DET
dpc-2620	42	5	case	case	NOUN
dpc-2620	42	6	study	study	NOUN
dpc-2620	42	7	it	it	PRON
dpc-2620	42	8	also	also	ADV
dpc-2620	42	9	led	lead	VERB
dpc-2620	42	10	to	to	ADP
dpc-2620	42	11	progressive	progressive	ADJ
dpc-2620	42	12	hair	hair	NOUN
dpc-2620	42	13	repigmentation	repigmentation	NOUN
dpc-2620	42	14	in	in	ADP
dpc-2620	42	15	an	an	DET
dpc-2620	42	16	old	old	ADJ
dpc-2620	42	17	multiple	multiple	ADJ
dpc-2620	42	18	myeloma	myeloma	NOUN
dpc-2620	42	19	patient	patient	NOUN
dpc-2620	43	1	[	[	X
dpc-2620	43	2	10	10	NUM
dpc-2620	43	3	]	]	PUNCT
dpc-2620	43	4	.	.	PUNCT
dpc-2620	44	1	pervaiz	pervaiz	PROPN
dpc-2620	44	2	et	et	PROPN
dpc-2620	44	3	al	al	PROPN
dpc-2620	44	4	 	 	SPACE
dpc-2620	45	1	[	[	X
dpc-2620	45	2	11	11	NUM
dpc-2620	45	3	]	]	PUNCT
dpc-2620	45	4	also	also	ADV
dpc-2620	45	5	reported	report	VERB
dpc-2620	45	6	the	the	DET
dpc-2620	45	7	inhibitory	inhibitory	ADJ
dpc-2620	45	8	influence	influence	NOUN
dpc-2620	45	9	of	of	ADP
dpc-2620	45	10	this	this	DET
dpc-2620	45	11	drug	drug	NOUN
dpc-2620	45	12	on	on	ADP
dpc-2620	45	13	the	the	DET
dpc-2620	45	14	progression	progression	NOUN
dpc-2620	45	15	of	of	ADP
dpc-2620	45	16	depigmented	depigmented	ADJ
dpc-2620	45	17	lesions	lesion	NOUN
dpc-2620	45	18	in	in	ADP
dpc-2620	45	19	a	a	DET
dpc-2620	45	20	vitiligo	vitiligo	NOUN
dpc-2620	45	21	mouse	mouse	NOUN
dpc-2620	45	22	model	model	NOUN
dpc-2620	45	23	.	.	PUNCT
dpc-2620	46	1	therefore	therefore	ADV
dpc-2620	46	2	,	,	PUNCT
dpc-2620	46	3	the	the	DET
dpc-2620	46	4	current	current	ADJ
dpc-2620	46	5	study	study	NOUN
dpc-2620	46	6	was	be	AUX
dpc-2620	46	7	designed	design	VERB
dpc-2620	46	8	to	to	PART
dpc-2620	46	9	check	check	VERB
dpc-2620	46	10	the	the	DET
dpc-2620	46	11	role	role	NOUN
dpc-2620	46	12	of	of	ADP
dpc-2620	46	13	lenalidomide	lenalidomide	NOUN
dpc-2620	46	14	on	on	ADP
dpc-2620	46	15	the	the	DET
dpc-2620	46	16	differentiation	differentiation	NOUN
dpc-2620	46	17	of	of	ADP
dpc-2620	46	18	murine	murine	ADJ
dpc-2620	46	19	hair	hair	NOUN
dpc-2620	46	20	follicle	follicle	NOUN
dpc-2620	46	21	derived	derive	VERB
dpc-2620	46	22	melanocyte	melanocyte	NOUN
dpc-2620	46	23	stem	stem	NOUN
dpc-2620	46	24	cells	cell	NOUN
dpc-2620	46	25	into	into	ADP
dpc-2620	46	26	pigment	pigment	NOUN
dpc-2620	46	27	producing	produce	VERB
dpc-2620	46	28	melanocytes	melanocyte	NOUN
dpc-2620	46	29	.	.	PUNCT
dpc-2620	47	1	objectives	objective	VERB
dpc-2620	47	2	the	the	DET
dpc-2620	47	3	aim	aim	NOUN
dpc-2620	47	4	of	of	ADP
dpc-2620	47	5	the	the	DET
dpc-2620	47	6	study	study	NOUN
dpc-2620	47	7	is	be	AUX
dpc-2620	47	8	to	to	PART
dpc-2620	47	9	check	check	VERB
dpc-2620	47	10	the	the	DET
dpc-2620	47	11	effect	effect	NOUN
dpc-2620	47	12	of	of	ADP
dpc-2620	47	13	lenalidomide	lenalidomide	NOUN
dpc-2620	47	14	in	in	ADP
dpc-2620	47	15	the	the	DET
dpc-2620	47	16	proliferation	proliferation	NOUN
dpc-2620	47	17	,	,	PUNCT
dpc-2620	47	18	migration	migration	NOUN
dpc-2620	47	19	of	of	ADP
dpc-2620	47	20	cultured	cultured	ADJ
dpc-2620	47	21	hair	hair	NOUN
dpc-2620	47	22	follicle	follicle	NOUN
dpc-2620	47	23	derived	derive	VERB
dpc-2620	47	24	melanocyte	melanocyte	NOUN
dpc-2620	47	25	stem	stem	NOUN
dpc-2620	47	26	cells	cell	NOUN
dpc-2620	47	27	and	and	CCONJ
dpc-2620	47	28	their	their	PRON
dpc-2620	47	29	differentiation	differentiation	NOUN
dpc-2620	47	30	into	into	ADP
dpc-2620	47	31	functional	functional	ADJ
dpc-2620	47	32	melanocytes	melanocyte	NOUN
dpc-2620	47	33	.	.	PUNCT
dpc-2620	48	1	methods	method	NOUN
dpc-2620	48	2	ethical	ethical	ADJ
dpc-2620	48	3	statement	statement	NOUN
dpc-2620	48	4	the	the	DET
dpc-2620	48	5	study	study	NOUN
dpc-2620	48	6	design	design	NOUN
dpc-2620	48	7	was	be	AUX
dpc-2620	48	8	based	base	VERB
dpc-2620	48	9	on	on	ADP
dpc-2620	48	10	the	the	DET
dpc-2620	48	11	guidelines	guideline	NOUN
dpc-2620	48	12	set	set	VERB
dpc-2620	48	13	by	by	ADP
dpc-2620	48	14	the	the	DET
dpc-2620	48	15	institutional	institutional	ADJ
dpc-2620	48	16	animal	animal	NOUN
dpc-2620	48	17	ethics	ethic	NOUN
dpc-2620	48	18	committee	committee	PROPN
dpc-2620	48	19	,	,	PUNCT
dpc-2620	48	20	panjab	panjab	PROPN
dpc-2620	48	21	university	university	PROPN
dpc-2620	48	22	,	,	PUNCT
dpc-2620	48	23	chandigarh	chandigarh	PROPN
dpc-2620	48	24	,	,	PUNCT
dpc-2620	48	25	india	india	PROPN
dpc-2620	48	26	(	(	PUNCT
dpc-2620	48	27	approval	approval	NOUN
dpc-2620	48	28	no	no	INTJ
dpc-2620	48	29	:	:	PUNCT
dpc-2620	48	30	pu/45/99	pu/45/99	PROPN
dpc-2620	48	31	/	/	SYM
dpc-2620	48	32	cpcsea/	cpcsea/	NUM
dpc-2620	48	33	iaec/2017/31	iaec/2017/31	NOUN
dpc-2620	48	34	)	)	PUNCT
dpc-2620	48	35	.	.	PUNCT
dpc-2620	49	1	c57bl/6	c57bl/6	NOUN
dpc-2620	49	2	mice	mouse	NOUN
dpc-2620	49	3	were	be	AUX
dpc-2620	49	4	maintained	maintain	VERB
dpc-2620	49	5	as	as	ADP
dpc-2620	49	6	per	per	ADP
dpc-2620	49	7	the	the	DET
dpc-2620	49	8	guiding	guide	VERB
dpc-2620	49	9	principles	principle	NOUN
dpc-2620	49	10	of	of	ADP
dpc-2620	49	11	the	the	DET
dpc-2620	49	12	committee	committee	NOUN
dpc-2620	49	13	for	for	ADP
dpc-2620	49	14	the	the	DET
dpc-2620	49	15	purpose	purpose	NOUN
dpc-2620	49	16	of	of	ADP
dpc-2620	49	17	control	control	NOUN
dpc-2620	49	18	and	and	CCONJ
dpc-2620	49	19	supervision	supervision	NOUN
dpc-2620	49	20	of	of	ADP
dpc-2620	49	21	experiments	experiment	NOUN
dpc-2620	49	22	on	on	ADP
dpc-2620	49	23	animals	animal	NOUN
dpc-2620	49	24	(	(	PUNCT
dpc-2620	49	25	cpcsea	cpcsea	NOUN
dpc-2620	49	26	)	)	PUNCT
dpc-2620	49	27	.	.	PUNCT
dpc-2620	50	1	reagents	reagent	VERB
dpc-2620	50	2	the	the	DET
dpc-2620	50	3	reagents	reagent	NOUN
dpc-2620	50	4	used	use	VERB
dpc-2620	50	5	in	in	ADP
dpc-2620	50	6	the	the	DET
dpc-2620	50	7	study	study	NOUN
dpc-2620	50	8	include	include	VERB
dpc-2620	50	9	dulbecco	dulbecco	NOUN
dpc-2620	50	10	’s	’s	PART
dpc-2620	50	11	modified	modify	VERB
dpc-2620	50	12	eagle	eagle	NOUN
dpc-2620	50	13	media	medium	NOUN
dpc-2620	50	14	(	(	PUNCT
dpc-2620	50	15	cat	cat	NOUN
dpc-2620	50	16	.	.	PUNCT
dpc-2620	51	1	no	no	INTJ
dpc-2620	51	2	.	.	PUNCT
dpc-2620	52	1	be12	be12	PROPN
dpc-2620	52	2	-	-	PUNCT
dpc-2620	52	3	604f	604f	PROPN
dpc-2620	52	4	)	)	PUNCT
dpc-2620	52	5	,	,	PUNCT
dpc-2620	52	6	fetal	fetal	ADJ
dpc-2620	52	7	bovine	bovine	NOUN
dpc-2620	52	8	serum	serum	NOUN
dpc-2620	52	9	(	(	PUNCT
dpc-2620	52	10	cat	cat	NOUN
dpc-2620	52	11	.	.	PUNCT
dpc-2620	53	1	no	no	INTJ
dpc-2620	53	2	.	.	NOUN
dpc-2620	54	1	10270106	10270106	NUM
dpc-2620	54	2	)	)	PUNCT
dpc-2620	54	3	,	,	PUNCT
dpc-2620	54	4	and	and	CCONJ
dpc-2620	54	5	recombinant	recombinant	ADJ
dpc-2620	54	6	human	human	ADJ
dpc-2620	54	7	fgf	fgf	NOUN
dpc-2620	54	8	-	-	PUNCT
dpc-2620	54	9	basic	basic	ADJ
dpc-2620	54	10	protein	protein	NOUN
dpc-2620	54	11	(	(	PUNCT
dpc-2620	54	12	cat	cat	NOUN
dpc-2620	54	13	.	.	PUNCT
dpc-2620	55	1	no	no	INTJ
dpc-2620	55	2	.	.	PUNCT
dpc-2620	55	3	phg0264	phg0264	ADJ
dpc-2620	55	4	)	)	PUNCT
dpc-2620	55	5	.	.	PUNCT
dpc-2620	56	1	the	the	DET
dpc-2620	56	2	antibodies	antibody	NOUN
dpc-2620	56	3	include	include	VERB
dpc-2620	56	4	anti	anti	ADJ
dpc-2620	56	5	-	-	ADJ
dpc-2620	56	6	mouse	mouse	ADJ
dpc-2620	56	7	af488	af488	NOUN
dpc-2620	56	8	-	-	PUNCT
dpc-2620	56	9	conjugated	conjugate	VERB
dpc-2620	56	10	cd34	cd34	PROPN
dpc-2620	56	11	(	(	PUNCT
dpc-2620	56	12	cat	cat	NOUN
dpc-2620	56	13	.	.	PUNCT
dpc-2620	57	1	no	no	INTJ
dpc-2620	57	2	.	.	PUNCT
dpc-2620	57	3	  	  	SPACE
dpc-2620	58	1	sc-7324af488	sc-7324af488	NOUN
dpc-2620	58	2	)	)	PUNCT
dpc-2620	58	3	,	,	PUNCT
dpc-2620	58	4	peconjugated	peconjugate	VERB
dpc-2620	58	5	trp2/	trp2/	VERB
dpc-2620	58	6	dct	dct	PROPN
dpc-2620	58	7	(	(	PUNCT
dpc-2620	58	8	cat.no	cat.no	NOUN
dpc-2620	58	9	.	.	PUNCT
dpc-2620	59	1	sc-74439pe	sc-74439pe	NOUN
dpc-2620	59	2	)	)	PUNCT
dpc-2620	59	3	,	,	PUNCT
dpc-2620	59	4	primary	primary	ADJ
dpc-2620	59	5	anti	anti	ADJ
dpc-2620	59	6	-	-	ADJ
dpc-2620	59	7	mouse	mouse	ADJ
dpc-2620	59	8	tyrosinase	tyrosinase	NOUN
dpc-2620	59	9	(	(	PUNCT
dpc-2620	59	10	cat	cat	NOUN
dpc-2620	59	11	.	.	PUNCT
dpc-2620	60	1	no	no	INTJ
dpc-2620	60	2	.	.	PUNCT
dpc-2620	60	3	sc-20035	sc-20035	PROPN
dpc-2620	60	4	)	)	PUNCT
dpc-2620	60	5	and	and	CCONJ
dpc-2620	60	6	nestin	nestin	NOUN
dpc-2620	60	7	(	(	PUNCT
dpc-2620	60	8	cat	cat	NOUN
dpc-2620	60	9	.	.	PUNCT
dpc-2620	61	1	n0	n0	ADJ
dpc-2620	61	2	  	  	SPACE
dpc-2620	61	3	sc-23972	sc-23972	ADJ
dpc-2620	61	4	)	)	PUNCT
dpc-2620	61	5	antibody	antibody	NOUN
dpc-2620	61	6	and	and	CCONJ
dpc-2620	61	7	secondary	secondary	ADJ
dpc-2620	61	8	antibody	antibody	NOUN
dpc-2620	61	9	anti	anti	ADJ
dpc-2620	61	10	-	-	ADJ
dpc-2620	61	11	mouse	mouse	ADJ
dpc-2620	61	12	igg	igg	PROPN
dpc-2620	61	13	-	-	PUNCT
dpc-2620	61	14	fitc	fitc	PROPN
dpc-2620	61	15	(	(	PUNCT
dpc-2620	61	16	sc-2010	sc-2010	NOUN
dpc-2620	61	17	)	)	PUNCT
dpc-2620	61	18	,	,	PUNCT
dpc-2620	61	19	purchased	purchase	VERB
dpc-2620	61	20	from	from	ADP
dpc-2620	61	21	santa	santa	PROPN
dpc-2620	61	22	cruz	cruz	PROPN
dpc-2620	61	23	biotechnology	biotechnology	PROPN
dpc-2620	61	24	.	.	PUNCT
dpc-2620	62	1	isolation	isolation	NOUN
dpc-2620	62	2	and	and	CCONJ
dpc-2620	62	3	culture	culture	NOUN
dpc-2620	62	4	of	of	ADP
dpc-2620	62	5	melscs	melscs	NOUN
dpc-2620	62	6	melscs	melscs	NOUN
dpc-2620	62	7	culture	culture	NOUN
dpc-2620	62	8	was	be	AUX
dpc-2620	62	9	established	establish	VERB
dpc-2620	62	10	from	from	ADP
dpc-2620	62	11	whisker	whisker	NOUN
dpc-2620	62	12	hair	hair	NOUN
dpc-2620	62	13	cells	cell	NOUN
dpc-2620	62	14	of	of	ADP
dpc-2620	62	15	c57bl/6	c57bl/6	NOUN
dpc-2620	62	16	mice	mouse	NOUN
dpc-2620	62	17	at	at	ADP
dpc-2620	62	18	4	4	NUM
dpc-2620	62	19	weeks	week	NOUN
dpc-2620	62	20	of	of	ADP
dpc-2620	62	21	age	age	NOUN
dpc-2620	62	22	.	.	PUNCT
dpc-2620	63	1	mice	mouse	NOUN
dpc-2620	63	2	were	be	AUX
dpc-2620	63	3	euthanized	euthanize	VERB
dpc-2620	63	4	and	and	CCONJ
dpc-2620	63	5	the	the	DET
dpc-2620	63	6	upper	upper	ADJ
dpc-2620	63	7	lips	lip	NOUN
dpc-2620	63	8	containing	contain	VERB
dpc-2620	63	9	vibrissae	vibrissa	NOUN
dpc-2620	63	10	were	be	AUX
dpc-2620	63	11	dissected	dissect	VERB
dpc-2620	63	12	as	as	SCONJ
dpc-2620	63	13	described	describe	VERB
dpc-2620	63	14	by	by	ADP
dpc-2620	63	15	gilanchi	gilanchi	NOUN
dpc-2620	63	16	[	[	X
dpc-2620	63	17	12].it	12].it	NUM
dpc-2620	63	18	was	be	AUX
dpc-2620	63	19	rinsed	rinse	VERB
dpc-2620	63	20	with	with	ADP
dpc-2620	63	21	betadine	betadine	NOUN
dpc-2620	63	22	and	and	CCONJ
dpc-2620	63	23	70	70	NUM
dpc-2620	63	24	%	%	NOUN
dpc-2620	63	25	ethanol	ethanol	NOUN
dpc-2620	63	26	for	for	ADP
dpc-2620	63	27	2	2	NUM
dpc-2620	63	28	minutes	minute	NOUN
dpc-2620	63	29	and	and	CCONJ
dpc-2620	63	30	placed	place	VERB
dpc-2620	63	31	in	in	ADP
dpc-2620	63	32	phosphate	phosphate	ADJ
dpc-2620	63	33	buffer	buffer	NOUN
dpc-2620	63	34	saline	saline	NOUN
dpc-2620	63	35	(	(	PUNCT
dpc-2620	63	36	pbs	pbs	PROPN
dpc-2620	63	37	)	)	PUNCT
dpc-2620	63	38	.	.	PUNCT
dpc-2620	64	1	hair	hair	NOUN
dpc-2620	64	2	follicles	follicle	NOUN
dpc-2620	64	3	were	be	AUX
dpc-2620	64	4	separated	separate	VERB
dpc-2620	64	5	from	from	ADP
dpc-2620	64	6	lip	lip	NOUN
dpc-2620	64	7	pad	pad	NOUN
dpc-2620	64	8	under	under	ADP
dpc-2620	64	9	sterile	sterile	ADJ
dpc-2620	64	10	conditions	condition	NOUN
dpc-2620	64	11	and	and	CCONJ
dpc-2620	64	12	were	be	AUX
dpc-2620	64	13	incubated	incubate	VERB
dpc-2620	64	14	overnight	overnight	ADV
dpc-2620	64	15	at	at	ADP
dpc-2620	64	16	room	room	NOUN
dpc-2620	64	17	temperature	temperature	NOUN
dpc-2620	64	18	in	in	ADP
dpc-2620	64	19	collagenase	collagenase	NOUN
dpc-2620	64	20	iv	iv	X
dpc-2620	64	21	(	(	PUNCT
dpc-2620	64	22	1mg	1mg	PROPN
dpc-2620	64	23	/	/	SYM
dpc-2620	64	24	ml	ml	NOUN
dpc-2620	64	25	)	)	PUNCT
dpc-2620	64	26	.	.	PUNCT
dpc-2620	65	1	after	after	ADP
dpc-2620	65	2	incubation	incubation	NOUN
dpc-2620	65	3	the	the	DET
dpc-2620	65	4	digested	digested	ADJ
dpc-2620	65	5	hair	hair	NOUN
dpc-2620	65	6	follicles	follicle	NOUN
dpc-2620	65	7	were	be	AUX
dpc-2620	65	8	pipetted	pipette	VERB
dpc-2620	65	9	thoroughly	thoroughly	ADV
dpc-2620	65	10	to	to	PART
dpc-2620	65	11	obtain	obtain	VERB
dpc-2620	65	12	single	single	ADJ
dpc-2620	65	13	cell	cell	NOUN
dpc-2620	65	14	suspension	suspension	NOUN
dpc-2620	65	15	.	.	PUNCT
dpc-2620	66	1	afterwards	afterwards	ADV
dpc-2620	66	2	,	,	PUNCT
dpc-2620	66	3	the	the	DET
dpc-2620	66	4	cell	cell	NOUN
dpc-2620	66	5	suspension	suspension	NOUN
dpc-2620	66	6	was	be	AUX
dpc-2620	66	7	centrifuged	centrifuge	VERB
dpc-2620	66	8	at	at	ADP
dpc-2620	66	9	1000	1000	NUM
dpc-2620	66	10	rpm	rpm	NOUN
dpc-2620	66	11	for	for	ADP
dpc-2620	66	12	5	5	NUM
dpc-2620	66	13	minutes	minute	NOUN
dpc-2620	66	14	and	and	CCONJ
dpc-2620	66	15	the	the	DET
dpc-2620	66	16	obtained	obtain	VERB
dpc-2620	66	17	pellet	pellet	NOUN
dpc-2620	66	18	was	be	AUX
dpc-2620	66	19	resuspended	resuspend	VERB
dpc-2620	66	20	in	in	ADP
dpc-2620	66	21	a	a	DET
dpc-2620	66	22	stem	stem	NOUN
dpc-2620	66	23	cell	cell	NOUN
dpc-2620	66	24	specific	specific	ADJ
dpc-2620	66	25	culture	culture	NOUN
dpc-2620	66	26	medium	medium	NOUN
dpc-2620	66	27	which	which	PRON
dpc-2620	66	28	contains	contain	VERB
dpc-2620	66	29	80	80	NUM
dpc-2620	66	30	%	%	NOUN
dpc-2620	66	31	knockout	knockout	NOUN
dpc-2620	66	32	™	™	VERB
dpc-2620	66	33	dmem	dmem	VERB
dpc-2620	66	34	/	/	SYM
dpc-2620	66	35	f12	f12	NOUN
dpc-2620	66	36	medium	medium	ADJ
dpc-2620	66	37	,	,	PUNCT
dpc-2620	66	38	20	20	NUM
dpc-2620	66	39	%	%	NOUN
dpc-2620	66	40	knockout	knockout	NOUN
dpc-2620	66	41	™	™	ADJ
dpc-2620	66	42	serum	serum	NOUN
dpc-2620	66	43	replacement	replacement	NOUN
dpc-2620	66	44	,	,	PUNCT
dpc-2620	66	45	200	200	NUM
dpc-2620	66	46	mm	mm	NOUN
dpc-2620	66	47	l	l	NOUN
dpc-2620	66	48	-	-	NOUN
dpc-2620	66	49	glutamine	glutamine	NOUN
dpc-2620	66	50	,	,	PUNCT
dpc-2620	66	51	0.1	0.1	NUM
dpc-2620	66	52	  	  	SPACE
dpc-2620	66	53	mm	mm	NUM
dpc-2620	66	54	β	β	NOUN
dpc-2620	66	55	-	-	NOUN
dpc-2620	66	56	mercaptoethanol	mercaptoethanol	ADJ
dpc-2620	66	57	,	,	PUNCT
dpc-2620	66	58	1	1	NUM
dpc-2620	66	59	%	%	NOUN
dpc-2620	66	60	nonessential	nonessential	ADJ
dpc-2620	66	61	amino	amino	ADJ
dpc-2620	66	62	acids	acid	NOUN
dpc-2620	66	63	and	and	CCONJ
dpc-2620	66	64	4	4	NUM
dpc-2620	66	65	ng	ng	NOUN
dpc-2620	66	66	/	/	SYM
dpc-2620	66	67	ml	ml	NOUN
dpc-2620	66	68	basic	basic	ADJ
dpc-2620	66	69	fibroblast	fibroblast	ADJ
dpc-2620	66	70	growth	growth	NOUN
dpc-2620	66	71	factor	factor	NOUN
dpc-2620	66	72	(	(	PUNCT
dpc-2620	66	73	bfgf	bfgf	NOUN
dpc-2620	66	74	)	)	PUNCT
dpc-2620	67	1	[	[	X
dpc-2620	67	2	13	13	NUM
dpc-2620	67	3	]	]	PUNCT
dpc-2620	67	4	.	.	PUNCT
dpc-2620	68	1	characterization	characterization	NOUN
dpc-2620	68	2	of	of	ADP
dpc-2620	68	3	cultured	cultured	ADJ
dpc-2620	68	4	spheres	sphere	NOUN
dpc-2620	68	5	cultured	cultured	ADJ
dpc-2620	68	6	spheres	sphere	NOUN
dpc-2620	68	7	were	be	AUX
dpc-2620	68	8	characterized	characterize	VERB
dpc-2620	68	9	for	for	ADP
dpc-2620	68	10	the	the	DET
dpc-2620	68	11	presence	presence	NOUN
dpc-2620	68	12	of	of	ADP
dpc-2620	68	13	nestin	nestin	NOUN
dpc-2620	68	14	which	which	PRON
dpc-2620	68	15	is	be	AUX
dpc-2620	68	16	a	a	DET
dpc-2620	68	17	neural	neural	ADJ
dpc-2620	68	18	crest	crest	NOUN
dpc-2620	68	19	marker	marker	NOUN
dpc-2620	68	20	.	.	PUNCT
dpc-2620	69	1	spheres	sphere	NOUN
dpc-2620	69	2	were	be	AUX
dpc-2620	69	3	fixed	fix	VERB
dpc-2620	69	4	in	in	ADP
dpc-2620	69	5	chilled	chill	VERB
dpc-2620	69	6	paraformaldehyde	paraformaldehyde	NOUN
dpc-2620	69	7	for	for	ADP
dpc-2620	69	8	10	10	NUM
dpc-2620	69	9	minutes	minute	NOUN
dpc-2620	69	10	and	and	CCONJ
dpc-2620	69	11	then	then	ADV
dpc-2620	69	12	washed	wash	VERB
dpc-2620	69	13	in	in	ADP
dpc-2620	69	14	pbs	pbs	PROPN
dpc-2620	69	15	.	.	PUNCT
dpc-2620	70	1	blocking	block	VERB
dpc-2620	70	2	was	be	AUX
dpc-2620	70	3	performed	perform	VERB
dpc-2620	70	4	overnight	overnight	ADV
dpc-2620	70	5	at	at	ADP
dpc-2620	70	6	4o	4o	NUM
dpc-2620	70	7	c	c	NOUN
dpc-2620	70	8	with	with	ADP
dpc-2620	70	9	3	3	NUM
dpc-2620	70	10	%	%	NOUN
dpc-2620	70	11	bsa	bsa	NOUN
dpc-2620	70	12	in	in	ADP
dpc-2620	70	13	a	a	DET
dpc-2620	70	14	humidified	humidified	ADJ
dpc-2620	70	15	chamber	chamber	NOUN
dpc-2620	70	16	.	.	PUNCT
dpc-2620	71	1	for	for	ADP
dpc-2620	71	2	nestin	nestin	NOUN
dpc-2620	71	3	immunostaining	immunostaining	NOUN
dpc-2620	71	4	,	,	PUNCT
dpc-2620	71	5	primary	primary	ADJ
dpc-2620	71	6	antibody	antibody	NOUN
dpc-2620	71	7	(	(	PUNCT
dpc-2620	71	8	dilution	dilution	NOUN
dpc-2620	71	9	1:100	1:100	NUM
dpc-2620	71	10	)	)	PUNCT
dpc-2620	71	11	and	and	CCONJ
dpc-2620	71	12	secondary	secondary	ADJ
dpc-2620	71	13	antibody	antibody	NOUN
dpc-2620	71	14	(	(	PUNCT
dpc-2620	71	15	dilution	dilution	NOUN
dpc-2620	71	16	1:200	1:200	NUM
dpc-2620	71	17	)	)	PUNCT
dpc-2620	71	18	were	be	AUX
dpc-2620	71	19	used	use	VERB
dpc-2620	71	20	.	.	PUNCT
dpc-2620	72	1	after	after	SCONJ
dpc-2620	72	2	antibody	antibody	NOUN
dpc-2620	72	3	incubation	incubation	NOUN
dpc-2620	72	4	pbs	pbs	NOUN
dpc-2620	72	5	washing	washing	NOUN
dpc-2620	72	6	was	be	AUX
dpc-2620	72	7	done	do	VERB
dpc-2620	72	8	and	and	CCONJ
dpc-2620	72	9	spheres	sphere	NOUN
dpc-2620	72	10	were	be	AUX
dpc-2620	72	11	then	then	ADV
dpc-2620	72	12	counterstained	counterstaine	VERB
dpc-2620	72	13	with	with	ADP
dpc-2620	72	14	dapi	dapi	PROPN
dpc-2620	72	15	.	.	PUNCT
dpc-2620	73	1	spheres	sphere	NOUN
dpc-2620	73	2	were	be	AUX
dpc-2620	73	3	washed	wash	VERB
dpc-2620	73	4	again	again	ADV
dpc-2620	73	5	with	with	ADP
dpc-2620	73	6	pbs	pbs	PROPN
dpc-2620	73	7	and	and	CCONJ
dpc-2620	73	8	examined	examine	VERB
dpc-2620	73	9	using	use	VERB
dpc-2620	73	10	confocal	confocal	ADJ
dpc-2620	73	11	microscope	microscope	NOUN
dpc-2620	73	12	.	.	PUNCT
dpc-2620	74	1	original	original	ADJ
dpc-2620	74	2	article	article	NOUN
dpc-2620	74	3	|	|	ADV
dpc-2620	74	4	dermatol	dermatol	ADJ
dpc-2620	74	5	pract	pract	NOUN
dpc-2620	74	6	concept	concept	NOUN
dpc-2620	74	7	.	.	PUNCT
dpc-2620	75	1	2023;13(2):e2023077	2023;13(2):e2023077	NUM
dpc-2620	75	2	3	3	NUM
dpc-2620	75	3	subculturing	subculturing	NOUN
dpc-2620	75	4	of	of	ADP
dpc-2620	75	5	cells	cell	NOUN
dpc-2620	75	6	from	from	ADP
dpc-2620	75	7	cultured	cultured	ADJ
dpc-2620	75	8	spheres	sphere	NOUN
dpc-2620	75	9	subculturing	subculture	VERB
dpc-2620	75	10	was	be	AUX
dpc-2620	75	11	done	do	VERB
dpc-2620	75	12	for	for	ADP
dpc-2620	75	13	further	further	ADJ
dpc-2620	75	14	propagation	propagation	NOUN
dpc-2620	75	15	of	of	ADP
dpc-2620	75	16	cells	cell	NOUN
dpc-2620	75	17	.	.	PUNCT
dpc-2620	76	1	for	for	ADP
dpc-2620	76	2	that	that	PRON
dpc-2620	76	3	,	,	PUNCT
dpc-2620	76	4	spheres	sphere	NOUN
dpc-2620	76	5	were	be	AUX
dpc-2620	76	6	easily	easily	ADV
dpc-2620	76	7	detached	detach	VERB
dpc-2620	76	8	by	by	ADP
dpc-2620	76	9	agitating	agitate	VERB
dpc-2620	76	10	the	the	DET
dpc-2620	76	11	culture	culture	NOUN
dpc-2620	76	12	plate	plate	NOUN
dpc-2620	76	13	.	.	PUNCT
dpc-2620	77	1	spheres	sphere	NOUN
dpc-2620	77	2	were	be	AUX
dpc-2620	77	3	then	then	ADV
dpc-2620	77	4	transferred	transfer	VERB
dpc-2620	77	5	to	to	ADP
dpc-2620	77	6	new	new	ADJ
dpc-2620	77	7	culture	culture	NOUN
dpc-2620	77	8	wells	well	NOUN
dpc-2620	77	9	,	,	PUNCT
dpc-2620	77	10	where	where	SCONJ
dpc-2620	77	11	they	they	PRON
dpc-2620	77	12	were	be	AUX
dpc-2620	77	13	cultured	cultured	ADJ
dpc-2620	77	14	in	in	ADP
dpc-2620	77	15	media	medium	NOUN
dpc-2620	77	16	having	having	AUX
dpc-2620	77	17	dmem	dmem	VERB
dpc-2620	77	18	,	,	PUNCT
dpc-2620	77	19	fbs	fbs	PROPN
dpc-2620	77	20	and	and	CCONJ
dpc-2620	77	21	recombinant	recombinant	ADJ
dpc-2620	77	22	human	human	ADJ
dpc-2620	77	23	fgf	fgf	NOUN
dpc-2620	77	24	-	-	PUNCT
dpc-2620	77	25	basic	basic	ADJ
dpc-2620	77	26	protein	protein	NOUN
dpc-2620	77	27	[	[	X
dpc-2620	77	28	14	14	NUM
dpc-2620	77	29	]	]	PUNCT
dpc-2620	77	30	.	.	PUNCT
dpc-2620	78	1	next	next	ADJ
dpc-2620	78	2	day	day	NOUN
dpc-2620	78	3	cells	cell	NOUN
dpc-2620	78	4	started	start	VERB
dpc-2620	78	5	coming	come	VERB
dpc-2620	78	6	out	out	ADP
dpc-2620	78	7	of	of	ADP
dpc-2620	78	8	the	the	DET
dpc-2620	78	9	sphere	sphere	NOUN
dpc-2620	78	10	and	and	CCONJ
dpc-2620	78	11	when	when	SCONJ
dpc-2620	78	12	the	the	DET
dpc-2620	78	13	cells	cell	NOUN
dpc-2620	78	14	reached	reach	VERB
dpc-2620	78	15	to	to	ADP
dpc-2620	78	16	80	80	NUM
dpc-2620	78	17	%	%	NOUN
dpc-2620	78	18	confluency	confluency	NOUN
dpc-2620	78	19	,	,	PUNCT
dpc-2620	78	20	they	they	PRON
dpc-2620	78	21	were	be	AUX
dpc-2620	78	22	further	far	ADV
dpc-2620	78	23	subcultured	subculture	VERB
dpc-2620	78	24	by	by	ADP
dpc-2620	78	25	trypsinization	trypsinization	NOUN
dpc-2620	78	26	method	method	NOUN
dpc-2620	78	27	using	use	VERB
dpc-2620	78	28	trypsin	trypsin	NOUN
dpc-2620	78	29	-	-	PUNCT
dpc-2620	78	30	edta	edta	NOUN
dpc-2620	78	31	.	.	PUNCT
dpc-2620	79	1	characterization	characterization	NOUN
dpc-2620	79	2	of	of	ADP
dpc-2620	79	3	cells	cell	NOUN
dpc-2620	79	4	obtained	obtain	VERB
dpc-2620	79	5	from	from	ADP
dpc-2620	79	6	spheres	sphere	NOUN
dpc-2620	79	7	cultured	cultured	ADJ
dpc-2620	79	8	cells	cell	NOUN
dpc-2620	79	9	obtained	obtain	VERB
dpc-2620	79	10	from	from	ADP
dpc-2620	79	11	the	the	DET
dpc-2620	79	12	spheres	sphere	NOUN
dpc-2620	79	13	were	be	AUX
dpc-2620	79	14	characterized	characterize	VERB
dpc-2620	79	15	by	by	ADP
dpc-2620	79	16	nestin	nestin	NOUN
dpc-2620	79	17	,	,	PUNCT
dpc-2620	79	18	cd34	cd34	PROPN
dpc-2620	79	19	,	,	PUNCT
dpc-2620	79	20	dct	dct	PROPN
dpc-2620	79	21	and	and	CCONJ
dpc-2620	79	22	tyr	tyr	PROPN
dpc-2620	79	23	immunostaining	immunostaining	NOUN
dpc-2620	79	24	and	and	CCONJ
dpc-2620	79	25	dopa	dopa	NOUN
dpc-2620	79	26	staining	stain	VERB
dpc-2620	79	27	.	.	PUNCT
dpc-2620	80	1	for	for	ADP
dpc-2620	80	2	immunostaining	immunostaining	NOUN
dpc-2620	80	3	,	,	PUNCT
dpc-2620	80	4	cells	cell	NOUN
dpc-2620	80	5	were	be	AUX
dpc-2620	80	6	fixed	fix	VERB
dpc-2620	80	7	in	in	ADP
dpc-2620	80	8	chilled	chill	VERB
dpc-2620	80	9	paraformaldehyde	paraformaldehyde	NOUN
dpc-2620	80	10	for	for	ADP
dpc-2620	80	11	10	10	NUM
dpc-2620	80	12	minutes	minute	NOUN
dpc-2620	80	13	and	and	CCONJ
dpc-2620	80	14	then	then	ADV
dpc-2620	80	15	washed	wash	VERB
dpc-2620	80	16	in	in	ADP
dpc-2620	80	17	pbs	pbs	PROPN
dpc-2620	80	18	.	.	PUNCT
dpc-2620	81	1	blocking	block	VERB
dpc-2620	81	2	was	be	AUX
dpc-2620	81	3	performed	perform	VERB
dpc-2620	81	4	overnight	overnight	ADV
dpc-2620	81	5	at	at	ADP
dpc-2620	81	6	4oc	4oc	ADJ
dpc-2620	81	7	with	with	ADP
dpc-2620	81	8	3	3	NUM
dpc-2620	81	9	%	%	NOUN
dpc-2620	81	10	bsa	bsa	NOUN
dpc-2620	81	11	in	in	ADP
dpc-2620	81	12	humidified	humidified	ADJ
dpc-2620	81	13	chamber	chamber	NOUN
dpc-2620	81	14	.	.	PUNCT
dpc-2620	82	1	next	next	ADJ
dpc-2620	82	2	day	day	NOUN
dpc-2620	82	3	,	,	PUNCT
dpc-2620	82	4	the	the	DET
dpc-2620	82	5	fixed	fix	VERB
dpc-2620	82	6	cells	cell	NOUN
dpc-2620	82	7	were	be	AUX
dpc-2620	82	8	incubated	incubate	VERB
dpc-2620	82	9	with	with	ADP
dpc-2620	82	10	fluorochrome	fluorochrome	NOUN
dpc-2620	82	11	conjugated	conjugate	VERB
dpc-2620	82	12	antibodies	antibodie	VERB
dpc-2620	82	13	cd34	cd34	PROPN
dpc-2620	82	14	and	and	CCONJ
dpc-2620	82	15	dct	dct	PROPN
dpc-2620	82	16	for	for	ADP
dpc-2620	82	17	3	3	NUM
dpc-2620	82	18	hours	hour	NOUN
dpc-2620	82	19	at	at	ADP
dpc-2620	82	20	room	room	NOUN
dpc-2620	82	21	temperature	temperature	NOUN
dpc-2620	82	22	(	(	PUNCT
dpc-2620	82	23	dilution	dilution	NOUN
dpc-2620	82	24	1:150	1:150	NUM
dpc-2620	82	25	)	)	PUNCT
dpc-2620	82	26	.	.	PUNCT
dpc-2620	83	1	for	for	ADP
dpc-2620	83	2	nestin	nestin	NOUN
dpc-2620	83	3	and	and	CCONJ
dpc-2620	83	4	tyrosinase	tyrosinase	NOUN
dpc-2620	83	5	immunostaining	immunostaining	NOUN
dpc-2620	83	6	,	,	PUNCT
dpc-2620	83	7	primary	primary	ADJ
dpc-2620	83	8	antibody	antibody	NOUN
dpc-2620	83	9	(	(	PUNCT
dpc-2620	83	10	dilution	dilution	NOUN
dpc-2620	83	11	1:100	1:100	NUM
dpc-2620	83	12	)	)	PUNCT
dpc-2620	83	13	and	and	CCONJ
dpc-2620	83	14	secondary	secondary	ADJ
dpc-2620	83	15	antibody	antibody	NOUN
dpc-2620	83	16	(	(	PUNCT
dpc-2620	83	17	dilution	dilution	NOUN
dpc-2620	83	18	1:200	1:200	NUM
dpc-2620	83	19	)	)	PUNCT
dpc-2620	83	20	were	be	AUX
dpc-2620	83	21	used	use	VERB
dpc-2620	83	22	for	for	ADP
dpc-2620	83	23	3	3	NUM
dpc-2620	83	24	hours	hour	NOUN
dpc-2620	83	25	and	and	CCONJ
dpc-2620	83	26	2	2	NUM
dpc-2620	83	27	hours	hour	NOUN
dpc-2620	83	28	respectively	respectively	ADV
dpc-2620	83	29	.	.	PUNCT
dpc-2620	84	1	after	after	ADP
dpc-2620	84	2	pbs	pbs	PROPN
dpc-2620	84	3	washing	washing	NOUN
dpc-2620	84	4	,	,	PUNCT
dpc-2620	84	5	cells	cell	NOUN
dpc-2620	84	6	were	be	AUX
dpc-2620	84	7	then	then	ADV
dpc-2620	84	8	counterstained	counterstaine	VERB
dpc-2620	84	9	with	with	ADP
dpc-2620	84	10	dapi	dapi	PROPN
dpc-2620	84	11	.	.	PUNCT
dpc-2620	85	1	cells	cell	NOUN
dpc-2620	85	2	were	be	AUX
dpc-2620	85	3	washed	wash	VERB
dpc-2620	85	4	again	again	ADV
dpc-2620	85	5	with	with	ADP
dpc-2620	85	6	pbs	pbs	PROPN
dpc-2620	85	7	and	and	CCONJ
dpc-2620	85	8	examined	examine	VERB
dpc-2620	85	9	using	use	VERB
dpc-2620	85	10	confocal	confocal	ADJ
dpc-2620	85	11	microscope	microscope	NOUN
dpc-2620	85	12	.	.	PUNCT
dpc-2620	86	1	for	for	ADP
dpc-2620	86	2	dopa	dopa	NOUN
dpc-2620	86	3	staining	stain	VERB
dpc-2620	86	4	,	,	PUNCT
dpc-2620	86	5	washing	washing	NOUN
dpc-2620	86	6	of	of	ADP
dpc-2620	86	7	cultured	cultured	ADJ
dpc-2620	86	8	cells	cell	NOUN
dpc-2620	86	9	was	be	AUX
dpc-2620	86	10	done	do	VERB
dpc-2620	86	11	with	with	ADP
dpc-2620	86	12	1x	1x	PROPN
dpc-2620	86	13	pbs	pbs	PROPN
dpc-2620	86	14	and	and	CCONJ
dpc-2620	86	15	then	then	ADV
dpc-2620	86	16	fixed	fix	VERB
dpc-2620	86	17	with	with	ADP
dpc-2620	86	18	chilled	chill	VERB
dpc-2620	86	19	paraformaldehyde	paraformaldehyde	NOUN
dpc-2620	86	20	for	for	ADP
dpc-2620	86	21	10	10	NUM
dpc-2620	86	22	 	 	SPACE
dpc-2620	86	23	minutes	minute	NOUN
dpc-2620	86	24	.	.	PUNCT
dpc-2620	87	1	10	10	NUM
dpc-2620	87	2	mm	mm	NOUN
dpc-2620	87	3	l	l	NOUN
dpc-2620	87	4	-	-	NOUN
dpc-2620	87	5	dopa	dopa	NOUN
dpc-2620	87	6	was	be	AUX
dpc-2620	87	7	added	add	VERB
dpc-2620	87	8	to	to	ADP
dpc-2620	87	9	the	the	DET
dpc-2620	87	10	cells	cell	NOUN
dpc-2620	87	11	and	and	CCONJ
dpc-2620	87	12	then	then	ADV
dpc-2620	87	13	incubated	incubate	VERB
dpc-2620	87	14	at	at	ADP
dpc-2620	87	15	37o	37o	NOUN
dpc-2620	87	16	c.	c.	NOUN
dpc-2620	87	17	cells	cell	NOUN
dpc-2620	87	18	were	be	AUX
dpc-2620	87	19	examined	examine	VERB
dpc-2620	87	20	hourly	hourly	ADV
dpc-2620	87	21	under	under	ADP
dpc-2620	87	22	the	the	DET
dpc-2620	87	23	microscope	microscope	NOUN
dpc-2620	87	24	for	for	ADP
dpc-2620	87	25	4	4	NUM
dpc-2620	87	26	hours	hour	NOUN
dpc-2620	87	27	.	.	PUNCT
dpc-2620	88	1	cell	cell	NOUN
dpc-2620	88	2	proliferation	proliferation	NOUN
dpc-2620	88	3	assay	assay	NOUN
dpc-2620	88	4	cell	cell	NOUN
dpc-2620	88	5	proliferation	proliferation	NOUN
dpc-2620	88	6	was	be	AUX
dpc-2620	88	7	checked	check	VERB
dpc-2620	88	8	by	by	ADP
dpc-2620	88	9	mtt	mtt	NOUN
dpc-2620	88	10	assay	assay	VERB
dpc-2620	88	11	by	by	ADP
dpc-2620	88	12	following	follow	VERB
dpc-2620	88	13	the	the	DET
dpc-2620	88	14	modified	modify	VERB
dpc-2620	88	15	procedure	procedure	NOUN
dpc-2620	88	16	of	of	ADP
dpc-2620	88	17	mosmann	mosmann	NOUN
dpc-2620	89	1	[	[	X
dpc-2620	89	2	15].cultured	15].culture	VERB
dpc-2620	89	3	melscs	melsc	NOUN
dpc-2620	89	4	(	(	PUNCT
dpc-2620	89	5	5×103	5×103	NUM
dpc-2620	89	6	)	)	PUNCT
dpc-2620	89	7	were	be	AUX
dpc-2620	89	8	plated	plate	VERB
dpc-2620	89	9	in	in	ADP
dpc-2620	89	10	the	the	DET
dpc-2620	89	11	96	96	NUM
dpc-2620	89	12	-	-	PUNCT
dpc-2620	89	13	well	well	NOUN
dpc-2620	89	14	cell	cell	NOUN
dpc-2620	89	15	culture	culture	NOUN
dpc-2620	89	16	plate	plate	NOUN
dpc-2620	89	17	.	.	PUNCT
dpc-2620	90	1	lenalidomide	lenalidomide	NOUN
dpc-2620	90	2	treatment	treatment	NOUN
dpc-2620	90	3	was	be	AUX
dpc-2620	90	4	given	give	VERB
dpc-2620	90	5	to	to	ADP
dpc-2620	90	6	the	the	DET
dpc-2620	90	7	cells	cell	NOUN
dpc-2620	90	8	at	at	ADP
dpc-2620	90	9	2.5	2.5	NUM
dpc-2620	90	10	μm	μm	NOUN
dpc-2620	90	11	and	and	CCONJ
dpc-2620	90	12	5	5	NUM
dpc-2620	90	13	 	 	SPACE
dpc-2620	90	14	μm	μm	NUM
dpc-2620	90	15	concentrations	concentration	NOUN
dpc-2620	90	16	,	,	PUNCT
dpc-2620	90	17	the	the	DET
dpc-2620	90	18	untreated	untreated	ADJ
dpc-2620	90	19	cells	cell	NOUN
dpc-2620	90	20	were	be	AUX
dpc-2620	90	21	considered	consider	VERB
dpc-2620	90	22	as	as	ADP
dpc-2620	90	23	control	control	NOUN
dpc-2620	90	24	.	.	PUNCT
dpc-2620	91	1	after	after	ADP
dpc-2620	91	2	24	24	NUM
dpc-2620	91	3	hours	hour	NOUN
dpc-2620	91	4	of	of	ADP
dpc-2620	91	5	lenalidomide	lenalidomide	NOUN
dpc-2620	91	6	treatment	treatment	NOUN
dpc-2620	91	7	,	,	PUNCT
dpc-2620	91	8	culture	culture	NOUN
dpc-2620	91	9	media	medium	NOUN
dpc-2620	91	10	was	be	AUX
dpc-2620	91	11	removed	remove	VERB
dpc-2620	91	12	from	from	ADP
dpc-2620	91	13	each	each	DET
dpc-2620	91	14	well	well	NOUN
dpc-2620	91	15	and	and	CCONJ
dpc-2620	91	16	100μl	100μl	ADV
dpc-2620	91	17	of	of	ADP
dpc-2620	91	18	mtt	mtt	NOUN
dpc-2620	91	19	(	(	PUNCT
dpc-2620	91	20	0.5	0.5	NUM
dpc-2620	91	21	mg	mg	PROPN
dpc-2620	91	22	/	/	SYM
dpc-2620	91	23	ml	ml	NOUN
dpc-2620	91	24	)	)	PUNCT
dpc-2620	91	25	solution	solution	NOUN
dpc-2620	91	26	was	be	AUX
dpc-2620	91	27	added	add	VERB
dpc-2620	91	28	.	.	PUNCT
dpc-2620	92	1	the	the	DET
dpc-2620	92	2	cells	cell	NOUN
dpc-2620	92	3	with	with	ADP
dpc-2620	92	4	mtt	mtt	NOUN
dpc-2620	92	5	(	(	PUNCT
dpc-2620	92	6	0.5mg	0.5mg	NOUN
dpc-2620	92	7	/	/	SYM
dpc-2620	92	8	ml	ml	NOUN
dpc-2620	92	9	)	)	PUNCT
dpc-2620	92	10	solution	solution	NOUN
dpc-2620	92	11	were	be	AUX
dpc-2620	92	12	incubated	incubate	VERB
dpc-2620	92	13	for	for	ADP
dpc-2620	92	14	4	4	NUM
dpc-2620	92	15	hours	hour	NOUN
dpc-2620	92	16	at	at	ADP
dpc-2620	92	17	37oc	37oc	NUM
dpc-2620	92	18	till	till	SCONJ
dpc-2620	92	19	the	the	DET
dpc-2620	92	20	formation	formation	NOUN
dpc-2620	92	21	of	of	ADP
dpc-2620	92	22	formazan	formazan	ADJ
dpc-2620	92	23	crystals	crystal	NOUN
dpc-2620	92	24	.	.	PUNCT
dpc-2620	93	1	after	after	ADP
dpc-2620	93	2	incubation	incubation	NOUN
dpc-2620	93	3	100	100	NUM
dpc-2620	93	4	μl	μl	ADP
dpc-2620	93	5	of	of	ADP
dpc-2620	93	6	dmso	dmso	NOUN
dpc-2620	93	7	was	be	AUX
dpc-2620	93	8	added	add	VERB
dpc-2620	93	9	to	to	ADP
dpc-2620	93	10	each	each	DET
dpc-2620	93	11	well	well	ADJ
dpc-2620	93	12	and	and	CCONJ
dpc-2620	93	13	proper	proper	ADJ
dpc-2620	93	14	dissolution	dissolution	NOUN
dpc-2620	93	15	of	of	ADP
dpc-2620	93	16	formazan	formazan	ADJ
dpc-2620	93	17	crystals	crystal	NOUN
dpc-2620	93	18	was	be	AUX
dpc-2620	93	19	done	do	VERB
dpc-2620	93	20	.	.	PUNCT
dpc-2620	94	1	optical	optical	ADJ
dpc-2620	94	2	density	density	NOUN
dpc-2620	94	3	was	be	AUX
dpc-2620	94	4	evaluated	evaluate	VERB
dpc-2620	94	5	using	use	VERB
dpc-2620	94	6	microplate	microplate	ADJ
dpc-2620	94	7	spectrophotometer	spectrophotometer	NOUN
dpc-2620	94	8	(	(	PUNCT
dpc-2620	94	9	epoch	epoch	NOUN
dpc-2620	94	10	)	)	PUNCT
dpc-2620	94	11	at	at	ADP
dpc-2620	94	12	560	560	NUM
dpc-2620	94	13	nm	nm	NOUN
dpc-2620	94	14	.	.	PUNCT
dpc-2620	95	1	boyden	boyden	PROPN
dpc-2620	95	2	chamber	chamber	PROPN
dpc-2620	95	3	migration	migration	NOUN
dpc-2620	95	4	assay	assay	VERB
dpc-2620	95	5	cultured	cultured	ADJ
dpc-2620	95	6	melscs	melsc	NOUN
dpc-2620	95	7	were	be	AUX
dpc-2620	95	8	starved	starve	VERB
dpc-2620	95	9	for	for	ADP
dpc-2620	95	10	about	about	ADV
dpc-2620	95	11	six	six	NUM
dpc-2620	95	12	hours	hour	NOUN
dpc-2620	95	13	in	in	ADP
dpc-2620	95	14	serum	serum	NOUN
dpc-2620	95	15	free	free	ADJ
dpc-2620	95	16	culture	culture	NOUN
dpc-2620	95	17	media	medium	NOUN
dpc-2620	95	18	.	.	PUNCT
dpc-2620	96	1	after	after	ADP
dpc-2620	96	2	the	the	DET
dpc-2620	96	3	starvation	starvation	NOUN
dpc-2620	96	4	period	period	NOUN
dpc-2620	96	5	,	,	PUNCT
dpc-2620	96	6	3	3	NUM
dpc-2620	96	7	×	×	NOUN
dpc-2620	96	8	104	104	NUM
dpc-2620	96	9	cells	cell	NOUN
dpc-2620	96	10	were	be	AUX
dpc-2620	96	11	plated	plate	VERB
dpc-2620	96	12	in	in	ADP
dpc-2620	96	13	serum	serum	NOUN
dpc-2620	96	14	-	-	PUNCT
dpc-2620	96	15	free	free	ADJ
dpc-2620	96	16	medium	medium	NOUN
dpc-2620	96	17	(	(	PUNCT
dpc-2620	96	18	no	no	DET
dpc-2620	96	19	chemoattractant	chemoattractant	NOUN
dpc-2620	96	20	)	)	PUNCT
dpc-2620	96	21	in	in	ADP
dpc-2620	96	22	the	the	DET
dpc-2620	96	23	upper	upper	ADJ
dpc-2620	96	24	chamber	chamber	NOUN
dpc-2620	96	25	.	.	PUNCT
dpc-2620	97	1	to	to	ADP
dpc-2620	97	2	the	the	DET
dpc-2620	97	3	lower	low	ADJ
dpc-2620	97	4	chamber	chamber	NOUN
dpc-2620	97	5	,	,	PUNCT
dpc-2620	97	6	medium	medium	NOUN
dpc-2620	97	7	with	with	ADP
dpc-2620	97	8	serum	serum	NOUN
dpc-2620	97	9	for	for	ADP
dpc-2620	97	10	control	control	NOUN
dpc-2620	97	11	group	group	NOUN
dpc-2620	97	12	and	and	CCONJ
dpc-2620	97	13	serum	serum	NOUN
dpc-2620	97	14	plus	plus	CCONJ
dpc-2620	97	15	lenalidomide	lenalidomide	VERB
dpc-2620	97	16	for	for	SCONJ
dpc-2620	97	17	treatment	treatment	NOUN
dpc-2620	97	18	groups	group	NOUN
dpc-2620	97	19	was	be	AUX
dpc-2620	97	20	added	add	VERB
dpc-2620	97	21	.	.	PUNCT
dpc-2620	98	1	cells	cell	NOUN
dpc-2620	98	2	were	be	AUX
dpc-2620	98	3	kept	keep	VERB
dpc-2620	98	4	at	at	ADP
dpc-2620	98	5	37	37	NUM
dpc-2620	98	6	°	°	ADP
dpc-2620	98	7	c	c	NOUN
dpc-2620	98	8	in	in	ADP
dpc-2620	98	9	co2	co2	NOUN
dpc-2620	98	10	incubator	incubator	NOUN
dpc-2620	98	11	for	for	ADP
dpc-2620	98	12	18	18	NUM
dpc-2620	98	13	hours	hour	NOUN
dpc-2620	98	14	.	.	PUNCT
dpc-2620	99	1	afterwards	afterwards	ADV
dpc-2620	99	2	,	,	PUNCT
dpc-2620	99	3	cells	cell	NOUN
dpc-2620	99	4	were	be	AUX
dpc-2620	99	5	fixed	fix	VERB
dpc-2620	99	6	with	with	ADP
dpc-2620	99	7	4	4	NUM
dpc-2620	99	8	%	%	NOUN
dpc-2620	99	9	formaldehyde	formaldehyde	NOUN
dpc-2620	99	10	and	and	CCONJ
dpc-2620	99	11	stained	stain	VERB
dpc-2620	99	12	with	with	ADP
dpc-2620	99	13	0.5	0.5	NUM
dpc-2620	99	14	%	%	NOUN
dpc-2620	99	15	crystal	crystal	NOUN
dpc-2620	99	16	violet	violet	NOUN
dpc-2620	99	17	.	.	PUNCT
dpc-2620	100	1	the	the	DET
dpc-2620	100	2	inside	inside	NOUN
dpc-2620	100	3	of	of	ADP
dpc-2620	100	4	each	each	DET
dpc-2620	100	5	insert	insert	NOUN
dpc-2620	100	6	was	be	AUX
dpc-2620	100	7	swabbed	swab	VERB
dpc-2620	100	8	using	use	VERB
dpc-2620	100	9	cotton	cotton	NOUN
dpc-2620	100	10	swabs	swab	NOUN
dpc-2620	100	11	.	.	PUNCT
dpc-2620	101	1	randomly	randomly	ADV
dpc-2620	101	2	selected	select	VERB
dpc-2620	101	3	fields	field	NOUN
dpc-2620	101	4	were	be	AUX
dpc-2620	101	5	photographed	photograph	VERB
dpc-2620	101	6	,	,	PUNCT
dpc-2620	101	7	and	and	CCONJ
dpc-2620	101	8	the	the	DET
dpc-2620	101	9	cells	cell	NOUN
dpc-2620	101	10	that	that	PRON
dpc-2620	101	11	had	have	AUX
dpc-2620	101	12	migrated	migrate	VERB
dpc-2620	101	13	were	be	AUX
dpc-2620	101	14	counted	count	VERB
dpc-2620	101	15	.	.	PUNCT
dpc-2620	102	1	in	in	ADP
dpc-2620	102	2	vitro	vitro	X
dpc-2620	102	3	treatment	treatment	NOUN
dpc-2620	102	4	of	of	ADP
dpc-2620	102	5	melscs	melsc	NOUN
dpc-2620	102	6	with	with	ADP
dpc-2620	102	7	lenalidomide	lenalidomide	NOUN
dpc-2620	102	8	and	and	CCONJ
dpc-2620	102	9	its	its	PRON
dpc-2620	102	10	effect	effect	NOUN
dpc-2620	102	11	on	on	ADP
dpc-2620	102	12	differentiation	differentiation	NOUN
dpc-2620	102	13	into	into	ADP
dpc-2620	102	14	functional	functional	ADJ
dpc-2620	102	15	melanocytes	melanocyte	NOUN
dpc-2620	102	16	cultured	cultured	ADJ
dpc-2620	102	17	melscs	melsc	NOUN
dpc-2620	102	18	were	be	AUX
dpc-2620	102	19	treated	treat	VERB
dpc-2620	102	20	with	with	ADP
dpc-2620	102	21	lenalidomide	lenalidomide	NOUN
dpc-2620	102	22	at	at	ADP
dpc-2620	102	23	concentrations	concentration	NOUN
dpc-2620	102	24	of	of	ADP
dpc-2620	102	25	2.5	2.5	NUM
dpc-2620	102	26	μm	μm	NOUN
dpc-2620	102	27	and	and	CCONJ
dpc-2620	102	28	5	5	NUM
dpc-2620	102	29	μm	μm	NOUN
dpc-2620	102	30	for	for	ADP
dpc-2620	102	31	2	2	NUM
dpc-2620	102	32	weeks	week	NOUN
dpc-2620	102	33	.	.	PUNCT
dpc-2620	103	1	the	the	DET
dpc-2620	103	2	media	medium	NOUN
dpc-2620	103	3	was	be	AUX
dpc-2620	103	4	changed	change	VERB
dpc-2620	103	5	in	in	ADP
dpc-2620	103	6	plate	plate	NOUN
dpc-2620	103	7	after	after	ADP
dpc-2620	103	8	every	every	DET
dpc-2620	103	9	48	48	NUM
dpc-2620	103	10	hours	hour	NOUN
dpc-2620	103	11	.	.	PUNCT
dpc-2620	104	1	after	after	ADP
dpc-2620	104	2	2	2	NUM
dpc-2620	104	3	weeks	week	NOUN
dpc-2620	104	4	of	of	ADP
dpc-2620	104	5	lenalidomide	lenalidomide	NOUN
dpc-2620	104	6	treatment	treatment	NOUN
dpc-2620	104	7	,	,	PUNCT
dpc-2620	104	8	its	its	PRON
dpc-2620	104	9	effect	effect	NOUN
dpc-2620	104	10	on	on	ADP
dpc-2620	104	11	the	the	DET
dpc-2620	104	12	differentiation	differentiation	NOUN
dpc-2620	104	13	of	of	ADP
dpc-2620	104	14	melscs	melsc	NOUN
dpc-2620	104	15	into	into	ADP
dpc-2620	104	16	melanocytes	melanocyte	NOUN
dpc-2620	104	17	was	be	AUX
dpc-2620	104	18	checked	check	VERB
dpc-2620	104	19	at	at	ADP
dpc-2620	104	20	both	both	CCONJ
dpc-2620	104	21	gene	gene	NOUN
dpc-2620	104	22	and	and	CCONJ
dpc-2620	104	23	protein	protein	NOUN
dpc-2620	104	24	level	level	NOUN
dpc-2620	104	25	.	.	PUNCT
dpc-2620	105	1	quantitative	quantitative	ADJ
dpc-2620	105	2	real	real	ADJ
dpc-2620	105	3	-	-	PUNCT
dpc-2620	105	4	time	time	NOUN
dpc-2620	105	5	polymerase	polymerase	NOUN
dpc-2620	105	6	chain	chain	NOUN
dpc-2620	105	7	reaction	reaction	NOUN
dpc-2620	105	8	(	(	PUNCT
dpc-2620	105	9	qpcr	qpcr	ADV
dpc-2620	105	10	)	)	PUNCT
dpc-2620	105	11	qpcr	qpcr	ADV
dpc-2620	105	12	was	be	AUX
dpc-2620	105	13	performed	perform	VERB
dpc-2620	105	14	to	to	PART
dpc-2620	105	15	analyze	analyze	VERB
dpc-2620	105	16	the	the	DET
dpc-2620	105	17	transcriptional	transcriptional	ADJ
dpc-2620	105	18	gene	gene	NOUN
dpc-2620	105	19	expression	expression	NOUN
dpc-2620	105	20	.	.	PUNCT
dpc-2620	106	1	rna	rna	NOUN
dpc-2620	106	2	was	be	AUX
dpc-2620	106	3	isolated	isolate	VERB
dpc-2620	106	4	using	use	VERB
dpc-2620	106	5	trizol	trizol	ADJ
dpc-2620	106	6	reagent	reagent	NOUN
dpc-2620	106	7	(	(	PUNCT
dpc-2620	106	8	sigma	sigma	PROPN
dpc-2620	106	9	)	)	PUNCT
dpc-2620	106	10	by	by	ADP
dpc-2620	106	11	following	follow	VERB
dpc-2620	106	12	manufacturer	manufacturer	NOUN
dpc-2620	106	13	’s	’s	PART
dpc-2620	106	14	guidelines	guideline	NOUN
dpc-2620	106	15	.	.	PUNCT
dpc-2620	107	1	gel	gel	NOUN
dpc-2620	107	2	electrophoresis	electrophoresis	NOUN
dpc-2620	107	3	was	be	AUX
dpc-2620	107	4	performed	perform	VERB
dpc-2620	107	5	after	after	SCONJ
dpc-2620	107	6	rna	rna	NOUN
dpc-2620	107	7	isolation	isolation	NOUN
dpc-2620	107	8	to	to	PART
dpc-2620	107	9	assess	assess	VERB
dpc-2620	107	10	its	its	PRON
dpc-2620	107	11	quality	quality	NOUN
dpc-2620	107	12	.	.	PUNCT
dpc-2620	108	1	absorbance	absorbance	NOUN
dpc-2620	108	2	at	at	ADP
dpc-2620	108	3	260	260	NUM
dpc-2620	108	4	and	and	CCONJ
dpc-2620	108	5	280	280	NUM
dpc-2620	108	6	 	 	SPACE
dpc-2620	108	7	nm	nm	NOUN
dpc-2620	108	8	measured	measure	VERB
dpc-2620	108	9	on	on	ADP
dpc-2620	108	10	nano	nano	NOUN
dpc-2620	108	11	-	-	PUNCT
dpc-2620	108	12	drop	drop	NOUN
dpc-2620	108	13	was	be	AUX
dpc-2620	108	14	used	use	VERB
dpc-2620	108	15	to	to	PART
dpc-2620	108	16	determine	determine	VERB
dpc-2620	108	17	the	the	DET
dpc-2620	108	18	concentration	concentration	NOUN
dpc-2620	108	19	and	and	CCONJ
dpc-2620	108	20	purity	purity	NOUN
dpc-2620	108	21	of	of	ADP
dpc-2620	108	22	rna	rna	PROPN
dpc-2620	108	23	.	.	PUNCT
dpc-2620	109	1	cdna	cdna	PROPN
dpc-2620	109	2	was	be	AUX
dpc-2620	109	3	synthesized	synthesize	VERB
dpc-2620	109	4	from	from	ADP
dpc-2620	109	5	the	the	DET
dpc-2620	109	6	isolated	isolated	ADJ
dpc-2620	109	7	rna	rna	NOUN
dpc-2620	109	8	using	use	VERB
dpc-2620	109	9	iscripttm	iscripttm	NOUN
dpc-2620	109	10	c	c	NOUN
dpc-2620	109	11	-	-	PUNCT
dpc-2620	109	12	dna	dna	PROPN
dpc-2620	109	13	synthesis	synthesis	NOUN
dpc-2620	109	14	kit	kit	NOUN
dpc-2620	109	15	(	(	PUNCT
dpc-2620	109	16	bio	bio	NOUN
dpc-2620	109	17	-	-	NOUN
dpc-2620	109	18	rad	rad	NOUN
dpc-2620	109	19	)	)	PUNCT
dpc-2620	109	20	.	.	PUNCT
dpc-2620	110	1	qpcr	qpcr	ADV
dpc-2620	110	2	was	be	AUX
dpc-2620	110	3	performed	perform	VERB
dpc-2620	110	4	using	use	VERB
dpc-2620	110	5	sybr(r	sybr(r	NOUN
dpc-2620	110	6	)	)	PUNCT
dpc-2620	110	7	green	green	PROPN
dpc-2620	110	8	jumpstart	jumpstart	PROPN
dpc-2620	110	9	(	(	PUNCT
dpc-2620	110	10	tm	tm	NOUN
dpc-2620	110	11	)	)	PUNCT
dpc-2620	110	12	taqreadymix	taqreadymix	NOUN
dpc-2620	110	13	(	(	PUNCT
dpc-2620	110	14	tm	tm	NOUN
dpc-2620	110	15	)	)	PUNCT
dpc-2620	110	16	master	master	NOUN
dpc-2620	110	17	mix	mix	NOUN
dpc-2620	110	18	on	on	ADP
dpc-2620	110	19	a	a	DET
dpc-2620	110	20	real	real	ADJ
dpc-2620	110	21	time	time	NOUN
dpc-2620	110	22	pcr	pcr	NOUN
dpc-2620	110	23	system	system	NOUN
dpc-2620	110	24	(	(	PUNCT
dpc-2620	110	25	roche	roche	PROPN
dpc-2620	110	26	lc480	lc480	PROPN
dpc-2620	110	27	)	)	PUNCT
dpc-2620	110	28	according	accord	VERB
dpc-2620	110	29	to	to	ADP
dpc-2620	110	30	manufacturer	manufacturer	NOUN
dpc-2620	110	31	’s	’s	PART
dpc-2620	110	32	guidelines	guideline	NOUN
dpc-2620	110	33	.	.	PUNCT
dpc-2620	111	1	the	the	DET
dpc-2620	111	2	forward	forward	ADV
dpc-2620	111	3	and	and	CCONJ
dpc-2620	111	4	reverse	reverse	VERB
dpc-2620	111	5	sequences	sequence	NOUN
dpc-2620	111	6	of	of	ADP
dpc-2620	111	7	primers	primer	NOUN
dpc-2620	111	8	are	be	AUX
dpc-2620	111	9	given	give	VERB
dpc-2620	111	10	in	in	ADP
dpc-2620	111	11	table	table	NOUN
dpc-2620	111	12	1	1	NUM
dpc-2620	111	13	.	.	PUNCT
dpc-2620	112	1	the	the	DET
dpc-2620	112	2	relative	relative	ADJ
dpc-2620	112	3	levels	level	NOUN
dpc-2620	112	4	of	of	ADP
dpc-2620	112	5	mrna	mrna	PROPN
dpc-2620	112	6	expression	expression	NOUN
dpc-2620	112	7	were	be	AUX
dpc-2620	112	8	calculated	calculate	VERB
dpc-2620	112	9	by	by	ADP
dpc-2620	112	10	following	follow	VERB
dpc-2620	112	11	the	the	DET
dpc-2620	112	12	method	method	NOUN
dpc-2620	112	13	of	of	ADP
dpc-2620	112	14	livak	livak	NOUN
dpc-2620	112	15	and	and	CCONJ
dpc-2620	112	16	schmittgen	schmittgen	NOUN
dpc-2620	113	1	[	[	X
dpc-2620	113	2	16	16	NUM
dpc-2620	113	3	]	]	PUNCT
dpc-2620	113	4	,	,	PUNCT
dpc-2620	113	5	normalized	normalize	VERB
dpc-2620	113	6	by	by	ADP
dpc-2620	113	7	β	β	NOUN
dpc-2620	113	8	-	-	NOUN
dpc-2620	113	9	actin	actin	NOUN
dpc-2620	113	10	.	.	PUNCT
dpc-2620	114	1	immunostaining	immunostaine	VERB
dpc-2620	114	2	of	of	ADP
dpc-2620	114	3	differentiated	differentiated	ADJ
dpc-2620	114	4	melanocytes	melanocyte	NOUN
dpc-2620	114	5	after	after	ADP
dpc-2620	114	6	14	14	NUM
dpc-2620	114	7	days	day	NOUN
dpc-2620	114	8	of	of	ADP
dpc-2620	114	9	differentiation	differentiation	NOUN
dpc-2620	114	10	assay	assay	NOUN
dpc-2620	114	11	melscs	melscs	NOUN
dpc-2620	114	12	cells	cell	NOUN
dpc-2620	114	13	were	be	AUX
dpc-2620	114	14	checked	check	VERB
dpc-2620	114	15	for	for	ADP
dpc-2620	114	16	melanocyte	melanocyte	NOUN
dpc-2620	114	17	marker	marker	NOUN
dpc-2620	114	18	tyr	tyr	NOUN
dpc-2620	114	19	and	and	CCONJ
dpc-2620	114	20	dct	dct	PROPN
dpc-2620	114	21	by	by	ADP
dpc-2620	114	22	immunostaining	immunostaine	VERB
dpc-2620	114	23	(	(	PUNCT
dpc-2620	114	24	protocol	protocol	NOUN
dpc-2620	114	25	discussed	discuss	VERB
dpc-2620	114	26	in	in	ADP
dpc-2620	114	27	characterization	characterization	NOUN
dpc-2620	114	28	of	of	ADP
dpc-2620	114	29	cells	cell	NOUN
dpc-2620	114	30	obtained	obtain	VERB
dpc-2620	114	31	from	from	ADP
dpc-2620	114	32	spheres	sphere	NOUN
dpc-2620	114	33	section	section	NOUN
dpc-2620	114	34	)	)	PUNCT
dpc-2620	114	35	.	.	PUNCT
dpc-2620	115	1	the	the	DET
dpc-2620	115	2	fluorescence	fluorescence	NOUN
dpc-2620	115	3	was	be	AUX
dpc-2620	115	4	quantified	quantify	VERB
dpc-2620	115	5	using	use	VERB
dpc-2620	115	6	image	image	NOUN
dpc-2620	115	7	-	-	PUNCT
dpc-2620	115	8	j	j	NOUN
dpc-2620	115	9	software	software	NOUN
dpc-2620	115	10	.	.	PUNCT
dpc-2620	116	1	statistical	statistical	ADJ
dpc-2620	116	2	analysis	analysis	NOUN
dpc-2620	116	3	statistical	statistical	ADJ
dpc-2620	116	4	analysis	analysis	NOUN
dpc-2620	116	5	was	be	AUX
dpc-2620	116	6	performed	perform	VERB
dpc-2620	116	7	by	by	ADP
dpc-2620	116	8	using	use	VERB
dpc-2620	116	9	graphpad	graphpad	NOUN
dpc-2620	116	10	prism	prism	NOUN
dpc-2620	116	11	6	6	NUM
dpc-2620	116	12	for	for	ADP
dpc-2620	116	13	windows	window	NOUN
dpc-2620	116	14	version	version	NOUN
dpc-2620	116	15	6.01	6.01	NUM
dpc-2620	116	16	(	(	PUNCT
dpc-2620	116	17	graphpad	graphpad	NOUN
dpc-2620	116	18	software	software	PROPN
dpc-2620	116	19	,	,	PUNCT
dpc-2620	116	20	inc	inc	PROPN
dpc-2620	116	21	.	.	PROPN
dpc-2620	116	22	)	)	PUNCT
dpc-2620	116	23	.	.	PUNCT
dpc-2620	117	1	final	final	ADJ
dpc-2620	117	2	results	result	NOUN
dpc-2620	117	3	were	be	AUX
dpc-2620	117	4	shown	show	VERB
dpc-2620	117	5	as	as	ADP
dpc-2620	117	6	mean	mean	ADJ
dpc-2620	117	7	with	with	ADP
dpc-2620	117	8	standard	standard	ADJ
dpc-2620	117	9	deviation	deviation	NOUN
dpc-2620	117	10	(	(	PUNCT
dpc-2620	117	11	mean	mean	NOUN
dpc-2620	117	12	±	±	NUM
dpc-2620	117	13	sd	sd	NOUN
dpc-2620	117	14	)	)	PUNCT
dpc-2620	117	15	.	.	PUNCT
dpc-2620	118	1	the	the	DET
dpc-2620	118	2	data	datum	NOUN
dpc-2620	118	3	was	be	AUX
dpc-2620	118	4	examined	examine	VERB
dpc-2620	118	5	for	for	ADP
dpc-2620	118	6	normality	normality	NOUN
dpc-2620	118	7	by	by	ADP
dpc-2620	118	8	the	the	DET
dpc-2620	118	9	shapiro	shapiro	PROPN
dpc-2620	118	10	–	–	PUNCT
dpc-2620	118	11	wilk	wilk	NOUN
dpc-2620	118	12	test	test	NOUN
dpc-2620	118	13	.	.	PUNCT
dpc-2620	119	1	two	two	NUM
dpc-2620	119	2	-	-	PUNCT
dpc-2620	119	3	tailed	tail	VERB
dpc-2620	119	4	student	student	NOUN
dpc-2620	119	5	t	t	PROPN
dpc-2620	119	6	test	test	NOUN
dpc-2620	119	7	was	be	AUX
dpc-2620	119	8	done	do	VERB
dpc-2620	119	9	to	to	PART
dpc-2620	119	10	calculate	calculate	VERB
dpc-2620	119	11	the	the	DET
dpc-2620	119	12	statistical	statistical	ADJ
dpc-2620	119	13	significance	significance	NOUN
dpc-2620	119	14	between	between	ADP
dpc-2620	119	15	two	two	NUM
dpc-2620	119	16	groups	group	NOUN
dpc-2620	119	17	,	,	PUNCT
dpc-2620	119	18	whereas	whereas	SCONJ
dpc-2620	119	19	one	one	NUM
dpc-2620	119	20	-	-	PUNCT
dpc-2620	119	21	way	way	NOUN
dpc-2620	119	22	analysis	analysis	NOUN
dpc-2620	119	23	of	of	ADP
dpc-2620	119	24	variance	variance	NOUN
dpc-2620	119	25	(	(	PUNCT
dpc-2620	119	26	one	one	NUM
dpc-2620	119	27	-	-	PUNCT
dpc-2620	119	28	way	way	NOUN
dpc-2620	119	29	anova	anova	PROPN
dpc-2620	119	30	)	)	PUNCT
dpc-2620	119	31	followed	follow	VERB
dpc-2620	119	32	by	by	ADP
dpc-2620	119	33	post	post	X
dpc-2620	119	34	hoc	hoc	X
dpc-2620	119	35	tukey	tukey	NOUN
dpc-2620	119	36	test	test	NOUN
dpc-2620	119	37	was	be	AUX
dpc-2620	119	38	used	use	VERB
dpc-2620	119	39	to	to	PART
dpc-2620	119	40	calculate	calculate	VERB
dpc-2620	119	41	statistical	statistical	ADJ
dpc-2620	119	42	significance	significance	NOUN
dpc-2620	119	43	for	for	ADP
dpc-2620	119	44	more	more	ADJ
dpc-2620	119	45	than	than	ADP
dpc-2620	119	46	two	two	NUM
dpc-2620	119	47	groups	group	NOUN
dpc-2620	119	48	.	.	PUNCT
dpc-2620	120	1	p	p	X
dpc-2620	120	2	-	-	PUNCT
dpc-2620	120	3	values	value	NOUN
dpc-2620	120	4	less	less	ADJ
dpc-2620	120	5	than	than	ADP
dpc-2620	120	6	0.05	0.05	NUM
dpc-2620	120	7	4	4	NUM
dpc-2620	120	8	original	original	ADJ
dpc-2620	120	9	article	article	NOUN
dpc-2620	120	10	|	|	ADV
dpc-2620	120	11	dermatol	dermatol	ADJ
dpc-2620	120	12	pract	pract	NOUN
dpc-2620	120	13	concept	concept	NOUN
dpc-2620	120	14	.	.	PUNCT
dpc-2620	121	1	2023;13(2):e2023077	2023;13(2):e2023077	NUM
dpc-2620	121	2	effect	effect	NOUN
dpc-2620	121	3	of	of	ADP
dpc-2620	121	4	lenalidomide	lenalidomide	NOUN
dpc-2620	121	5	on	on	ADP
dpc-2620	121	6	the	the	DET
dpc-2620	121	7	differentiation	differentiation	NOUN
dpc-2620	121	8	of	of	ADP
dpc-2620	121	9	melscs	melsc	NOUN
dpc-2620	121	10	into	into	ADP
dpc-2620	121	11	functional	functional	ADJ
dpc-2620	121	12	melanocytes	melanocyte	NOUN
dpc-2620	121	13	the	the	DET
dpc-2620	121	14	cultured	cultured	ADJ
dpc-2620	121	15	cells	cell	NOUN
dpc-2620	121	16	derived	derive	VERB
dpc-2620	121	17	from	from	ADP
dpc-2620	121	18	spheres	sphere	NOUN
dpc-2620	121	19	were	be	AUX
dpc-2620	121	20	treated	treat	VERB
dpc-2620	121	21	with	with	ADP
dpc-2620	121	22	lenalidomide	lenalidomide	NOUN
dpc-2620	121	23	for	for	ADP
dpc-2620	121	24	14	14	NUM
dpc-2620	121	25	days	day	NOUN
dpc-2620	121	26	to	to	PART
dpc-2620	121	27	check	check	VERB
dpc-2620	121	28	its	its	PRON
dpc-2620	121	29	effect	effect	NOUN
dpc-2620	121	30	on	on	ADP
dpc-2620	121	31	the	the	DET
dpc-2620	121	32	differentiation	differentiation	NOUN
dpc-2620	121	33	of	of	ADP
dpc-2620	121	34	melscs	melsc	NOUN
dpc-2620	121	35	into	into	ADP
dpc-2620	121	36	functional	functional	ADJ
dpc-2620	121	37	melanocytes	melanocyte	NOUN
dpc-2620	121	38	.	.	PUNCT
dpc-2620	122	1	after	after	SCONJ
dpc-2620	122	2	14	14	NUM
dpc-2620	122	3	 	 	SPACE
dpc-2620	122	4	days	day	NOUN
dpc-2620	122	5	of	of	ADP
dpc-2620	122	6	treatment	treatment	NOUN
dpc-2620	122	7	cell	cell	NOUN
dpc-2620	122	8	were	be	AUX
dpc-2620	122	9	checked	check	VERB
dpc-2620	122	10	for	for	ADP
dpc-2620	122	11	expression	expression	NOUN
dpc-2620	122	12	of	of	ADP
dpc-2620	122	13	melanocyte	melanocyte	ADJ
dpc-2620	122	14	specific	specific	ADJ
dpc-2620	122	15	genes	gene	NOUN
dpc-2620	122	16	.	.	PUNCT
dpc-2620	123	1	qpcr	qpcr	ADJ
dpc-2620	123	2	results	result	NOUN
dpc-2620	123	3	showed	show	VERB
dpc-2620	123	4	that	that	PRON
dpc-2620	123	5	lenalidomide	lenalidomide	NOUN
dpc-2620	123	6	significantly	significantly	ADV
dpc-2620	123	7	enhanced	enhance	VERB
dpc-2620	123	8	the	the	DET
dpc-2620	123	9	expression	expression	NOUN
dpc-2620	123	10	of	of	ADP
dpc-2620	123	11	melanocyte	melanocyte	ADJ
dpc-2620	123	12	specific	specific	ADJ
dpc-2620	123	13	genes	gene	NOUN
dpc-2620	123	14	(	(	PUNCT
dpc-2620	123	15	dct	dct	PROPN
dpc-2620	123	16	,	,	PUNCT
dpc-2620	123	17	tyrp1	tyrp1	PROPN
dpc-2620	123	18	,	,	PUNCT
dpc-2620	123	19	tyr	tyr	PROPN
dpc-2620	123	20	,	,	PUNCT
dpc-2620	123	21	mitf	mitf	NOUN
dpc-2620	123	22	,	,	PUNCT
dpc-2620	123	23	sox10	sox10	PROPN
dpc-2620	123	24	,	,	PUNCT
dpc-2620	123	25	sox9	sox9	PROPN
dpc-2620	123	26	)	)	PUNCT
dpc-2620	123	27	as	as	SCONJ
dpc-2620	123	28	compared	compare	VERB
dpc-2620	123	29	to	to	ADP
dpc-2620	123	30	control	control	NOUN
dpc-2620	123	31	.	.	PUNCT
dpc-2620	124	1	after	after	ADP
dpc-2620	124	2	lenalidomide	lenalidomide	NOUN
dpc-2620	124	3	treatment	treatment	NOUN
dpc-2620	124	4	,	,	PUNCT
dpc-2620	124	5	the	the	DET
dpc-2620	124	6	expression	expression	NOUN
dpc-2620	124	7	of	of	ADP
dpc-2620	124	8	tyr	tyr	PROPN
dpc-2620	124	9	was	be	AUX
dpc-2620	124	10	found	find	VERB
dpc-2620	124	11	higher	high	ADJ
dpc-2620	124	12	at	at	ADP
dpc-2620	124	13	2.5	2.5	NUM
dpc-2620	124	14	µm	µm	NOUN
dpc-2620	124	15	(	(	PUNCT
dpc-2620	124	16	1.902	1.902	NUM
dpc-2620	124	17	±	±	NUM
dpc-2620	124	18	0.023	0.023	NUM
dpc-2620	124	19	fold	fold	NOUN
dpc-2620	124	20	)	)	PUNCT
dpc-2620	124	21	and	and	CCONJ
dpc-2620	124	22	5	5	NUM
dpc-2620	124	23	µm	µm	NOUN
dpc-2620	124	24	concentrations	concentration	NOUN
dpc-2620	124	25	(	(	PUNCT
dpc-2620	124	26	3.516	3.516	NUM
dpc-2620	124	27	±	±	NOUN
dpc-2620	124	28	0.269	0.269	NUM
dpc-2620	124	29	fold	fold	NOUN
dpc-2620	124	30	)	)	PUNCT
dpc-2620	124	31	as	as	SCONJ
dpc-2620	124	32	compared	compare	VERB
dpc-2620	124	33	to	to	ADP
dpc-2620	124	34	control	control	NOUN
dpc-2620	124	35	.	.	PUNCT
dpc-2620	125	1	similarly	similarly	ADV
dpc-2620	125	2	,	,	PUNCT
dpc-2620	125	3	we	we	PRON
dpc-2620	125	4	observed	observe	VERB
dpc-2620	125	5	a	a	DET
dpc-2620	125	6	significant	significant	ADJ
dpc-2620	125	7	elevation	elevation	NOUN
dpc-2620	125	8	in	in	ADP
dpc-2620	125	9	the	the	DET
dpc-2620	125	10	expression	expression	NOUN
dpc-2620	125	11	of	of	ADP
dpc-2620	125	12	tyrp1	tyrp1	NOUN
dpc-2620	125	13	(	(	PUNCT
dpc-2620	125	14	2.543	2.543	NUM
dpc-2620	125	15	±	±	NUM
dpc-2620	125	16	0.08	0.08	NUM
dpc-2620	125	17	fold	fold	NOUN
dpc-2620	125	18	)	)	PUNCT
dpc-2620	125	19	and	and	CCONJ
dpc-2620	125	20	(	(	PUNCT
dpc-2620	125	21	1.715	1.715	NUM
dpc-2620	125	22	±	±	NOUN
dpc-2620	125	23	0.104	0.104	NUM
dpc-2620	125	24	fold	fold	NOUN
dpc-2620	125	25	)	)	PUNCT
dpc-2620	125	26	,	,	PUNCT
dpc-2620	125	27	dct	dct	PROPN
dpc-2620	125	28	(	(	PUNCT
dpc-2620	125	29	1.786	1.786	NUM
dpc-2620	125	30	±	±	NUM
dpc-2620	125	31	0.335	0.335	NUM
dpc-2620	125	32	fold	fold	NOUN
dpc-2620	125	33	)	)	PUNCT
dpc-2620	125	34	and	and	CCONJ
dpc-2620	125	35	(	(	PUNCT
dpc-2620	125	36	3.516	3.516	NUM
dpc-2620	125	37	±	±	NUM
dpc-2620	125	38	1.353	1.353	NUM
dpc-2620	125	39	fold	fold	NOUN
dpc-2620	125	40	)	)	PUNCT
dpc-2620	125	41	,	,	PUNCT
dpc-2620	125	42	mitf	mitf	NOUN
dpc-2620	125	43	(	(	PUNCT
dpc-2620	125	44	1.640	1.640	NUM
dpc-2620	125	45	±	±	NUM
dpc-2620	125	46	0.080	0.080	NUM
dpc-2620	125	47	fold	fold	NOUN
dpc-2620	125	48	)	)	PUNCT
dpc-2620	125	49	and	and	CCONJ
dpc-2620	125	50	(	(	PUNCT
dpc-2620	125	51	1.498	1.498	NUM
dpc-2620	125	52	±	±	NUM
dpc-2620	125	53	0.188	0.188	NUM
dpc-2620	125	54	fold	fold	NOUN
dpc-2620	125	55	)	)	PUNCT
dpc-2620	125	56	,	,	PUNCT
dpc-2620	125	57	sox9	sox9	PROPN
dpc-2620	125	58	(	(	PUNCT
dpc-2620	125	59	2.738	2.738	NUM
dpc-2620	125	60	±	±	NUM
dpc-2620	125	61	0.129	0.129	NUM
dpc-2620	125	62	fold	fold	NOUN
dpc-2620	125	63	)	)	PUNCT
dpc-2620	125	64	and	and	CCONJ
dpc-2620	125	65	(	(	PUNCT
dpc-2620	125	66	1.166	1.166	NUM
dpc-2620	125	67	±	±	NUM
dpc-2620	125	68	0.470	0.470	NUM
dpc-2620	125	69	fold	fold	NOUN
dpc-2620	125	70	)	)	PUNCT
dpc-2620	125	71	,	,	PUNCT
dpc-2620	125	72	and	and	CCONJ
dpc-2620	125	73	sox10	sox10	NOUN
dpc-2620	125	74	(	(	PUNCT
dpc-2620	125	75	1.077	1.077	NUM
dpc-2620	125	76	±	±	NUM
dpc-2620	125	77	0.408	0.408	NUM
dpc-2620	125	78	fold	fold	NOUN
dpc-2620	125	79	)	)	PUNCT
dpc-2620	125	80	and	and	CCONJ
dpc-2620	125	81	(	(	PUNCT
dpc-2620	125	82	5.508	5.508	NUM
dpc-2620	125	83	±	±	NUM
dpc-2620	125	84	2.203	2.203	NUM
dpc-2620	125	85	fold	fold	NOUN
dpc-2620	125	86	)	)	PUNCT
dpc-2620	125	87	in	in	ADP
dpc-2620	125	88	2.5	2.5	NUM
dpc-2620	125	89	µm	µm	NOUN
dpc-2620	125	90	and	and	CCONJ
dpc-2620	125	91	5	5	NUM
dpc-2620	125	92	µm	µm	NOUN
dpc-2620	125	93	concentrations	concentration	NOUN
dpc-2620	125	94	,	,	PUNCT
dpc-2620	125	95	respectively	respectively	ADV
dpc-2620	125	96	(	(	PUNCT
dpc-2620	125	97	figure	figure	NOUN
dpc-2620	125	98	3	3	NUM
dpc-2620	125	99	)	)	PUNCT
dpc-2620	125	100	.	.	PUNCT
dpc-2620	126	1	differentiation	differentiation	NOUN
dpc-2620	126	2	of	of	ADP
dpc-2620	126	3	melscs	melsc	NOUN
dpc-2620	126	4	into	into	ADP
dpc-2620	126	5	functional	functional	ADJ
dpc-2620	126	6	melanocyte	melanocyte	NOUN
dpc-2620	126	7	was	be	AUX
dpc-2620	126	8	further	far	ADV
dpc-2620	126	9	confirmed	confirm	VERB
dpc-2620	126	10	by	by	ADP
dpc-2620	126	11	protein	protein	NOUN
dpc-2620	126	12	expression	expression	NOUN
dpc-2620	126	13	of	of	ADP
dpc-2620	126	14	melanocyte	melanocyte	ADJ
dpc-2620	126	15	specific	specific	ADJ
dpc-2620	126	16	genes	gene	NOUN
dpc-2620	126	17	tyr	tyr	NOUN
dpc-2620	126	18	and	and	CCONJ
dpc-2620	126	19	dct	dct	PROPN
dpc-2620	126	20	.	.	PUNCT
dpc-2620	127	1	it	it	PRON
dpc-2620	127	2	was	be	AUX
dpc-2620	127	3	found	find	VERB
dpc-2620	127	4	that	that	PRON
dpc-2620	127	5	lenalidomide	lenalidomide	NOUN
dpc-2620	127	6	treatment	treatment	NOUN
dpc-2620	127	7	significantly	significantly	ADV
dpc-2620	127	8	increased	increase	VERB
dpc-2620	127	9	the	the	DET
dpc-2620	127	10	protein	protein	NOUN
dpc-2620	127	11	expression	expression	NOUN
dpc-2620	127	12	of	of	ADP
dpc-2620	127	13	tyrosinase	tyrosinase	NOUN
dpc-2620	127	14	in	in	ADP
dpc-2620	127	15	treated	treat	VERB
dpc-2620	127	16	melscs	melsc	NOUN
dpc-2620	127	17	.	.	PUNCT
dpc-2620	128	1	after	after	ADP
dpc-2620	128	2	14	14	NUM
dpc-2620	128	3	days	day	NOUN
dpc-2620	128	4	of	of	ADP
dpc-2620	128	5	lenalidomide	lenalidomide	NOUN
dpc-2620	128	6	treatment	treatment	NOUN
dpc-2620	128	7	,	,	PUNCT
dpc-2620	128	8	number	number	NOUN
dpc-2620	128	9	of	of	ADP
dpc-2620	128	10	tyr	tyr	PROPN
dpc-2620	128	11	positive	positive	ADJ
dpc-2620	128	12	cells	cell	NOUN
dpc-2620	128	13	were	be	AUX
dpc-2620	128	14	found	find	VERB
dpc-2620	128	15	significantly	significantly	ADV
dpc-2620	128	16	higher	high	ADJ
dpc-2620	128	17	at	at	ADP
dpc-2620	128	18	both	both	DET
dpc-2620	128	19	2.5	2.5	NUM
dpc-2620	128	20	  	  	SPACE
dpc-2620	128	21	µm	µm	ADP
dpc-2620	128	22	(	(	PUNCT
dpc-2620	128	23	14.33	14.33	NUM
dpc-2620	128	24	times	time	NOUN
dpc-2620	128	25	)	)	PUNCT
dpc-2620	128	26	and	and	CCONJ
dpc-2620	128	27	5	5	NUM
dpc-2620	128	28	µm	µm	ADP
dpc-2620	128	29	concentration	concentration	NOUN
dpc-2620	128	30	of	of	ADP
dpc-2620	128	31	lenalidomide	lenalidomide	NOUN
dpc-2620	128	32	(	(	PUNCT
dpc-2620	128	33	7.33	7.33	NUM
dpc-2620	128	34	times	time	NOUN
dpc-2620	128	35	)	)	PUNCT
dpc-2620	128	36	as	as	SCONJ
dpc-2620	128	37	compared	compare	VERB
dpc-2620	128	38	to	to	ADP
dpc-2620	128	39	control	control	NOUN
dpc-2620	128	40	.	.	PUNCT
dpc-2620	129	1	similarly	similarly	ADV
dpc-2620	129	2	,	,	PUNCT
dpc-2620	129	3	we	we	PRON
dpc-2620	129	4	observed	observe	VERB
dpc-2620	129	5	a	a	DET
dpc-2620	129	6	significant	significant	ADJ
dpc-2620	129	7	elevation	elevation	NOUN
dpc-2620	129	8	in	in	ADP
dpc-2620	129	9	the	the	DET
dpc-2620	129	10	expression	expression	NOUN
dpc-2620	129	11	of	of	ADP
dpc-2620	129	12	dct	dct	PROPN
dpc-2620	129	13	(	(	PUNCT
dpc-2620	129	14	1.56	1.56	NUM
dpc-2620	129	15	 	 	SPACE
dpc-2620	129	16	±	±	NUM
dpc-2620	129	17	0.1081	0.1081	NUM
dpc-2620	129	18	fold	fold	NOUN
dpc-2620	129	19	)	)	PUNCT
dpc-2620	129	20	and	and	CCONJ
dpc-2620	129	21	(	(	PUNCT
dpc-2620	129	22	1.33	1.33	NUM
dpc-2620	129	23	±	±	NUM
dpc-2620	129	24	0.12	0.12	NUM
dpc-2620	129	25	fold	fold	NOUN
dpc-2620	129	26	)	)	PUNCT
dpc-2620	129	27	in	in	ADP
dpc-2620	129	28	2.5	2.5	NUM
dpc-2620	129	29	µm	µm	NOUN
dpc-2620	129	30	and	and	CCONJ
dpc-2620	129	31	5	5	NUM
dpc-2620	129	32	 	 	SPACE
dpc-2620	129	33	µm	µm	NOUN
dpc-2620	129	34	concentrations	concentration	NOUN
dpc-2620	129	35	,	,	PUNCT
dpc-2620	129	36	respectively	respectively	ADV
dpc-2620	129	37	(	(	PUNCT
dpc-2620	129	38	figure	figure	NOUN
dpc-2620	129	39	4	4	NUM
dpc-2620	129	40	)	)	PUNCT
dpc-2620	129	41	.	.	PUNCT
dpc-2620	130	1	hence	hence	ADV
dpc-2620	130	2	,	,	PUNCT
dpc-2620	130	3	the	the	DET
dpc-2620	130	4	results	result	NOUN
dpc-2620	130	5	from	from	ADP
dpc-2620	130	6	immunocytochemistry	immunocytochemistry	NOUN
dpc-2620	130	7	also	also	ADV
dpc-2620	130	8	showed	show	VERB
dpc-2620	130	9	that	that	SCONJ
dpc-2620	130	10	the	the	DET
dpc-2620	130	11	protein	protein	NOUN
dpc-2620	130	12	expression	expression	NOUN
dpc-2620	130	13	of	of	ADP
dpc-2620	130	14	tyr	tyr	PROPN
dpc-2620	130	15	and	and	CCONJ
dpc-2620	130	16	dct	dct	PROPN
dpc-2620	130	17	was	be	AUX
dpc-2620	130	18	significantly	significantly	ADV
dpc-2620	130	19	higher	high	ADJ
dpc-2620	130	20	in	in	ADP
dpc-2620	130	21	lenalidomide	lenalidomide	NOUN
dpc-2620	130	22	treated	treat	VERB
dpc-2620	130	23	cells	cell	NOUN
dpc-2620	130	24	in	in	ADP
dpc-2620	130	25	comparison	comparison	NOUN
dpc-2620	130	26	to	to	ADP
dpc-2620	130	27	control	control	NOUN
dpc-2620	130	28	(	(	PUNCT
dpc-2620	130	29	figure	figure	NOUN
dpc-2620	130	30	4	4	NUM
dpc-2620	130	31	)	)	PUNCT
dpc-2620	130	32	.	.	PUNCT
dpc-2620	131	1	conclusions	conclusion	NOUN
dpc-2620	131	2	vitiligo	vitiligo	VERB
dpc-2620	131	3	is	be	AUX
dpc-2620	131	4	an	an	DET
dpc-2620	131	5	autoimmune	autoimmune	ADJ
dpc-2620	131	6	disease	disease	NOUN
dpc-2620	131	7	characterized	characterize	VERB
dpc-2620	131	8	by	by	ADP
dpc-2620	131	9	cutaneous	cutaneous	ADJ
dpc-2620	131	10	depigmentation	depigmentation	NOUN
dpc-2620	131	11	caused	cause	VERB
dpc-2620	131	12	by	by	ADP
dpc-2620	131	13	autoimmune	autoimmune	ADJ
dpc-2620	131	14	-	-	PUNCT
dpc-2620	131	15	mediated	mediate	VERB
dpc-2620	131	16	damage	damage	NOUN
dpc-2620	131	17	of	of	ADP
dpc-2620	131	18	melanocytes	melanocyte	NOUN
dpc-2620	131	19	.	.	PUNCT
dpc-2620	132	1	despite	despite	SCONJ
dpc-2620	132	2	continuous	continuous	ADJ
dpc-2620	132	3	research	research	NOUN
dpc-2620	132	4	is	be	AUX
dpc-2620	132	5	being	be	AUX
dpc-2620	132	6	(	(	PUNCT
dpc-2620	132	7	*	*	PUNCT
dpc-2620	132	8	p	p	X
dpc-2620	132	9	  	  	SPACE
dpc-2620	132	10	<	<	NOUN
dpc-2620	132	11	0.05	0.05	NUM
dpc-2620	132	12	,	,	PUNCT
dpc-2620	132	13	*	*	PUNCT
dpc-2620	132	14	*	*	PUNCT
dpc-2620	132	15	p	p	X
dpc-2620	132	16	<	<	X
dpc-2620	132	17	0.01	0.01	NUM
dpc-2620	132	18	,	,	PUNCT
dpc-2620	132	19	*	*	PUNCT
dpc-2620	132	20	*	*	PUNCT
dpc-2620	132	21	*	*	PUNCT
dpc-2620	132	22	p	p	X
dpc-2620	132	23	<	<	X
dpc-2620	132	24	0.001	0.001	NUM
dpc-2620	132	25	and	and	CCONJ
dpc-2620	132	26	*	*	NOUN
dpc-2620	132	27	*	*	PUNCT
dpc-2620	132	28	*	*	PUNCT
dpc-2620	132	29	*	*	PUNCT
dpc-2620	132	30	p	p	X
dpc-2620	132	31	<	<	NOUN
dpc-2620	132	32	0.0001	0.0001	NUM
dpc-2620	132	33	)	)	PUNCT
dpc-2620	132	34	were	be	AUX
dpc-2620	132	35	considered	consider	VERB
dpc-2620	132	36	as	as	ADP
dpc-2620	132	37	significant	significant	ADJ
dpc-2620	132	38	.	.	PUNCT
dpc-2620	133	1	results	result	VERB
dpc-2620	133	2	primary	primary	ADJ
dpc-2620	133	3	culture	culture	NOUN
dpc-2620	133	4	and	and	CCONJ
dpc-2620	133	5	characterization	characterization	NOUN
dpc-2620	133	6	of	of	ADP
dpc-2620	133	7	melscs	melscs	NOUN
dpc-2620	133	8	melscs	melsc	NOUN
dpc-2620	133	9	were	be	AUX
dpc-2620	133	10	cultured	cultured	ADJ
dpc-2620	133	11	from	from	ADP
dpc-2620	133	12	whisker	whisker	NOUN
dpc-2620	133	13	hair	hair	NOUN
dpc-2620	133	14	cells	cell	NOUN
dpc-2620	133	15	of	of	ADP
dpc-2620	133	16	c57bl/6mice	c57bl/6mice	NOUN
dpc-2620	133	17	.	.	PUNCT
dpc-2620	134	1	on	on	ADP
dpc-2620	134	2	the	the	DET
dpc-2620	134	3	5th	5th	ADJ
dpc-2620	134	4	day	day	NOUN
dpc-2620	134	5	of	of	ADP
dpc-2620	134	6	cell	cell	NOUN
dpc-2620	134	7	plating	plating	NOUN
dpc-2620	134	8	,	,	PUNCT
dpc-2620	134	9	some	some	PRON
dpc-2620	134	10	of	of	ADP
dpc-2620	134	11	the	the	DET
dpc-2620	134	12	cells	cell	NOUN
dpc-2620	134	13	started	start	VERB
dpc-2620	134	14	aggregating	aggregate	VERB
dpc-2620	134	15	and	and	CCONJ
dpc-2620	134	16	forming	form	VERB
dpc-2620	134	17	spheres	sphere	NOUN
dpc-2620	134	18	.	.	PUNCT
dpc-2620	135	1	a	a	DET
dpc-2620	135	2	well	well	ADV
dpc-2620	135	3	-	-	PUNCT
dpc-2620	135	4	marked	mark	VERB
dpc-2620	135	5	sphere	sphere	NOUN
dpc-2620	135	6	took	take	VERB
dpc-2620	135	7	around	around	ADV
dpc-2620	135	8	10	10	NUM
dpc-2620	135	9	to	to	PART
dpc-2620	135	10	15	15	NUM
dpc-2620	135	11	days	day	NOUN
dpc-2620	135	12	in	in	ADP
dpc-2620	135	13	formation	formation	NOUN
dpc-2620	135	14	(	(	PUNCT
dpc-2620	135	15	figure	figure	NOUN
dpc-2620	135	16	1a	1a	NOUN
dpc-2620	135	17	)	)	PUNCT
dpc-2620	135	18	.	.	PUNCT
dpc-2620	136	1	spheres	sphere	NOUN
dpc-2620	136	2	were	be	AUX
dpc-2620	136	3	characterized	characterize	VERB
dpc-2620	136	4	for	for	ADP
dpc-2620	136	5	neural	neural	ADJ
dpc-2620	136	6	crest	crest	NOUN
dpc-2620	136	7	stem	stem	NOUN
dpc-2620	136	8	cells	cell	NOUN
dpc-2620	136	9	marker	marker	NOUN
dpc-2620	136	10	nestin	nestin	NOUN
dpc-2620	136	11	,	,	PUNCT
dpc-2620	136	12	and	and	CCONJ
dpc-2620	136	13	it	it	PRON
dpc-2620	136	14	was	be	AUX
dpc-2620	136	15	found	find	VERB
dpc-2620	136	16	that	that	SCONJ
dpc-2620	136	17	the	the	DET
dpc-2620	136	18	cells	cell	NOUN
dpc-2620	136	19	of	of	ADP
dpc-2620	136	20	the	the	DET
dpc-2620	136	21	spheres	sphere	NOUN
dpc-2620	136	22	showed	show	VERB
dpc-2620	136	23	positive	positive	ADJ
dpc-2620	136	24	staining	staining	NOUN
dpc-2620	136	25	for	for	ADP
dpc-2620	136	26	nestin	nestin	NOUN
dpc-2620	136	27	(	(	PUNCT
dpc-2620	136	28	figure	figure	NOUN
dpc-2620	136	29	1d	1d	NUM
dpc-2620	136	30	)	)	PUNCT
dpc-2620	136	31	.	.	PUNCT
dpc-2620	137	1	for	for	ADP
dpc-2620	137	2	subculturing	subculturing	NOUN
dpc-2620	137	3	of	of	ADP
dpc-2620	137	4	melscs	melsc	NOUN
dpc-2620	137	5	,	,	PUNCT
dpc-2620	137	6	spheres	sphere	NOUN
dpc-2620	137	7	were	be	AUX
dpc-2620	137	8	taken	take	VERB
dpc-2620	137	9	out	out	ADP
dpc-2620	137	10	and	and	CCONJ
dpc-2620	137	11	plated	plate	VERB
dpc-2620	137	12	in	in	ADP
dpc-2620	137	13	a	a	DET
dpc-2620	137	14	new	new	ADJ
dpc-2620	137	15	culture	culture	NOUN
dpc-2620	137	16	plate	plate	NOUN
dpc-2620	137	17	.	.	PUNCT
dpc-2620	138	1	the	the	DET
dpc-2620	138	2	next	next	ADJ
dpc-2620	138	3	day	day	NOUN
dpc-2620	138	4	,	,	PUNCT
dpc-2620	138	5	the	the	DET
dpc-2620	138	6	cells	cell	NOUN
dpc-2620	138	7	began	begin	VERB
dpc-2620	138	8	to	to	PART
dpc-2620	138	9	migrate	migrate	VERB
dpc-2620	138	10	out	out	ADP
dpc-2620	138	11	of	of	ADP
dpc-2620	138	12	the	the	DET
dpc-2620	138	13	spheres	sphere	NOUN
dpc-2620	138	14	gradually	gradually	ADV
dpc-2620	138	15	(	(	PUNCT
dpc-2620	138	16	figure	figure	NOUN
dpc-2620	138	17	1b	1b	NUM
dpc-2620	138	18	)	)	PUNCT
dpc-2620	138	19	.	.	PUNCT
dpc-2620	139	1	these	these	DET
dpc-2620	139	2	cells	cell	NOUN
dpc-2620	139	3	were	be	AUX
dpc-2620	139	4	than	than	SCONJ
dpc-2620	139	5	further	far	ADV
dpc-2620	139	6	characterized	characterize	VERB
dpc-2620	139	7	for	for	ADP
dpc-2620	139	8	specific	specific	ADJ
dpc-2620	139	9	stem	stem	NOUN
dpc-2620	139	10	cell	cell	NOUN
dpc-2620	139	11	marker	marker	NOUN
dpc-2620	139	12	nestin	nestin	NOUN
dpc-2620	139	13	,	,	PUNCT
dpc-2620	139	14	cd34	cd34	PROPN
dpc-2620	139	15	,	,	PUNCT
dpc-2620	139	16	and	and	CCONJ
dpc-2620	139	17	melanocyte	melanocyte	NOUN
dpc-2620	139	18	stem	stem	NOUN
dpc-2620	139	19	cell	cell	NOUN
dpc-2620	139	20	marker	marker	NOUN
dpc-2620	139	21	,	,	PUNCT
dpc-2620	139	22	dct	dct	PROPN
dpc-2620	139	23	and	and	CCONJ
dpc-2620	139	24	melanocyte	melanocyte	VERB
dpc-2620	139	25	specific	specific	ADJ
dpc-2620	139	26	marker	marker	NOUN
dpc-2620	139	27	tyr	tyr	NOUN
dpc-2620	139	28	.	.	PUNCT
dpc-2620	140	1	we	we	PRON
dpc-2620	140	2	observed	observe	VERB
dpc-2620	140	3	that	that	SCONJ
dpc-2620	140	4	these	these	DET
dpc-2620	140	5	spherederived	spherederive	VERB
dpc-2620	140	6	cultured	cultured	ADJ
dpc-2620	140	7	cells	cell	NOUN
dpc-2620	140	8	were	be	AUX
dpc-2620	140	9	nestin	nestin	ADJ
dpc-2620	140	10	(	(	PUNCT
dpc-2620	140	11	figure	figure	NOUN
dpc-2620	140	12	1e	1e	NUM
dpc-2620	140	13	)	)	PUNCT
dpc-2620	140	14	and	and	CCONJ
dpc-2620	140	15	dct	dct	PROPN
dpc-2620	140	16	(	(	PUNCT
dpc-2620	140	17	figure	figure	NOUN
dpc-2620	140	18	1	1	NUM
dpc-2620	140	19	g	g	NOUN
dpc-2620	140	20	)	)	PUNCT
dpc-2620	140	21	positive	positive	ADJ
dpc-2620	140	22	and	and	CCONJ
dpc-2620	140	23	were	be	AUX
dpc-2620	140	24	negative	negative	ADJ
dpc-2620	140	25	for	for	ADP
dpc-2620	140	26	cd34	cd34	PROPN
dpc-2620	140	27	(	(	PUNCT
dpc-2620	140	28	figure	figure	NOUN
dpc-2620	140	29	1f	1f	NUM
dpc-2620	140	30	)	)	PUNCT
dpc-2620	140	31	and	and	CCONJ
dpc-2620	140	32	tyr	tyr	PROPN
dpc-2620	140	33	(	(	PUNCT
dpc-2620	140	34	figure	figure	NOUN
dpc-2620	140	35	1h	1h	NUM
dpc-2620	140	36	)	)	PUNCT
dpc-2620	140	37	.	.	PUNCT
dpc-2620	141	1	further	far	ADV
dpc-2620	141	2	,	,	PUNCT
dpc-2620	141	3	dopa	dopa	NOUN
dpc-2620	141	4	staining	stain	VERB
dpc-2620	141	5	was	be	AUX
dpc-2620	141	6	performed	perform	VERB
dpc-2620	141	7	to	to	PART
dpc-2620	141	8	check	check	VERB
dpc-2620	141	9	the	the	DET
dpc-2620	141	10	presence	presence	NOUN
dpc-2620	141	11	of	of	ADP
dpc-2620	141	12	melanocyte	melanocyte	NOUN
dpc-2620	141	13	contamination	contamination	NOUN
dpc-2620	141	14	in	in	ADP
dpc-2620	141	15	melscs	melscs	NOUN
dpc-2620	141	16	culture	culture	NOUN
dpc-2620	141	17	.	.	PUNCT
dpc-2620	142	1	the	the	DET
dpc-2620	142	2	results	result	NOUN
dpc-2620	142	3	indicated	indicate	VERB
dpc-2620	142	4	that	that	SCONJ
dpc-2620	142	5	cells	cell	NOUN
dpc-2620	142	6	were	be	AUX
dpc-2620	142	7	negative	negative	ADJ
dpc-2620	142	8	for	for	ADP
dpc-2620	142	9	dopa	dopa	NOUN
dpc-2620	142	10	,	,	PUNCT
dpc-2620	142	11	compared	compare	VERB
dpc-2620	142	12	to	to	ADP
dpc-2620	142	13	melanocytes	melanocyte	NOUN
dpc-2620	142	14	taken	take	VERB
dpc-2620	142	15	as	as	ADP
dpc-2620	142	16	positive	positive	ADJ
dpc-2620	142	17	control	control	NOUN
dpc-2620	142	18	(	(	PUNCT
dpc-2620	142	19	figure	figure	NOUN
dpc-2620	142	20	1c	1c	NOUN
dpc-2620	142	21	)	)	PUNCT
dpc-2620	142	22	.	.	PUNCT
dpc-2620	143	1	effect	effect	NOUN
dpc-2620	143	2	of	of	ADP
dpc-2620	143	3	lenalidomide	lenalidomide	NOUN
dpc-2620	143	4	on	on	ADP
dpc-2620	143	5	the	the	DET
dpc-2620	143	6	proliferation	proliferation	NOUN
dpc-2620	143	7	and	and	CCONJ
dpc-2620	143	8	 	 	SPACE
dpc-2620	143	9	migration	migration	NOUN
dpc-2620	143	10	of	of	ADP
dpc-2620	143	11	melscs	melscs	ADJ
dpc-2620	143	12	effect	effect	NOUN
dpc-2620	143	13	of	of	ADP
dpc-2620	143	14	lenalidomide	lenalidomide	NOUN
dpc-2620	143	15	was	be	AUX
dpc-2620	143	16	checked	check	VERB
dpc-2620	143	17	on	on	ADP
dpc-2620	143	18	the	the	DET
dpc-2620	143	19	proliferation	proliferation	NOUN
dpc-2620	143	20	of	of	ADP
dpc-2620	143	21	melscs	melsc	NOUN
dpc-2620	143	22	and	and	CCONJ
dpc-2620	143	23	we	we	PRON
dpc-2620	143	24	found	find	VERB
dpc-2620	143	25	that	that	SCONJ
dpc-2620	143	26	after	after	ADP
dpc-2620	143	27	24	24	NUM
dpc-2620	143	28	hours	hour	NOUN
dpc-2620	143	29	of	of	ADP
dpc-2620	143	30	treatment	treatment	NOUN
dpc-2620	143	31	,	,	PUNCT
dpc-2620	143	32	it	it	PRON
dpc-2620	143	33	increased	increase	VERB
dpc-2620	143	34	the	the	DET
dpc-2620	143	35	proliferation	proliferation	NOUN
dpc-2620	143	36	of	of	ADP
dpc-2620	143	37	melscs	melsc	NOUN
dpc-2620	143	38	at	at	ADP
dpc-2620	143	39	both	both	PRON
dpc-2620	143	40	2.5	2.5	NUM
dpc-2620	143	41	µm	µm	NOUN
dpc-2620	143	42	and	and	CCONJ
dpc-2620	143	43	5	5	NUM
dpc-2620	143	44	µm	µm	NOUN
dpc-2620	143	45	concentrations	concentration	NOUN
dpc-2620	143	46	in	in	ADP
dpc-2620	143	47	comparison	comparison	NOUN
dpc-2620	143	48	to	to	ADP
dpc-2620	143	49	untreated	untreated	ADJ
dpc-2620	143	50	control	control	NOUN
dpc-2620	143	51	,	,	PUNCT
dpc-2620	143	52	although	although	SCONJ
dpc-2620	143	53	the	the	DET
dpc-2620	143	54	increase	increase	NOUN
dpc-2620	143	55	was	be	AUX
dpc-2620	143	56	insignificant	insignificant	ADJ
dpc-2620	143	57	(	(	PUNCT
dpc-2620	143	58	figure	figure	VERB
dpc-2620	143	59	2,aand	2,aand	PROPN
dpc-2620	143	60	b	b	NOUN
dpc-2620	143	61	)	)	PUNCT
dpc-2620	143	62	.	.	PUNCT
dpc-2620	144	1	further	far	ADV
dpc-2620	144	2	it	it	PRON
dpc-2620	144	3	significantly	significantly	ADV
dpc-2620	144	4	enhanced	enhance	VERB
dpc-2620	144	5	the	the	DET
dpc-2620	144	6	migration	migration	NOUN
dpc-2620	144	7	of	of	ADP
dpc-2620	144	8	melscs	melsc	NOUN
dpc-2620	144	9	at	at	ADP
dpc-2620	144	10	both	both	DET
dpc-2620	144	11	concentrations	concentration	NOUN
dpc-2620	144	12	in	in	ADP
dpc-2620	144	13	comparison	comparison	NOUN
dpc-2620	144	14	to	to	ADP
dpc-2620	144	15	control	control	NOUN
dpc-2620	144	16	.	.	PUNCT
dpc-2620	145	1	the	the	DET
dpc-2620	145	2	percentage	percentage	NOUN
dpc-2620	145	3	of	of	ADP
dpc-2620	145	4	migrated	migrate	VERB
dpc-2620	145	5	cells	cell	NOUN
dpc-2620	145	6	increased	increase	VERB
dpc-2620	145	7	by	by	ADP
dpc-2620	145	8	88	88	NUM
dpc-2620	145	9	%	%	NOUN
dpc-2620	145	10	and	and	CCONJ
dpc-2620	145	11	95	95	NUM
dpc-2620	145	12	%	%	NOUN
dpc-2620	145	13	in	in	ADP
dpc-2620	145	14	2.5	2.5	NUM
dpc-2620	145	15	µm	µm	NOUN
dpc-2620	145	16	and	and	CCONJ
dpc-2620	145	17	5	5	NUM
dpc-2620	145	18	µm	µm	NUM
dpc-2620	145	19	treated	treat	VERB
dpc-2620	145	20	wells	well	NOUN
dpc-2620	145	21	respectively	respectively	ADV
dpc-2620	145	22	in	in	ADP
dpc-2620	145	23	comparison	comparison	NOUN
dpc-2620	145	24	to	to	ADP
dpc-2620	145	25	control	control	NOUN
dpc-2620	145	26	(	(	PUNCT
dpc-2620	145	27	figure	figure	NOUN
dpc-2620	145	28	2	2	NUM
dpc-2620	145	29	,	,	PUNCT
dpc-2620	145	30	c	c	NOUN
dpc-2620	145	31	and	and	CCONJ
dpc-2620	145	32	d	d	NOUN
dpc-2620	145	33	)	)	PUNCT
dpc-2620	145	34	.	.	PUNCT
dpc-2620	146	1	table	table	NOUN
dpc-2620	146	2	1	1	NUM
dpc-2620	146	3	.	.	PUNCT
dpc-2620	147	1	primers	primer	NOUN
dpc-2620	147	2	used	use	VERB
dpc-2620	147	3	for	for	ADP
dpc-2620	147	4	qpcr	qpcr	ADV
dpc-2620	147	5	,	,	PUNCT
dpc-2620	147	6	their	their	PRON
dpc-2620	147	7	amplicon	amplicon	NOUN
dpc-2620	147	8	length	length	NOUN
dpc-2620	147	9	and	and	CCONJ
dpc-2620	147	10	annealing	anneal	VERB
dpc-2620	147	11	temperature	temperature	NOUN
dpc-2620	147	12	.	.	PUNCT
dpc-2620	148	1	gene	gene	NOUN
dpc-2620	148	2	forward	forward	ADP
dpc-2620	148	3	primer	primer	NOUN
dpc-2620	148	4	reverse	reverse	NOUN
dpc-2620	148	5	primer	primer	NOUN
dpc-2620	148	6	amplicon	amplicon	NOUN
dpc-2620	148	7	length	length	NOUN
dpc-2620	148	8	annealing	anneal	VERB
dpc-2620	148	9	temperature	temperature	NOUN
dpc-2620	148	10	β	β	NOUN
dpc-2620	148	11	-	-	NOUN
dpc-2620	148	12	actin	actin	ADJ
dpc-2620	148	13	5	5	NUM
dpc-2620	148	14	’	'	PUNCT
dpc-2620	148	15	gaattgctatgtgtctgggt	gaattgctatgtgtctgggt	NOUN
dpc-2620	148	16	3	3	NUM
dpc-2620	148	17	’	'	PUNCT
dpc-2620	148	18	5	5	NUM
dpc-2620	148	19	’	'	PUNCT
dpc-2620	148	20	catcttcaaacctccatgatg	catcttcaaacctccatgatg	NOUN
dpc-2620	148	21	3	3	NUM
dpc-2620	148	22	’	'	PUNCT
dpc-2620	148	23	257bp	257bp	ADJ
dpc-2620	148	24	58oc	58oc	NOUN
dpc-2620	148	25	tyr	tyr	NOUN
dpc-2620	148	26	5	5	NUM
dpc-2620	148	27	’	'	PUNCT
dpc-2620	148	28	gggcccaaattgtacagaga	gggcccaaattgtacagaga	NOUN
dpc-2620	148	29	3	3	NUM
dpc-2620	148	30	’	’	SYM
dpc-2620	148	31	5	5	NUM
dpc-2620	148	32	’	'	PUNCT
dpc-2620	148	33	atgggtgttgacccattgtt	atgggtgttgacccattgtt	ADJ
dpc-2620	148	34	3	3	NUM
dpc-2620	148	35	’	'	PUNCT
dpc-2620	148	36	174bp	174bp	ADJ
dpc-2620	148	37	58oc	58oc	NOUN
dpc-2620	148	38	tyrp1	tyrp1	NOUN
dpc-2620	148	39	5	5	NUM
dpc-2620	148	40	’	'	PUNCT
dpc-2620	148	41	aagttcaatggccaggtcag	aagttcaatggccaggtcag	NOUN
dpc-2620	148	42	3	3	NUM
dpc-2620	148	43	’	’	SYM
dpc-2620	148	44	5	5	NUM
dpc-2620	148	45	’	'	PUNCT
dpc-2620	148	46	tcagtgaggagaggctggtt	tcagtgaggagaggctggtt	ADJ
dpc-2620	148	47	3	3	NUM
dpc-2620	148	48	’	'	PUNCT
dpc-2620	148	49	157bp	157bp	ADJ
dpc-2620	148	50	58oc	58oc	NOUN
dpc-2620	148	51	dct	dct	PROPN
dpc-2620	148	52	5	5	NUM
dpc-2620	148	53	’	'	PUNCT
dpc-2620	148	54	agcagacggaacactggact	agcagacggaacactggact	NOUN
dpc-2620	148	55	3	3	NUM
dpc-2620	148	56	’	’	SYM
dpc-2620	148	57	5	5	NUM
dpc-2620	148	58	’	'	PUNCT
dpc-2620	148	59	gcatctgtggaagggttgtt	gcatctgtggaagggttgtt	NOUN
dpc-2620	148	60	3	3	NUM
dpc-2620	148	61	’	'	PUNCT
dpc-2620	148	62	180bp	180bp	ADJ
dpc-2620	148	63	58oc	58oc	NOUN
dpc-2620	148	64	mitf	mitf	NOUN
dpc-2620	148	65	5	5	NUM
dpc-2620	148	66	’	'	PUNCT
dpc-2620	148	67	ggaacagcaacgagctaagg	ggaacagcaacgagctaagg	X
dpc-2620	148	68	3	3	NUM
dpc-2620	148	69	’	’	SYM
dpc-2620	148	70	5	5	NUM
dpc-2620	148	71	’	'	PUNCT
dpc-2620	148	72	tgatgatccgattcaccaga	tgatgatccgattcaccaga	NOUN
dpc-2620	148	73	3	3	NUM
dpc-2620	148	74	’	'	PUNCT
dpc-2620	148	75	170bp	170bp	ADJ
dpc-2620	148	76	58oc	58oc	NOUN
dpc-2620	148	77	sox9	sox9	NOUN
dpc-2620	148	78	5	5	NUM
dpc-2620	148	79	’	'	PUNCT
dpc-2620	148	80	cgactacgctgaccatcaga	cgactacgctgaccatcaga	NOUN
dpc-2620	148	81	3	3	NUM
dpc-2620	148	82	’	’	SYM
dpc-2620	148	83	5	5	NUM
dpc-2620	148	84	’	'	PUNCT
dpc-2620	148	85	agactggttgttcccagtgc	agactggttgttcccagtgc	ADJ
dpc-2620	148	86	3	3	NUM
dpc-2620	148	87	’	'	PUNCT
dpc-2620	148	88	188bp	188bp	NOUN
dpc-2620	148	89	58oc	58oc	NOUN
dpc-2620	148	90	sox10	sox10	NOUN
dpc-2620	148	91	5	5	NUM
dpc-2620	148	92	’	'	PUNCT
dpc-2620	148	93	agcccaggtgaagacagaga	agcccaggtgaagacagaga	NOUN
dpc-2620	148	94	3	3	NUM
dpc-2620	148	95	’	’	SYM
dpc-2620	148	96	5	5	NUM
dpc-2620	148	97	’	'	PUNCT
dpc-2620	148	98	atagggtcctgagggctgat	atagggtcctgagggctgat	PROPN
dpc-2620	148	99	3	3	NUM
dpc-2620	148	100	’	'	PUNCT
dpc-2620	148	101	175bp	175bp	PROPN
dpc-2620	148	102	58oc	58oc	NOUN
dpc-2620	148	103	original	original	ADJ
dpc-2620	148	104	article	article	NOUN
dpc-2620	148	105	|	|	ADV
dpc-2620	148	106	dermatol	dermatol	ADJ
dpc-2620	148	107	pract	pract	NOUN
dpc-2620	148	108	concept	concept	NOUN
dpc-2620	148	109	.	.	PUNCT
dpc-2620	149	1	2023;13(2):e2023077	2023;13(2):e2023077	NUM
dpc-2620	149	2	5	5	NUM
dpc-2620	149	3	disorders	disorder	NOUN
dpc-2620	149	4	and	and	CCONJ
dpc-2620	149	5	has	have	AUX
dpc-2620	149	6	shown	show	VERB
dpc-2620	149	7	therapeutic	therapeutic	ADJ
dpc-2620	149	8	effects	effect	NOUN
dpc-2620	149	9	on	on	ADP
dpc-2620	149	10	various	various	ADJ
dpc-2620	149	11	autoimmune	autoimmune	ADJ
dpc-2620	149	12	or	or	CCONJ
dpc-2620	149	13	inflammatory	inflammatory	ADJ
dpc-2620	149	14	diseases	disease	NOUN
dpc-2620	149	15	.	.	PUNCT
dpc-2620	150	1	dasanu	dasanu	NOUN
dpc-2620	150	2	et	et	NOUN
dpc-2620	150	3	al	al	PROPN
dpc-2620	151	1	[	[	X
dpc-2620	151	2	10	10	NUM
dpc-2620	151	3	]	]	PUNCT
dpc-2620	151	4	reported	report	VERB
dpc-2620	151	5	the	the	DET
dpc-2620	151	6	first	first	ADJ
dpc-2620	151	7	case	case	NOUN
dpc-2620	151	8	of	of	ADP
dpc-2620	151	9	progressive	progressive	ADJ
dpc-2620	151	10	hair	hair	NOUN
dpc-2620	151	11	repigmentation	repigmentation	NOUN
dpc-2620	151	12	with	with	ADP
dpc-2620	151	13	the	the	DET
dpc-2620	151	14	use	use	NOUN
dpc-2620	151	15	of	of	ADP
dpc-2620	151	16	this	this	DET
dpc-2620	151	17	drug	drug	NOUN
dpc-2620	151	18	in	in	ADP
dpc-2620	151	19	an	an	DET
dpc-2620	151	20	elderly	elderly	ADJ
dpc-2620	151	21	patient	patient	NOUN
dpc-2620	151	22	of	of	ADP
dpc-2620	151	23	multiple	multiple	ADJ
dpc-2620	151	24	myeloma	myeloma	NOUN
dpc-2620	151	25	.	.	PUNCT
dpc-2620	152	1	further	far	ADV
dpc-2620	152	2	they	they	PRON
dpc-2620	152	3	hypothesized	hypothesize	VERB
dpc-2620	152	4	that	that	SCONJ
dpc-2620	152	5	lenalidomide	lenalidomide	NOUN
dpc-2620	152	6	may	may	AUX
dpc-2620	152	7	be	be	AUX
dpc-2620	152	8	capable	capable	ADJ
dpc-2620	152	9	of	of	ADP
dpc-2620	152	10	stimulating	stimulate	VERB
dpc-2620	152	11	migration	migration	NOUN
dpc-2620	152	12	and	and	CCONJ
dpc-2620	152	13	differentiation	differentiation	NOUN
dpc-2620	152	14	of	of	ADP
dpc-2620	152	15	melanocytes	melanocyte	NOUN
dpc-2620	152	16	elucidated	elucidate	VERB
dpc-2620	152	17	,	,	PUNCT
dpc-2620	152	18	a	a	DET
dpc-2620	152	19	definitive	definitive	ADJ
dpc-2620	152	20	cure	cure	NOUN
dpc-2620	152	21	still	still	ADV
dpc-2620	152	22	remains	remain	VERB
dpc-2620	152	23	elusive	elusive	ADJ
dpc-2620	152	24	.	.	PUNCT
dpc-2620	153	1	therefore	therefore	ADV
dpc-2620	153	2	,	,	PUNCT
dpc-2620	153	3	many	many	ADJ
dpc-2620	153	4	newer	new	ADJ
dpc-2620	153	5	therapeutic	therapeutic	ADJ
dpc-2620	153	6	options	option	NOUN
dpc-2620	153	7	are	be	AUX
dpc-2620	153	8	being	be	AUX
dpc-2620	153	9	explored	explore	VERB
dpc-2620	153	10	to	to	PART
dpc-2620	153	11	improve	improve	VERB
dpc-2620	153	12	the	the	DET
dpc-2620	153	13	outcome	outcome	NOUN
dpc-2620	153	14	;	;	PUNCT
dpc-2620	153	15	immunomodulators	immunomodulator	NOUN
dpc-2620	153	16	being	be	AUX
dpc-2620	153	17	the	the	DET
dpc-2620	153	18	most	most	ADV
dpc-2620	153	19	recent	recent	ADJ
dpc-2620	153	20	and	and	CCONJ
dpc-2620	153	21	exciting	exciting	ADJ
dpc-2620	153	22	additions	addition	NOUN
dpc-2620	153	23	.	.	PUNCT
dpc-2620	154	1	lenalidomide	lenalidomide	PROPN
dpc-2620	154	2	is	be	AUX
dpc-2620	154	3	an	an	DET
dpc-2620	154	4	fda	fda	PROPN
dpc-2620	154	5	approved	approve	VERB
dpc-2620	154	6	immunomodulatory	immunomodulatory	ADJ
dpc-2620	154	7	imide	imide	NOUN
dpc-2620	154	8	drug	drug	NOUN
dpc-2620	154	9	which	which	PRON
dpc-2620	154	10	is	be	AUX
dpc-2620	154	11	currently	currently	ADV
dpc-2620	154	12	being	be	AUX
dpc-2620	154	13	investigated	investigate	VERB
dpc-2620	154	14	in	in	ADP
dpc-2620	154	15	various	various	ADJ
dpc-2620	154	16	figure	figure	NOUN
dpc-2620	154	17	1	1	NUM
dpc-2620	154	18	.	.	PUNCT
dpc-2620	154	19	representative	representative	ADJ
dpc-2620	154	20	images	image	NOUN
dpc-2620	154	21	showing	show	VERB
dpc-2620	154	22	(	(	PUNCT
dpc-2620	154	23	a	a	NOUN
dpc-2620	154	24	)	)	PUNCT
dpc-2620	154	25	primary	primary	ADJ
dpc-2620	154	26	culture	culture	NOUN
dpc-2620	154	27	of	of	ADP
dpc-2620	154	28	melanocyte	melanocyte	NOUN
dpc-2620	154	29	stem	stem	NOUN
dpc-2620	154	30	cells	cell	NOUN
dpc-2620	154	31	at	at	ADP
dpc-2620	154	32	day	day	NOUN
dpc-2620	154	33	0	0	NUM
dpc-2620	154	34	,	,	PUNCT
dpc-2620	154	35	day	day	NOUN
dpc-2620	154	36	5	5	NUM
dpc-2620	154	37	,	,	PUNCT
dpc-2620	154	38	day	day	NOUN
dpc-2620	154	39	10	10	NUM
dpc-2620	154	40	and	and	CCONJ
dpc-2620	154	41	day	day	NOUN
dpc-2620	154	42	15	15	NUM
dpc-2620	154	43	,	,	PUNCT
dpc-2620	154	44	(	(	PUNCT
dpc-2620	154	45	b	b	X
dpc-2620	154	46	)	)	PUNCT
dpc-2620	154	47	subculture	subculture	NOUN
dpc-2620	154	48	of	of	ADP
dpc-2620	154	49	melscs	melsc	NOUN
dpc-2620	154	50	at	at	ADP
dpc-2620	154	51	3	3	NUM
dpc-2620	154	52	hours	hour	NOUN
dpc-2620	154	53	and	and	CCONJ
dpc-2620	154	54	day	day	NOUN
dpc-2620	154	55	1	1	NUM
dpc-2620	154	56	,	,	PUNCT
dpc-2620	154	57	(	(	PUNCT
dpc-2620	154	58	c	c	X
dpc-2620	154	59	)	)	PUNCT
dpc-2620	154	60	dopa	dopa	NOUN
dpc-2620	154	61	staining	staining	NOUN
dpc-2620	154	62	of	of	ADP
dpc-2620	154	63	melanocyte	melanocyte	NOUN
dpc-2620	154	64	stem	stem	NOUN
dpc-2620	154	65	cells	cell	NOUN
dpc-2620	154	66	and	and	CCONJ
dpc-2620	154	67	melanocytes	melanocyte	NOUN
dpc-2620	154	68	(	(	PUNCT
dpc-2620	154	69	taken	take	VERB
dpc-2620	154	70	as	as	ADP
dpc-2620	154	71	positive	positive	ADJ
dpc-2620	154	72	control	control	NOUN
dpc-2620	154	73	)	)	PUNCT
dpc-2620	154	74	after	after	ADP
dpc-2620	154	75	4	4	NUM
dpc-2620	154	76	hours	hour	NOUN
dpc-2620	154	77	,	,	PUNCT
dpc-2620	154	78	(	(	PUNCT
dpc-2620	154	79	d	d	X
dpc-2620	154	80	)	)	PUNCT
dpc-2620	154	81	  	  	SPACE
dpc-2620	154	82	confocal	confocal	ADJ
dpc-2620	154	83	imaging	imaging	NOUN
dpc-2620	154	84	indicating	indicate	VERB
dpc-2620	154	85	nestin	nestin	NOUN
dpc-2620	154	86	immunostaining	immunostaine	VERB
dpc-2620	154	87	for	for	ADP
dpc-2620	154	88	the	the	DET
dpc-2620	154	89	characterization	characterization	NOUN
dpc-2620	154	90	of	of	ADP
dpc-2620	154	91	melsc	melsc	NOUN
dpc-2620	154	92	spheres	sphere	NOUN
dpc-2620	154	93	.	.	PUNCT
dpc-2620	155	1	representative	representative	ADJ
dpc-2620	155	2	images	image	NOUN
dpc-2620	155	3	from	from	ADP
dpc-2620	155	4	confocal	confocal	ADJ
dpc-2620	155	5	microscopy	microscopy	NOUN
dpc-2620	155	6	showing	show	VERB
dpc-2620	155	7	the	the	DET
dpc-2620	155	8	characterization	characterization	NOUN
dpc-2620	155	9	of	of	ADP
dpc-2620	155	10	melscs	melsc	NOUN
dpc-2620	155	11	by	by	ADP
dpc-2620	155	12	immunostaining	immunostaine	VERB
dpc-2620	155	13	with	with	ADP
dpc-2620	155	14	(	(	PUNCT
dpc-2620	155	15	e	e	NOUN
dpc-2620	155	16	)	)	PUNCT
dpc-2620	155	17	nestin	nestin	NOUN
dpc-2620	155	18	,	,	PUNCT
dpc-2620	155	19	(	(	PUNCT
dpc-2620	155	20	f	f	X
dpc-2620	155	21	)	)	PUNCT
dpc-2620	155	22	cd34	cd34	PROPN
dpc-2620	155	23	,	,	PUNCT
dpc-2620	155	24	(	(	PUNCT
dpc-2620	155	25	g	g	NOUN
dpc-2620	155	26	)	)	PUNCT
dpc-2620	155	27	dct	dct	PROPN
dpc-2620	155	28	,	,	PUNCT
dpc-2620	155	29	and	and	CCONJ
dpc-2620	155	30	(	(	PUNCT
dpc-2620	155	31	h	h	NOUN
dpc-2620	155	32	)	)	PUNCT
dpc-2620	155	33	tyrosinase	tyrosinase	NOUN
dpc-2620	155	34	.	.	PUNCT
dpc-2620	156	1	6	6	NUM
dpc-2620	156	2	original	original	ADJ
dpc-2620	156	3	article	article	NOUN
dpc-2620	156	4	|	|	ADV
dpc-2620	156	5	dermatol	dermatol	ADJ
dpc-2620	156	6	pract	pract	NOUN
dpc-2620	156	7	concept	concept	NOUN
dpc-2620	156	8	.	.	PUNCT
dpc-2620	157	1	2023;13(2):e2023077	2023;13(2):e2023077	NUM
dpc-2620	157	2	b	b	PROPN
dpc-2620	157	3	pe	pe	PROPN
dpc-2620	157	4	rc	rc	PROPN
dpc-2620	157	5	en	en	X
dpc-2620	157	6	ta	ta	PROPN
dpc-2620	157	7	ge	ge	PROPN
dpc-2620	157	8	p	p	PROPN
dpc-2620	157	9	ro	ro	PROPN
dpc-2620	157	10	lif	lif	PROPN
dpc-2620	157	11	er	er	INTJ
dpc-2620	157	12	at	at	ADP
dpc-2620	157	13	io	io	PROPN
dpc-2620	157	14	n	n	PROPN
dpc-2620	157	15	of	of	ADP
dpc-2620	157	16	m	m	PROPN
dpc-2620	157	17	el	el	PROPN
dpc-2620	157	18	sc	sc	PROPN
dpc-2620	157	19	s	s	VERB
dpc-2620	157	20	len	len	ADJ
dpc-2620	157	21	2.5	2.5	NUM
dpc-2620	157	22	µm	µm	ADP
dpc-2620	157	23	len	len	NOUN
dpc-2620	157	24	5	5	NUM
dpc-2620	157	25	µm	µm	ADP
dpc-2620	157	26	control	control	NOUN
dpc-2620	157	27	0	0	NUM
dpc-2620	157	28	50	50	NUM
dpc-2620	157	29	100	100	NUM
dpc-2620	157	30	150	150	NUM
dpc-2620	157	31	a	a	DET
dpc-2620	157	32	len	len	ADJ
dpc-2620	157	33	2.5	2.5	NUM
dpc-2620	157	34	µm	µm	ADP
dpc-2620	157	35	len	len	ADJ
dpc-2620	157	36	5	5	NUM
dpc-2620	157	37	µmcontrol	µmcontrol	NOUN
dpc-2620	157	38	proliferation	proliferation	NOUN
dpc-2620	157	39	of	of	ADP
dpc-2620	157	40	melanocyte	melanocyte	NOUN
dpc-2620	157	41	stem	stem	NOUN
dpc-2620	157	42	cells	cell	NOUN
dpc-2620	157	43	(	(	PUNCT
dpc-2620	157	44	24hr	24hr	ADJ
dpc-2620	157	45	)	)	PUNCT
dpc-2620	158	1	c	c	NOUN
dpc-2620	158	2	len	len	NOUN
dpc-2620	158	3	2.5	2.5	NUM
dpc-2620	158	4	µm	µm	ADP
dpc-2620	158	5	len	len	ADJ
dpc-2620	158	6	5	5	NUM
dpc-2620	158	7	µmcontrol	µmcontrol	ADP
dpc-2620	158	8	migration	migration	NOUN
dpc-2620	158	9	assay	assay	NOUN
dpc-2620	158	10	of	of	ADP
dpc-2620	158	11	melanocyte	melanocyte	NOUN
dpc-2620	158	12	stem	stem	NOUN
dpc-2620	158	13	cells	cell	NOUN
dpc-2620	158	14	(	(	PUNCT
dpc-2620	158	15	18hr	18hr	NOUN
dpc-2620	158	16	)	)	PUNCT
dpc-2620	159	1	d	d	X
dpc-2620	159	2	pe	pe	PROPN
dpc-2620	159	3	rc	rc	PROPN
dpc-2620	159	4	en	en	X
dpc-2620	159	5	ta	ta	PROPN
dpc-2620	159	6	ge	ge	PROPN
dpc-2620	159	7	m	m	VERB
dpc-2620	159	8	ig	ig	INTJ
dpc-2620	159	9	ra	ra	NOUN
dpc-2620	159	10	ti	ti	NOUN
dpc-2620	159	11	on	on	ADP
dpc-2620	159	12	o	o	PROPN
dpc-2620	159	13	f	f	PROPN
dpc-2620	159	14	m	m	PROPN
dpc-2620	159	15	el	el	PROPN
dpc-2620	159	16	sc	sc	PROPN
dpc-2620	159	17	s	s	VERB
dpc-2620	159	18	len	len	ADJ
dpc-2620	159	19	2.5	2.5	NUM
dpc-2620	159	20	µm	µm	ADP
dpc-2620	159	21	len	len	NOUN
dpc-2620	159	22	5	5	NUM
dpc-2620	159	23	µm	µm	ADP
dpc-2620	159	24	control	control	NOUN
dpc-2620	159	25	0	0	NUM
dpc-2620	159	26	50	50	NUM
dpc-2620	159	27	100	100	NUM
dpc-2620	159	28	250	250	NUM
dpc-2620	159	29	150	150	NUM
dpc-2620	159	30	200	200	NUM
dpc-2620	159	31	figure	figure	NOUN
dpc-2620	159	32	2	2	NUM
dpc-2620	159	33	.	.	PUNCT
dpc-2620	160	1	(	(	PUNCT
dpc-2620	160	2	a	a	X
dpc-2620	160	3	)	)	PUNCT
dpc-2620	160	4	representative	representative	ADJ
dpc-2620	160	5	pictures	picture	NOUN
dpc-2620	160	6	of	of	ADP
dpc-2620	160	7	cultured	cultured	ADJ
dpc-2620	160	8	melscs	melsc	NOUN
dpc-2620	160	9	.	.	PUNCT
dpc-2620	161	1	(	(	PUNCT
dpc-2620	161	2	b	b	X
dpc-2620	161	3	)	)	PUNCT
dpc-2620	161	4	bar	bar	NOUN
dpc-2620	161	5	diagram	diagram	NOUN
dpc-2620	161	6	showing	show	VERB
dpc-2620	161	7	the	the	DET
dpc-2620	161	8	effect	effect	NOUN
dpc-2620	161	9	of	of	ADP
dpc-2620	161	10	lenalidomide	lenalidomide	NOUN
dpc-2620	161	11	(	(	PUNCT
dpc-2620	161	12	2.5	2.5	NUM
dpc-2620	161	13	µm	µm	NOUN
dpc-2620	161	14	and	and	CCONJ
dpc-2620	161	15	5	5	NUM
dpc-2620	161	16	µm	µm	NOUN
dpc-2620	161	17	)	)	PUNCT
dpc-2620	161	18	on	on	ADP
dpc-2620	161	19	the	the	DET
dpc-2620	161	20	proliferation	proliferation	NOUN
dpc-2620	161	21	of	of	ADP
dpc-2620	161	22	melscs	melsc	NOUN
dpc-2620	161	23	as	as	ADP
dpc-2620	161	24	compared	compare	VERB
dpc-2620	161	25	to	to	ADP
dpc-2620	161	26	untreated	untreated	ADJ
dpc-2620	161	27	control	control	NOUN
dpc-2620	161	28	cells	cell	NOUN
dpc-2620	161	29	after	after	ADP
dpc-2620	161	30	24	24	NUM
dpc-2620	161	31	hours	hour	NOUN
dpc-2620	161	32	of	of	ADP
dpc-2620	161	33	treatment	treatment	NOUN
dpc-2620	161	34	.	.	PUNCT
dpc-2620	162	1	(	(	PUNCT
dpc-2620	162	2	c	c	X
dpc-2620	162	3	)	)	PUNCT
dpc-2620	162	4	light	light	ADJ
dpc-2620	162	5	microscopic	microscopic	ADJ
dpc-2620	162	6	images	image	NOUN
dpc-2620	162	7	depicting	depict	VERB
dpc-2620	162	8	the	the	DET
dpc-2620	162	9	migration	migration	NOUN
dpc-2620	162	10	of	of	ADP
dpc-2620	162	11	melscs	melsc	NOUN
dpc-2620	162	12	in	in	ADP
dpc-2620	162	13	control	control	NOUN
dpc-2620	162	14	,	,	PUNCT
dpc-2620	162	15	2.5	2.5	NUM
dpc-2620	162	16	µm	µm	NOUN
dpc-2620	162	17	and	and	CCONJ
dpc-2620	162	18	5	5	NUM
dpc-2620	162	19	µm	µm	NOUN
dpc-2620	162	20	lenalidomide	lenalidomide	NOUN
dpc-2620	162	21	treated	treat	VERB
dpc-2620	162	22	cells	cell	NOUN
dpc-2620	162	23	at	at	ADP
dpc-2620	162	24	18	18	NUM
dpc-2620	162	25	hours	hour	NOUN
dpc-2620	162	26	.	.	PUNCT
dpc-2620	163	1	(	(	PUNCT
dpc-2620	163	2	d	d	X
dpc-2620	163	3	)	)	PUNCT
dpc-2620	163	4	bar	bar	NOUN
dpc-2620	163	5	diagram	diagram	NOUN
dpc-2620	163	6	displaying	display	VERB
dpc-2620	163	7	the	the	DET
dpc-2620	163	8	effect	effect	NOUN
dpc-2620	163	9	of	of	ADP
dpc-2620	163	10	lenalidomide	lenalidomide	NOUN
dpc-2620	163	11	(	(	PUNCT
dpc-2620	163	12	2.5	2.5	NUM
dpc-2620	163	13	 	 	SPACE
dpc-2620	163	14	µm	µm	NOUN
dpc-2620	163	15	and	and	CCONJ
dpc-2620	163	16	5	5	NUM
dpc-2620	163	17	µm	µm	NOUN
dpc-2620	163	18	)	)	PUNCT
dpc-2620	163	19	on	on	ADP
dpc-2620	163	20	migration	migration	NOUN
dpc-2620	163	21	(	(	PUNCT
dpc-2620	163	22	at	at	ADP
dpc-2620	163	23	18	18	NUM
dpc-2620	163	24	hours	hour	NOUN
dpc-2620	163	25	)	)	PUNCT
dpc-2620	163	26	of	of	ADP
dpc-2620	163	27	melscs	melsc	NOUN
dpc-2620	163	28	as	as	SCONJ
dpc-2620	163	29	compared	compare	VERB
dpc-2620	163	30	to	to	ADP
dpc-2620	163	31	control	control	NOUN
dpc-2620	163	32	.	.	PUNCT
dpc-2620	164	1	data	datum	NOUN
dpc-2620	164	2	are	be	AUX
dpc-2620	164	3	presented	present	VERB
dpc-2620	164	4	as	as	ADP
dpc-2620	164	5	mean	mean	NOUN
dpc-2620	164	6	±	±	NUM
dpc-2620	164	7	standard	standard	ADJ
dpc-2620	164	8	deviation	deviation	NOUN
dpc-2620	164	9	;	;	PUNCT
dpc-2620	164	10	statistical	statistical	ADJ
dpc-2620	164	11	significance	significance	NOUN
dpc-2620	164	12	is	be	AUX
dpc-2620	164	13	shown	show	VERB
dpc-2620	164	14	by	by	ADP
dpc-2620	164	15	*	*	PROPN
dpc-2620	164	16	p	p	X
dpc-2620	164	17	<	<	X
dpc-2620	164	18	0.05	0.05	NUM
dpc-2620	164	19	,	,	PUNCT
dpc-2620	164	20	*	*	PUNCT
dpc-2620	164	21	*	*	PUNCT
dpc-2620	164	22	p	p	X
dpc-2620	164	23	<	<	X
dpc-2620	164	24	0.01	0.01	NUM
dpc-2620	164	25	.	.	PUNCT
dpc-2620	165	1	a	a	DET
dpc-2620	165	2	fo	fo	INTJ
dpc-2620	165	3	ld	ld	PROPN
dpc-2620	165	4	c	c	PROPN
dpc-2620	165	5	ha	ha	INTJ
dpc-2620	165	6	ng	ng	PROPN
dpc-2620	165	7	e	e	PROPN
dpc-2620	165	8	(	(	PUNCT
dpc-2620	165	9	d	d	NOUN
dpc-2620	165	10	ct	ct	PROPN
dpc-2620	165	11	e	e	X
dpc-2620	165	12	xp	xp	X
dpc-2620	165	13	re	re	VERB
dpc-2620	165	14	ss	ss	PROPN
dpc-2620	165	15	io	io	PROPN
dpc-2620	165	16	n	n	CCONJ
dpc-2620	165	17	)	)	PUNCT
dpc-2620	165	18	len	len	NOUN
dpc-2620	165	19	2.5	2.5	NUM
dpc-2620	165	20	µm	µm	ADP
dpc-2620	165	21	len	len	NOUN
dpc-2620	165	22	5	5	NUM
dpc-2620	165	23	µm	µm	ADP
dpc-2620	165	24	control	control	NOUN
dpc-2620	165	25	0	0	NUM
dpc-2620	165	26	2	2	NUM
dpc-2620	165	27	1	1	NUM
dpc-2620	165	28	3	3	NUM
dpc-2620	165	29	b	b	NOUN
dpc-2620	165	30	fo	fo	INTJ
dpc-2620	165	31	ld	ld	INTJ
dpc-2620	166	1	c	c	PROPN
dpc-2620	166	2	ha	ha	INTJ
dpc-2620	166	3	ng	ng	PROPN
dpc-2620	166	4	e	e	PROPN
dpc-2620	166	5	(	(	PUNCT
dpc-2620	166	6	t	t	PROPN
dpc-2620	166	7	yr	yr	PROPN
dpc-2620	166	8	p1	p1	PROPN
dpc-2620	166	9	e	e	PROPN
dpc-2620	166	10	xp	xp	X
dpc-2620	166	11	re	re	VERB
dpc-2620	166	12	ss	ss	PROPN
dpc-2620	166	13	io	io	PROPN
dpc-2620	166	14	n	n	CCONJ
dpc-2620	166	15	)	)	PUNCT
dpc-2620	166	16	len	len	NOUN
dpc-2620	166	17	2.5	2.5	NUM
dpc-2620	166	18	µm	µm	ADP
dpc-2620	166	19	len	len	NOUN
dpc-2620	166	20	5	5	NUM
dpc-2620	166	21	µm	µm	ADP
dpc-2620	166	22	control	control	NOUN
dpc-2620	166	23	0	0	NUM
dpc-2620	166	24	2	2	NUM
dpc-2620	166	25	1	1	NUM
dpc-2620	166	26	3	3	NUM
dpc-2620	166	27	c	c	NOUN
dpc-2620	166	28	fo	fo	INTJ
dpc-2620	166	29	ld	ld	INTJ
dpc-2620	167	1	c	c	PROPN
dpc-2620	167	2	ha	ha	INTJ
dpc-2620	167	3	ng	ng	PROPN
dpc-2620	167	4	e	e	PROPN
dpc-2620	167	5	(	(	PUNCT
dpc-2620	167	6	t	t	PROPN
dpc-2620	167	7	yr	yr	NOUN
dpc-2620	167	8	e	e	X
dpc-2620	167	9	xp	xp	X
dpc-2620	167	10	re	re	VERB
dpc-2620	167	11	ss	ss	PROPN
dpc-2620	167	12	io	io	PROPN
dpc-2620	167	13	n	n	CCONJ
dpc-2620	167	14	)	)	PUNCT
dpc-2620	167	15	len	len	NOUN
dpc-2620	167	16	2.5	2.5	NUM
dpc-2620	167	17	µm	µm	ADP
dpc-2620	167	18	len	len	NOUN
dpc-2620	167	19	5	5	NUM
dpc-2620	167	20	µm	µm	ADP
dpc-2620	167	21	control	control	NOUN
dpc-2620	167	22	0	0	NUM
dpc-2620	167	23	4	4	NUM
dpc-2620	167	24	2	2	NUM
dpc-2620	167	25	6	6	NUM
dpc-2620	167	26	d	d	NOUN
dpc-2620	167	27	fo	fo	INTJ
dpc-2620	167	28	ld	ld	PROPN
dpc-2620	168	1	c	c	PROPN
dpc-2620	168	2	ha	ha	INTJ
dpc-2620	168	3	ng	ng	PROPN
dpc-2620	168	4	e	e	PROPN
dpc-2620	168	5	(	(	PUNCT
dpc-2620	168	6	m	m	VERB
dpc-2620	168	7	it	it	PRON
dpc-2620	168	8	f	f	X
dpc-2620	168	9	ex	ex	X
dpc-2620	168	10	pr	pr	NOUN
dpc-2620	168	11	es	es	X
dpc-2620	168	12	si	si	X
dpc-2620	168	13	on	on	ADV
dpc-2620	168	14	)	)	PUNCT
dpc-2620	168	15	len	len	PROPN
dpc-2620	168	16	2.5	2.5	NUM
dpc-2620	168	17	µm	µm	ADP
dpc-2620	168	18	len	len	NOUN
dpc-2620	168	19	5	5	NUM
dpc-2620	168	20	µm	µm	ADP
dpc-2620	168	21	control	control	NOUN
dpc-2620	168	22	0.0	0.0	NUM
dpc-2620	168	23	1.5	1.5	NUM
dpc-2620	168	24	1.0	1.0	NUM
dpc-2620	168	25	0.5	0.5	NUM
dpc-2620	168	26	2.0	2.0	NUM
dpc-2620	168	27	e	e	NOUN
dpc-2620	168	28	fo	fo	ADP
dpc-2620	168	29	ld	ld	PROPN
dpc-2620	168	30	c	c	PROPN
dpc-2620	168	31	ha	ha	INTJ
dpc-2620	168	32	ng	ng	PROPN
dpc-2620	168	33	e	e	PROPN
dpc-2620	168	34	(	(	PUNCT
dpc-2620	168	35	s	s	VERB
dpc-2620	168	36	o	o	X
dpc-2620	168	37	x1	x1	PROPN
dpc-2620	168	38	0	0	PUNCT
dpc-2620	169	1	ex	ex	PRON
dpc-2620	169	2	pr	pr	NOUN
dpc-2620	169	3	es	es	X
dpc-2620	169	4	si	si	X
dpc-2620	169	5	on	on	ADV
dpc-2620	169	6	)	)	PUNCT
dpc-2620	169	7	len	len	PROPN
dpc-2620	169	8	2.5	2.5	NUM
dpc-2620	169	9	µm	µm	ADP
dpc-2620	169	10	len	len	NOUN
dpc-2620	169	11	5	5	NUM
dpc-2620	169	12	µm	µm	ADP
dpc-2620	169	13	control	control	NOUN
dpc-2620	169	14	0	0	NUM
dpc-2620	169	15	8	8	NUM
dpc-2620	169	16	6	6	NUM
dpc-2620	169	17	4	4	NUM
dpc-2620	169	18	2	2	NUM
dpc-2620	169	19	10	10	NUM
dpc-2620	169	20	f	f	NOUN
dpc-2620	169	21	fo	fo	INTJ
dpc-2620	169	22	ld	ld	INTJ
dpc-2620	169	23	c	c	PROPN
dpc-2620	169	24	ha	ha	INTJ
dpc-2620	169	25	ng	ng	PROPN
dpc-2620	169	26	e	e	PROPN
dpc-2620	169	27	(	(	PUNCT
dpc-2620	169	28	s	s	PROPN
dpc-2620	169	29	o	o	X
dpc-2620	169	30	x9	x9	PROPN
dpc-2620	169	31	e	e	X
dpc-2620	169	32	xp	xp	X
dpc-2620	169	33	re	re	VERB
dpc-2620	169	34	ss	ss	PROPN
dpc-2620	169	35	io	io	PROPN
dpc-2620	169	36	n	n	CCONJ
dpc-2620	169	37	)	)	PUNCT
dpc-2620	169	38	len	len	NOUN
dpc-2620	169	39	2.5	2.5	NUM
dpc-2620	169	40	µm	µm	ADP
dpc-2620	169	41	len	len	NOUN
dpc-2620	169	42	5	5	NUM
dpc-2620	169	43	µm	µm	ADP
dpc-2620	169	44	control	control	NOUN
dpc-2620	169	45	0	0	NUM
dpc-2620	169	46	4	4	NUM
dpc-2620	169	47	ns2	ns2	NOUN
dpc-2620	169	48	3	3	NUM
dpc-2620	169	49	1	1	NUM
dpc-2620	169	50	figure	figure	NOUN
dpc-2620	169	51	3	3	NUM
dpc-2620	169	52	.	.	PUNCT
dpc-2620	169	53	bar	bar	NOUN
dpc-2620	169	54	diagram	diagram	NOUN
dpc-2620	169	55	showing	show	VERB
dpc-2620	169	56	relative	relative	ADJ
dpc-2620	169	57	mrna	mrna	NOUN
dpc-2620	169	58	expression	expression	NOUN
dpc-2620	169	59	of	of	ADP
dpc-2620	169	60	(	(	PUNCT
dpc-2620	169	61	a	a	X
dpc-2620	169	62	)	)	PUNCT
dpc-2620	169	63	dct	dct	PROPN
dpc-2620	169	64	(	(	PUNCT
dpc-2620	169	65	b	b	NOUN
dpc-2620	169	66	)	)	PUNCT
dpc-2620	169	67	tyrp1	tyrp1	NOUN
dpc-2620	169	68	(	(	PUNCT
dpc-2620	169	69	c	c	X
dpc-2620	169	70	)	)	PUNCT
dpc-2620	169	71	tyr	tyr	NOUN
dpc-2620	169	72	(	(	PUNCT
dpc-2620	169	73	d	d	NOUN
dpc-2620	169	74	)	)	PUNCT
dpc-2620	169	75	mitf	mitf	NOUN
dpc-2620	169	76	(	(	PUNCT
dpc-2620	169	77	e	e	NOUN
dpc-2620	169	78	)	)	PUNCT
dpc-2620	169	79	sox10	sox10	NOUN
dpc-2620	169	80	and	and	CCONJ
dpc-2620	169	81	(	(	PUNCT
dpc-2620	169	82	f	f	X
dpc-2620	169	83	)	)	PUNCT
dpc-2620	169	84	sox9	sox9	PROPN
dpc-2620	169	85	in	in	ADP
dpc-2620	169	86	control	control	NOUN
dpc-2620	169	87	,	,	PUNCT
dpc-2620	169	88	2.5	2.5	NUM
dpc-2620	169	89	µm	µm	NOUN
dpc-2620	169	90	lenalidomide	lenalidomide	NOUN
dpc-2620	169	91	and	and	CCONJ
dpc-2620	169	92	5	5	NUM
dpc-2620	169	93	µm	µm	NOUN
dpc-2620	169	94	lenalidomide	lenalidomide	NOUN
dpc-2620	169	95	treated	treat	VERB
dpc-2620	169	96	melscs	melsc	NOUN
dpc-2620	169	97	.	.	PUNCT
dpc-2620	170	1	the	the	DET
dpc-2620	170	2	relative	relative	ADJ
dpc-2620	170	3	level	level	NOUN
dpc-2620	170	4	of	of	ADP
dpc-2620	170	5	target	target	NOUN
dpc-2620	170	6	gene	gene	NOUN
dpc-2620	170	7	expression	expression	NOUN
dpc-2620	170	8	was	be	AUX
dpc-2620	170	9	calculated	calculate	VERB
dpc-2620	170	10	by	by	ADP
dpc-2620	170	11	livak	livak	ADJ
dpc-2620	170	12	and	and	CCONJ
dpc-2620	170	13	schmittgen	schmittgen	NOUN
dpc-2620	170	14	method	method	NOUN
dpc-2620	170	15	and	and	CCONJ
dpc-2620	170	16	normalized	normalize	VERB
dpc-2620	170	17	with	with	ADP
dpc-2620	170	18	β	β	NOUN
dpc-2620	170	19	-	-	NOUN
dpc-2620	170	20	actin	actin	NOUN
dpc-2620	170	21	.	.	PUNCT
dpc-2620	171	1	data	datum	NOUN
dpc-2620	171	2	are	be	AUX
dpc-2620	171	3	presented	present	VERB
dpc-2620	171	4	as	as	ADP
dpc-2620	171	5	mean	mean	NOUN
dpc-2620	171	6	±	±	NUM
dpc-2620	171	7	standard	standard	ADJ
dpc-2620	171	8	deviation	deviation	NOUN
dpc-2620	171	9	;	;	PUNCT
dpc-2620	171	10	statistical	statistical	ADJ
dpc-2620	171	11	significance	significance	NOUN
dpc-2620	171	12	is	be	AUX
dpc-2620	171	13	shown	show	VERB
dpc-2620	171	14	by	by	ADP
dpc-2620	171	15	(	(	PUNCT
dpc-2620	171	16	*	*	PUNCT
dpc-2620	171	17	p	p	X
dpc-2620	171	18	 	 	SPACE
dpc-2620	171	19	<	<	NOUN
dpc-2620	171	20	0.05	0.05	NUM
dpc-2620	171	21	,	,	PUNCT
dpc-2620	171	22	*	*	PUNCT
dpc-2620	171	23	*	*	PUNCT
dpc-2620	171	24	p	p	X
dpc-2620	171	25	<	<	X
dpc-2620	171	26	0.01	0.01	NUM
dpc-2620	171	27	,	,	PUNCT
dpc-2620	171	28	*	*	PUNCT
dpc-2620	171	29	*	*	PUNCT
dpc-2620	171	30	*	*	PUNCT
dpc-2620	171	31	p	p	X
dpc-2620	171	32	<	<	X
dpc-2620	171	33	0.001	0.001	NUM
dpc-2620	171	34	and	and	CCONJ
dpc-2620	171	35	*	*	NOUN
dpc-2620	171	36	*	*	PUNCT
dpc-2620	171	37	*	*	PUNCT
dpc-2620	171	38	*	*	PUNCT
dpc-2620	171	39	p	p	X
dpc-2620	171	40	<	<	X
dpc-2620	171	41	0.0001	0.0001	NUM
dpc-2620	171	42	)	)	PUNCT
dpc-2620	171	43	.	.	PUNCT
dpc-2620	172	1	original	original	ADJ
dpc-2620	172	2	article	article	NOUN
dpc-2620	172	3	|	|	ADV
dpc-2620	172	4	dermatol	dermatol	ADJ
dpc-2620	172	5	pract	pract	NOUN
dpc-2620	172	6	concept	concept	NOUN
dpc-2620	172	7	.	.	PUNCT
dpc-2620	173	1	2023;13(2):e2023077	2023;13(2):e2023077	NUM
dpc-2620	173	2	7	7	NUM
dpc-2620	173	3	for	for	ADP
dpc-2620	173	4	neural	neural	ADJ
dpc-2620	173	5	crest	crest	NOUN
dpc-2620	173	6	cell	cell	NOUN
dpc-2620	173	7	marker	marker	NOUN
dpc-2620	173	8	,	,	PUNCT
dpc-2620	173	9	nestin	nestin	NOUN
dpc-2620	173	10	.	.	PUNCT
dpc-2620	174	1	nestin	nestin	ADJ
dpc-2620	174	2	-	-	PUNCT
dpc-2620	174	3	positive	positive	ADJ
dpc-2620	174	4	neural	neural	ADJ
dpc-2620	174	5	crest	crest	NOUN
dpc-2620	174	6	-	-	PUNCT
dpc-2620	174	7	derived	derive	VERB
dpc-2620	174	8	stem	stem	NOUN
dpc-2620	174	9	cells	cell	NOUN
dpc-2620	174	10	have	have	VERB
dpc-2620	174	11	the	the	DET
dpc-2620	174	12	ability	ability	NOUN
dpc-2620	174	13	to	to	PART
dpc-2620	174	14	form	form	VERB
dpc-2620	174	15	neurospheres	neurosphere	NOUN
dpc-2620	174	16	[	[	X
dpc-2620	174	17	19,20	19,20	X
dpc-2620	174	18	]	]	PUNCT
dpc-2620	174	19	.	.	PUNCT
dpc-2620	175	1	the	the	DET
dpc-2620	175	2	cultured	cultured	ADJ
dpc-2620	175	3	spheres	sphere	NOUN
dpc-2620	175	4	were	be	AUX
dpc-2620	175	5	later	later	ADV
dpc-2620	175	6	transferred	transfer	VERB
dpc-2620	175	7	to	to	ADP
dpc-2620	175	8	new	new	ADJ
dpc-2620	175	9	culture	culture	NOUN
dpc-2620	175	10	and	and	CCONJ
dpc-2620	175	11	cells	cell	NOUN
dpc-2620	175	12	started	start	VERB
dpc-2620	175	13	migrating	migrate	VERB
dpc-2620	175	14	out	out	ADP
dpc-2620	175	15	of	of	ADP
dpc-2620	175	16	these	these	DET
dpc-2620	175	17	spheres	sphere	NOUN
dpc-2620	175	18	and	and	CCONJ
dpc-2620	175	19	were	be	AUX
dpc-2620	175	20	characterized	characterize	VERB
dpc-2620	175	21	for	for	ADP
dpc-2620	175	22	the	the	DET
dpc-2620	175	23	various	various	ADJ
dpc-2620	175	24	markers	marker	NOUN
dpc-2620	175	25	like	like	ADP
dpc-2620	175	26	nestin	nestin	NOUN
dpc-2620	175	27	,	,	PUNCT
dpc-2620	175	28	cd34	cd34	PROPN
dpc-2620	175	29	,	,	PUNCT
dpc-2620	175	30	tyrosinase	tyrosinase	NOUN
dpc-2620	175	31	,	,	PUNCT
dpc-2620	175	32	dct	dct	PROPN
dpc-2620	175	33	and	and	CCONJ
dpc-2620	175	34	dopa	dopa	NOUN
dpc-2620	175	35	.	.	PUNCT
dpc-2620	176	1	the	the	DET
dpc-2620	176	2	results	result	NOUN
dpc-2620	176	3	showed	show	VERB
dpc-2620	176	4	that	that	SCONJ
dpc-2620	176	5	these	these	DET
dpc-2620	176	6	cells	cell	NOUN
dpc-2620	176	7	expressed	express	VERB
dpc-2620	176	8	nestin	nestin	NOUN
dpc-2620	176	9	,	,	PUNCT
dpc-2620	176	10	a	a	DET
dpc-2620	176	11	marker	marker	NOUN
dpc-2620	176	12	for	for	ADP
dpc-2620	176	13	neural	neural	ADJ
dpc-2620	176	14	progenitors	progenitor	NOUN
dpc-2620	176	15	that	that	PRON
dpc-2620	176	16	is	be	AUX
dpc-2620	176	17	also	also	ADV
dpc-2620	176	18	expressed	express	VERB
dpc-2620	176	19	by	by	ADP
dpc-2620	176	20	stem	stem	NOUN
dpc-2620	176	21	cells	cell	NOUN
dpc-2620	176	22	of	of	ADP
dpc-2620	176	23	the	the	DET
dpc-2620	176	24	hair	hair	NOUN
dpc-2620	176	25	follicle	follicle	NOUN
dpc-2620	176	26	bulge	bulge	NOUN
dpc-2620	177	1	[	[	X
dpc-2620	177	2	21	21	NUM
dpc-2620	177	3	]	]	PUNCT
dpc-2620	177	4	.	.	PUNCT
dpc-2620	178	1	cultured	cultured	ADJ
dpc-2620	178	2	cells	cell	NOUN
dpc-2620	178	3	were	be	AUX
dpc-2620	178	4	also	also	ADV
dpc-2620	178	5	positive	positive	ADJ
dpc-2620	178	6	for	for	ADP
dpc-2620	178	7	dct	dct	PROPN
dpc-2620	178	8	,	,	PUNCT
dpc-2620	178	9	which	which	PRON
dpc-2620	178	10	is	be	AUX
dpc-2620	178	11	a	a	DET
dpc-2620	178	12	marker	marker	NOUN
dpc-2620	178	13	of	of	ADP
dpc-2620	178	14	melscs	melsc	NOUN
dpc-2620	178	15	in	in	ADP
dpc-2620	178	16	hair	hair	NOUN
dpc-2620	178	17	matrix	matrix	NOUN
dpc-2620	178	18	[	[	X
dpc-2620	178	19	22	22	NUM
dpc-2620	178	20	]	]	PUNCT
dpc-2620	178	21	but	but	CCONJ
dpc-2620	178	22	were	be	AUX
dpc-2620	178	23	negative	negative	ADJ
dpc-2620	178	24	for	for	ADP
dpc-2620	178	25	cd34	cd34	PROPN
dpc-2620	178	26	.	.	PUNCT
dpc-2620	179	1	cd34	cd34	PROPN
dpc-2620	179	2	negative	negative	ADJ
dpc-2620	179	3	neural	neural	ADJ
dpc-2620	179	4	crest	crest	NOUN
dpc-2620	179	5	derived	derive	VERB
dpc-2620	179	6	melanocyte	melanocyte	NOUN
dpc-2620	179	7	stem	stem	NOUN
dpc-2620	179	8	cells	cell	NOUN
dpc-2620	179	9	to	to	PART
dpc-2620	179	10	promote	promote	VERB
dpc-2620	179	11	repigmentation	repigmentation	NOUN
dpc-2620	179	12	.	.	PUNCT
dpc-2620	180	1	also	also	ADV
dpc-2620	180	2	,	,	PUNCT
dpc-2620	180	3	in	in	ADP
dpc-2620	180	4	a	a	DET
dpc-2620	180	5	previous	previous	ADJ
dpc-2620	180	6	study	study	NOUN
dpc-2620	180	7	from	from	ADP
dpc-2620	180	8	our	our	PRON
dpc-2620	180	9	laboratory	laboratory	NOUN
dpc-2620	180	10	we	we	PRON
dpc-2620	180	11	have	have	AUX
dpc-2620	180	12	shown	show	VERB
dpc-2620	180	13	that	that	DET
dpc-2620	180	14	lenalidomide	lenalidomide	NOUN
dpc-2620	180	15	inhibited	inhibit	VERB
dpc-2620	180	16	the	the	DET
dpc-2620	180	17	vitiligo	vitiligo	NOUN
dpc-2620	180	18	progression	progression	NOUN
dpc-2620	180	19	in	in	ADP
dpc-2620	180	20	a	a	DET
dpc-2620	180	21	vitiligo	vitiligo	NOUN
dpc-2620	180	22	mouse	mouse	NOUN
dpc-2620	180	23	model	model	NOUN
dpc-2620	180	24	 	 	SPACE
dpc-2620	181	1	[	[	X
dpc-2620	181	2	11	11	NUM
dpc-2620	181	3	]	]	PUNCT
dpc-2620	181	4	.	.	PUNCT
dpc-2620	182	1	for	for	ADP
dpc-2620	182	2	the	the	DET
dpc-2620	182	3	repigmentation	repigmentation	NOUN
dpc-2620	182	4	of	of	ADP
dpc-2620	182	5	vitiliginous	vitiliginous	ADJ
dpc-2620	182	6	skin	skin	NOUN
dpc-2620	182	7	,	,	PUNCT
dpc-2620	182	8	melanocyte	melanocyte	NOUN
dpc-2620	182	9	reservoir	reservoir	NOUN
dpc-2620	182	10	in	in	ADP
dpc-2620	182	11	the	the	DET
dpc-2620	182	12	hair	hair	NOUN
dpc-2620	182	13	follicles	follicle	NOUN
dpc-2620	182	14	must	must	AUX
dpc-2620	182	15	be	be	AUX
dpc-2620	182	16	activated	activate	VERB
dpc-2620	182	17	,	,	PUNCT
dpc-2620	182	18	differentiated	differentiate	VERB
dpc-2620	182	19	and	and	CCONJ
dpc-2620	182	20	migrated	migrate	VERB
dpc-2620	182	21	toward	toward	ADP
dpc-2620	182	22	depigmented	depigmented	ADJ
dpc-2620	182	23	epidermis	epidermis	NOUN
dpc-2620	182	24	of	of	ADP
dpc-2620	182	25	vitiliginous	vitiliginous	ADJ
dpc-2620	182	26	skin	skin	NOUN
dpc-2620	182	27	 	 	SPACE
dpc-2620	183	1	[	[	X
dpc-2620	183	2	17,18	17,18	NUM
dpc-2620	183	3	]	]	PUNCT
dpc-2620	183	4	.	.	PUNCT
dpc-2620	184	1	in	in	ADP
dpc-2620	184	2	this	this	DET
dpc-2620	184	3	study	study	NOUN
dpc-2620	184	4	effect	effect	NOUN
dpc-2620	184	5	of	of	ADP
dpc-2620	184	6	lenalidomide	lenalidomide	NOUN
dpc-2620	184	7	was	be	AUX
dpc-2620	184	8	directly	directly	ADV
dpc-2620	184	9	checked	check	VERB
dpc-2620	184	10	on	on	ADP
dpc-2620	184	11	the	the	DET
dpc-2620	184	12	cultured	cultured	ADJ
dpc-2620	184	13	hair	hair	NOUN
dpc-2620	184	14	follicle	follicle	NOUN
dpc-2620	184	15	derived	derive	VERB
dpc-2620	184	16	melanocyte	melanocyte	NOUN
dpc-2620	184	17	stem	stem	NOUN
dpc-2620	184	18	cells	cell	NOUN
dpc-2620	184	19	.	.	PUNCT
dpc-2620	185	1	cells	cell	NOUN
dpc-2620	185	2	from	from	ADP
dpc-2620	185	3	the	the	DET
dpc-2620	185	4	murine	murine	ADJ
dpc-2620	185	5	whisker	whisker	NOUN
dpc-2620	185	6	hair	hair	NOUN
dpc-2620	185	7	were	be	AUX
dpc-2620	185	8	isolated	isolate	VERB
dpc-2620	185	9	and	and	CCONJ
dpc-2620	185	10	cultured	cultured	ADJ
dpc-2620	185	11	.	.	PUNCT
dpc-2620	186	1	these	these	DET
dpc-2620	186	2	cells	cell	NOUN
dpc-2620	186	3	formed	form	VERB
dpc-2620	186	4	spheres	sphere	NOUN
dpc-2620	186	5	and	and	CCONJ
dpc-2620	186	6	were	be	AUX
dpc-2620	186	7	found	find	VERB
dpc-2620	186	8	positive	positive	ADJ
dpc-2620	186	9	len	len	ADJ
dpc-2620	186	10	2.5	2.5	NUM
dpc-2620	186	11	µm	µm	ADP
dpc-2620	186	12	len	len	ADJ
dpc-2620	186	13	5	5	NUM
dpc-2620	186	14	µmcontrol	µmcontrol	ADP
dpc-2620	186	15	0.0	0.0	NUM
dpc-2620	186	16	0.5	0.5	NUM
dpc-2620	186	17	1.0	1.0	NUM
dpc-2620	186	18	1.5	1.5	NUM
dpc-2620	186	19	2.0	2.0	NUM
dpc-2620	186	20	2.5	2.5	NUM
dpc-2620	186	21	d	d	NOUN
dpc-2620	186	22	re	re	X
dpc-2620	186	23	la	la	X
dpc-2620	186	24	ti	ti	X
dpc-2620	186	25	ve	ve	AUX
dpc-2620	186	26	in	in	ADP
dpc-2620	186	27	te	te	PROPN
dpc-2620	186	28	ns	ns	NUM
dpc-2620	186	29	it	it	PRON
dpc-2620	186	30	y	y	PROPN
dpc-2620	186	31	of	of	ADP
dpc-2620	186	32	d	d	PROPN
dpc-2620	186	33	ct	ct	PROPN
dpc-2620	187	1	(	(	PUNCT
dpc-2620	187	2	f	f	PROPN
dpc-2620	187	3	ol	ol	PROPN
dpc-2620	188	1	d	d	PROPN
dpc-2620	188	2	ch	ch	PROPN
dpc-2620	188	3	an	an	DET
dpc-2620	188	4	ge	ge	PROPN
dpc-2620	188	5	)	)	PUNCT
dpc-2620	188	6	len	len	PROPN
dpc-2620	188	7	2.5	2.5	NUM
dpc-2620	188	8	µm	µm	ADP
dpc-2620	188	9	len	len	ADJ
dpc-2620	188	10	5	5	NUM
dpc-2620	188	11	µmcontrol	µmcontrol	NOUN
dpc-2620	188	12	0	0	NUM
dpc-2620	188	13	10	10	NUM
dpc-2620	188	14	20	20	NUM
dpc-2620	189	1	30	30	NUM
dpc-2620	189	2	b	b	NUM
dpc-2620	189	3	ty	ty	NUM
dpc-2620	189	4	r	r	NOUN
dpc-2620	189	5	+	+	NUM
dpc-2620	189	6	ce	ce	PROPN
dpc-2620	189	7	ll	ll	AUX
dpc-2620	189	8	s/	s/	VERB
dpc-2620	189	9	m	m	VERB
dpc-2620	189	10	m	m	VERB
dpc-2620	189	11	2	2	NUM
dpc-2620	189	12	figure	figure	NOUN
dpc-2620	189	13	4	4	NUM
dpc-2620	189	14	.	.	PUNCT
dpc-2620	189	15	representative	representative	ADJ
dpc-2620	189	16	images	image	NOUN
dpc-2620	189	17	from	from	ADP
dpc-2620	189	18	confocal	confocal	ADJ
dpc-2620	189	19	microscopy	microscopy	NOUN
dpc-2620	189	20	showing	show	VERB
dpc-2620	189	21	the	the	DET
dpc-2620	189	22	effect	effect	NOUN
dpc-2620	189	23	of	of	ADP
dpc-2620	189	24	lenalidomide	lenalidomide	NOUN
dpc-2620	189	25	at	at	ADP
dpc-2620	189	26	2.5	2.5	NUM
dpc-2620	189	27	µm	µm	NOUN
dpc-2620	189	28	and	and	CCONJ
dpc-2620	189	29	5	5	NUM
dpc-2620	189	30	µm	µm	NOUN
dpc-2620	189	31	concentrations	concentration	NOUN
dpc-2620	189	32	on	on	ADP
dpc-2620	189	33	melanocyte	melanocyte	NOUN
dpc-2620	189	34	differentiation	differentiation	NOUN
dpc-2620	189	35	markers	marker	NOUN
dpc-2620	189	36	(	(	PUNCT
dpc-2620	189	37	a	a	X
dpc-2620	189	38	)	)	PUNCT
dpc-2620	189	39	tyr	tyr	PROPN
dpc-2620	189	40	and	and	CCONJ
dpc-2620	189	41	(	(	PUNCT
dpc-2620	189	42	c	c	X
dpc-2620	189	43	)	)	PUNCT
dpc-2620	189	44	dct	dct	NOUN
dpc-2620	189	45	in	in	ADP
dpc-2620	189	46	melscs	melsc	NOUN
dpc-2620	189	47	after	after	ADP
dpc-2620	189	48	14	14	NUM
dpc-2620	189	49	days	day	NOUN
dpc-2620	189	50	of	of	ADP
dpc-2620	189	51	treatment	treatment	NOUN
dpc-2620	189	52	.	.	PUNCT
dpc-2620	190	1	(	(	PUNCT
dpc-2620	190	2	b	b	X
dpc-2620	190	3	)	)	PUNCT
dpc-2620	190	4	bar	bar	NOUN
dpc-2620	190	5	diagrams	diagram	NOUN
dpc-2620	190	6	depicting	depict	VERB
dpc-2620	190	7	the	the	DET
dpc-2620	190	8	tyr	tyr	PROPN
dpc-2620	190	9	positive	positive	ADJ
dpc-2620	190	10	cells	cell	NOUN
dpc-2620	190	11	after	after	ADP
dpc-2620	190	12	lenalidomide	lenalidomide	NOUN
dpc-2620	190	13	(	(	PUNCT
dpc-2620	190	14	2.5	2.5	NUM
dpc-2620	190	15	µm	µm	NOUN
dpc-2620	190	16	and	and	CCONJ
dpc-2620	190	17	5	5	NUM
dpc-2620	190	18	µm	µm	NOUN
dpc-2620	190	19	)	)	PUNCT
dpc-2620	190	20	treatment	treatment	NOUN
dpc-2620	190	21	in	in	ADP
dpc-2620	190	22	melscs	melsc	NOUN
dpc-2620	190	23	.	.	PUNCT
dpc-2620	191	1	(	(	PUNCT
dpc-2620	191	2	d	d	X
dpc-2620	191	3	)	)	PUNCT
dpc-2620	191	4	bar	bar	NOUN
dpc-2620	191	5	diagrams	diagram	NOUN
dpc-2620	191	6	display	display	VERB
dpc-2620	191	7	the	the	DET
dpc-2620	191	8	relative	relative	ADJ
dpc-2620	191	9	fold	fold	ADJ
dpc-2620	191	10	change	change	NOUN
dpc-2620	191	11	of	of	ADP
dpc-2620	191	12	dct	dct	PROPN
dpc-2620	191	13	in	in	ADP
dpc-2620	191	14	control	control	NOUN
dpc-2620	191	15	and	and	CCONJ
dpc-2620	191	16	lenalidomide	lenalidomide	NOUN
dpc-2620	191	17	(	(	PUNCT
dpc-2620	191	18	2.5	2.5	NUM
dpc-2620	191	19	µm	µm	NOUN
dpc-2620	191	20	and	and	CCONJ
dpc-2620	191	21	5	5	NUM
dpc-2620	191	22	µm	µm	NOUN
dpc-2620	191	23	)	)	PUNCT
dpc-2620	191	24	treated	treat	VERB
dpc-2620	191	25	melscs	melsc	NOUN
dpc-2620	191	26	after	after	ADP
dpc-2620	191	27	14	14	NUM
dpc-2620	191	28	days	day	NOUN
dpc-2620	191	29	of	of	ADP
dpc-2620	191	30	their	their	PRON
dpc-2620	191	31	differentiation	differentiation	NOUN
dpc-2620	191	32	.	.	PUNCT
dpc-2620	192	1	representative	representative	ADJ
dpc-2620	192	2	images	image	NOUN
dpc-2620	192	3	of	of	ADP
dpc-2620	192	4	both	both	DET
dpc-2620	192	5	proteins	protein	NOUN
dpc-2620	192	6	are	be	AUX
dpc-2620	192	7	from	from	ADP
dpc-2620	192	8	3	3	NUM
dpc-2620	192	9	 	 	SPACE
dpc-2620	192	10	independent	independent	ADJ
dpc-2620	192	11	experiments	experiment	NOUN
dpc-2620	192	12	that	that	PRON
dpc-2620	192	13	were	be	AUX
dpc-2620	192	14	quantified	quantify	VERB
dpc-2620	192	15	by	by	ADP
dpc-2620	192	16	using	use	VERB
dpc-2620	192	17	imagej	imagej	ADJ
dpc-2620	192	18	software	software	NOUN
dpc-2620	192	19	.	.	PUNCT
dpc-2620	193	1	data	datum	NOUN
dpc-2620	193	2	are	be	AUX
dpc-2620	193	3	presented	present	VERB
dpc-2620	193	4	as	as	ADP
dpc-2620	193	5	mean	mean	NOUN
dpc-2620	193	6	±	±	NUM
dpc-2620	193	7	standard	standard	ADJ
dpc-2620	193	8	deviation	deviation	NOUN
dpc-2620	193	9	;	;	PUNCT
dpc-2620	193	10	statistical	statistical	ADJ
dpc-2620	193	11	significance	significance	NOUN
dpc-2620	193	12	is	be	AUX
dpc-2620	193	13	shown	show	VERB
dpc-2620	193	14	by	by	ADP
dpc-2620	193	15	*	*	PROPN
dpc-2620	193	16	p	p	X
dpc-2620	193	17	<	<	X
dpc-2620	193	18	0.05	0.05	NUM
dpc-2620	193	19	,	,	PUNCT
dpc-2620	193	20	*	*	PUNCT
dpc-2620	193	21	*	*	PUNCT
dpc-2620	193	22	*	*	PUNCT
dpc-2620	193	23	p	p	X
dpc-2620	193	24	<	<	X
dpc-2620	193	25	0.0001	0.0001	NUM
dpc-2620	193	26	,	,	PUNCT
dpc-2620	193	27	*	*	PUNCT
dpc-2620	193	28	*	*	PUNCT
dpc-2620	193	29	*	*	PUNCT
dpc-2620	193	30	*	*	PUNCT
dpc-2620	193	31	p	p	X
dpc-2620	193	32	<	<	X
dpc-2620	193	33	0.0001	0.0001	NUM
dpc-2620	193	34	.	.	NOUN
dpc-2620	193	35	8	8	NUM
dpc-2620	193	36	original	original	ADJ
dpc-2620	193	37	article	article	NOUN
dpc-2620	193	38	|	|	ADV
dpc-2620	193	39	dermatol	dermatol	ADJ
dpc-2620	193	40	pract	pract	NOUN
dpc-2620	193	41	concept	concept	NOUN
dpc-2620	193	42	.	.	PUNCT
dpc-2620	194	1	2023;13(2):e2023077	2023;13(2):e2023077	PROPN
dpc-2620	194	2	kumar	kumar	PROPN
dpc-2620	194	3	and	and	CCONJ
dpc-2620	194	4	council	council	PROPN
dpc-2620	194	5	of	of	ADP
dpc-2620	194	6	scientific	scientific	ADJ
dpc-2620	194	7	and	and	CCONJ
dpc-2620	194	8	industrial	industrial	ADJ
dpc-2620	194	9	research	research	NOUN
dpc-2620	194	10	,	,	PUNCT
dpc-2620	194	11	new	new	PROPN
dpc-2620	194	12	delhi	delhi	PROPN
dpc-2620	194	13	,	,	PUNCT
dpc-2620	194	14	india	india	PROPN
dpc-2620	194	15	(	(	PUNCT
dpc-2620	194	16	09/135(0735)/2016	09/135(0735)/2016	PROPN
dpc-2620	194	17	-	-	PUNCT
dpc-2620	194	18	emr	emr	PROPN
dpc-2620	194	19	-	-	PUNCT
dpc-2620	194	20	i	i	PROPN
dpc-2620	194	21	)	)	PUNCT
dpc-2620	194	22	to	to	PART
dpc-2620	194	23	grant	grant	VERB
dpc-2620	194	24	fellowship	fellowship	NOUN
dpc-2620	194	25	to	to	ADP
dpc-2620	194	26	uma	uma	PROPN
dpc-2620	194	27	kumari	kumari	PROPN
dpc-2620	194	28	.	.	PUNCT
dpc-2620	195	1	references	reference	NOUN
dpc-2620	195	2	1	1	NUM
dpc-2620	195	3	.	.	PUNCT
dpc-2620	196	1	nishimura	nishimura	PROPN
dpc-2620	196	2	ek	ek	PROPN
dpc-2620	196	3	.	.	PROPN
dpc-2620	196	4	melanocyte	melanocyte	NOUN
dpc-2620	196	5	stem	stem	NOUN
dpc-2620	196	6	cells	cell	NOUN
dpc-2620	196	7	:	:	PUNCT
dpc-2620	196	8	a	a	DET
dpc-2620	196	9	melanocyte	melanocyte	NOUN
dpc-2620	196	10	reservoir	reservoir	NOUN
dpc-2620	196	11	in	in	ADP
dpc-2620	196	12	hair	hair	NOUN
dpc-2620	196	13	follicles	follicle	NOUN
dpc-2620	196	14	for	for	ADP
dpc-2620	196	15	hair	hair	NOUN
dpc-2620	196	16	and	and	CCONJ
dpc-2620	196	17	skin	skin	NOUN
dpc-2620	196	18	pigmentation	pigmentation	NOUN
dpc-2620	196	19	.	.	PUNCT
dpc-2620	196	20	  	  	SPACE
dpc-2620	197	1	pigment	pigment	ADJ
dpc-2620	197	2	cell	cell	NOUN
dpc-2620	197	3	melanoma	melanoma	NOUN
dpc-2620	197	4	res	re	NOUN
dpc-2620	197	5	.	.	PUNCT
dpc-2620	198	1	2011;24(3):401	2011;24(3):401	NUM
dpc-2620	198	2	-	-	SYM
dpc-2620	198	3	410	410	NUM
dpc-2620	198	4	.	.	PUNCT
dpc-2620	199	1	doi	doi	NOUN
dpc-2620	199	2	:	:	PUNCT
dpc-2620	199	3	10.1111	10.1111	NUM
dpc-2620	199	4	/	/	SYM
dpc-2620	199	5	j.1755	j.1755	ADJ
dpc-2620	199	6	-148x.2011.00855.x	-148x.2011.00855.x	NOUN
dpc-2620	199	7	.	.	PUNCT
dpc-2620	200	1	pmid	pmid	NOUN
dpc-2620	200	2	:	:	PUNCT
dpc-2620	200	3	21466661	21466661	NUM
dpc-2620	200	4	.	.	PUNCT
dpc-2620	201	1	2	2	X
dpc-2620	201	2	.	.	X
dpc-2620	201	3	li	li	PROPN
dpc-2620	201	4	h	h	PROPN
dpc-2620	201	5	,	,	PUNCT
dpc-2620	201	6	fan	fan	PROPN
dpc-2620	201	7	l	l	PROPN
dpc-2620	201	8	,	,	PUNCT
dpc-2620	201	9	zhu	zhu	PROPN
dpc-2620	201	10	s	s	PART
dpc-2620	201	11	,	,	PUNCT
dpc-2620	201	12	et	et	PROPN
dpc-2620	201	13	al	al	PROPN
dpc-2620	201	14	.	.	PUNCT
dpc-2620	202	1	epilation	epilation	NOUN
dpc-2620	202	2	induces	induce	VERB
dpc-2620	202	3	hair	hair	NOUN
dpc-2620	202	4	and	and	CCONJ
dpc-2620	202	5	skin	skin	NOUN
dpc-2620	202	6	pigmentation	pigmentation	NOUN
dpc-2620	202	7	through	through	ADP
dpc-2620	202	8	an	an	DET
dpc-2620	202	9	edn3	edn3	NOUN
dpc-2620	202	10	/	/	SYM
dpc-2620	202	11	ednrb	ednrb	NOUN
dpc-2620	202	12	-	-	PUNCT
dpc-2620	202	13	dependent	dependent	ADJ
dpc-2620	202	14	regenerative	regenerative	ADJ
dpc-2620	202	15	response	response	NOUN
dpc-2620	202	16	of	of	ADP
dpc-2620	202	17	melanocyte	melanocyte	NOUN
dpc-2620	202	18	stem	stem	NOUN
dpc-2620	202	19	cells	cell	NOUN
dpc-2620	202	20	.	.	PUNCT
dpc-2620	202	21	 	 	SPACE
dpc-2620	203	1	sci	sci	PROPN
dpc-2620	203	2	rep	rep	PROPN
dpc-2620	203	3	.	.	PROPN
dpc-2620	203	4	2017;7(1):1	2017;7(1):1	PROPN
dpc-2620	203	5	-	-	SYM
dpc-2620	203	6	13	13	NUM
dpc-2620	203	7	.	.	PUNCT
dpc-2620	204	1	doi	doi	NOUN
dpc-2620	204	2	:	:	PUNCT
dpc-2620	204	3	10.1038	10.1038	NUM
dpc-2620	204	4	/	/	SYM
dpc-2620	204	5	s41598	s41598	NOUN
dpc-2620	204	6	-	-	PUNCT
dpc-2620	204	7	017	017	NUM
dpc-2620	204	8	-	-	PUNCT
dpc-2620	204	9	07683	07683	NUM
dpc-2620	204	10	-	-	PUNCT
dpc-2620	204	11	x.	x.	NOUN
dpc-2620	204	12	pmid	pmid	PROPN
dpc-2620	204	13	:	:	PUNCT
dpc-2620	204	14	28779103	28779103	NUM
dpc-2620	204	15	.	.	PUNCT
dpc-2620	205	1	pmcid	pmcid	NOUN
dpc-2620	205	2	:	:	PUNCT
dpc-2620	205	3	pmc5544680	pmc5544680	NOUN
dpc-2620	205	4	.	.	PUNCT
dpc-2620	206	1	3	3	X
dpc-2620	206	2	.	.	X
dpc-2620	206	3	falabella	falabella	PROPN
dpc-2620	206	4	r.	r.	PROPN
dpc-2620	206	5	vitiligo	vitiligo	PROPN
dpc-2620	206	6	and	and	CCONJ
dpc-2620	206	7	the	the	DET
dpc-2620	206	8	melanocyte	melanocyte	NOUN
dpc-2620	206	9	reservoir	reservoir	NOUN
dpc-2620	206	10	.	.	PUNCT
dpc-2620	207	1	indian	indian	PROPN
dpc-2620	207	2	j.	j.	PROPN
dpc-2620	207	3	dermatol	dermatol	PROPN
dpc-2620	207	4	.	.	PUNCT
dpc-2620	208	1	2009;54(4):313	2009;54(4):313	NUM
dpc-2620	208	2	-	-	PUNCT
dpc-2620	208	3	318	318	NUM
dpc-2620	208	4	.	.	PUNCT
dpc-2620	209	1	doi	doi	NOUN
dpc-2620	209	2	:	:	PUNCT
dpc-2620	209	3	  	  	SPACE
dpc-2620	209	4	10.4103/0019	10.4103/0019	PROPN
dpc-2620	209	5	-	-	SYM
dpc-2620	209	6	5154.57604	5154.57604	NUM
dpc-2620	209	7	.	.	PUNCT
dpc-2620	210	1	pmid	pmid	NOUN
dpc-2620	210	2	:	:	PUNCT
dpc-2620	210	3	20101329	20101329	NUM
dpc-2620	210	4	;	;	PUNCT
dpc-2620	210	5	pmcid	pmcid	ADJ
dpc-2620	210	6	:	:	PUNCT
dpc-2620	210	7	pmc2807704	pmc2807704	NOUN
dpc-2620	210	8	.	.	PUNCT
dpc-2620	211	1	4	4	X
dpc-2620	211	2	.	.	X
dpc-2620	211	3	bellono	bellono	PROPN
dpc-2620	211	4	nw	nw	PROPN
dpc-2620	211	5	,	,	PUNCT
dpc-2620	211	6	oancea	oancea	PROPN
dpc-2620	211	7	ev	ev	PROPN
dpc-2620	211	8	.	.	PROPN
dpc-2620	211	9	ion	ion	NOUN
dpc-2620	211	10	transport	transport	NOUN
dpc-2620	211	11	in	in	ADP
dpc-2620	211	12	pigmentation	pigmentation	NOUN
dpc-2620	211	13	.	.	PUNCT
dpc-2620	212	1	arch	arch	ADJ
dpc-2620	212	2	biochem	biochem	PROPN
dpc-2620	212	3	.	.	PUNCT
dpc-2620	213	1	2014;563:35	2014;563:35	NUM
dpc-2620	213	2	-	-	PUNCT
dpc-2620	213	3	41.doi	41.doi	NOUN
dpc-2620	213	4	:	:	PUNCT
dpc-2620	213	5	10.1016	10.1016	NUM
dpc-2620	213	6	/	/	SYM
dpc-2620	213	7	j.abb.2014.06.020	j.abb.2014.06.020	PROPN
dpc-2620	213	8	.	.	PUNCT
dpc-2620	214	1	pmid	pmid	NOUN
dpc-2620	214	2	:	:	PUNCT
dpc-2620	214	3	25034214	25034214	NUM
dpc-2620	214	4	;	;	PUNCT
dpc-2620	214	5	pmcid	pmcid	NOUN
dpc-2620	214	6	:	:	PUNCT
dpc-2620	214	7	pmc4497562	pmc4497562	NOUN
dpc-2620	214	8	.	.	PUNCT
dpc-2620	215	1	5	5	X
dpc-2620	215	2	.	.	X
dpc-2620	215	3	nordlund	nordlund	PROPN
dpc-2620	215	4	jj	jj	PROPN
dpc-2620	215	5	.	.	PUNCT
dpc-2620	216	1	the	the	DET
dpc-2620	216	2	pigmentary	pigmentary	ADJ
dpc-2620	216	3	system	system	NOUN
dpc-2620	216	4	and	and	CCONJ
dpc-2620	216	5	inflammation	inflammation	NOUN
dpc-2620	216	6	.	.	PUNCT
dpc-2620	217	1	pigment	pigment	ADJ
dpc-2620	217	2	cell	cell	NOUN
dpc-2620	217	3	res.1992;5(5):362	res.1992;5(5):362	PROPN
dpc-2620	217	4	-	-	PUNCT
dpc-2620	217	5	365.doi	365.doi	PROPN
dpc-2620	217	6	:	:	PUNCT
dpc-2620	217	7	10.1111	10.1111	NUM
dpc-2620	217	8	/	/	SYM
dpc-2620	217	9	j.1600	j.1600	NOUN
dpc-2620	217	10	-	-	PUNCT
dpc-2620	217	11	0749.1992	0749.1992	PROPN
dpc-2620	217	12	.	.	PUNCT
dpc-2620	218	1	tb00563.x	tb00563.x	NOUN
dpc-2620	218	2	.	.	PUNCT
dpc-2620	219	1	pmid	pmid	NOUN
dpc-2620	219	2	:	:	PUNCT
dpc-2620	219	3	1292021	1292021	NUM
dpc-2620	219	4	.	.	PUNCT
dpc-2620	220	1	6	6	X
dpc-2620	220	2	.	.	X
dpc-2620	220	3	lai	lai	PROPN
dpc-2620	220	4	yc	yc	PROPN
dpc-2620	220	5	,	,	PUNCT
dpc-2620	220	6	yew	yew	PROPN
dpc-2620	220	7	yw	yw	PROPN
dpc-2620	220	8	,	,	PUNCT
dpc-2620	220	9	kennedy	kennedy	PROPN
dpc-2620	220	10	c	c	PROPN
dpc-2620	220	11	,	,	PUNCT
dpc-2620	220	12	et	et	PROPN
dpc-2620	220	13	al	al	PROPN
dpc-2620	220	14	.	.	PROPN
dpc-2620	220	15	vitiligo	vitiligo	PROPN
dpc-2620	220	16	and	and	CCONJ
dpc-2620	220	17	depression	depression	NOUN
dpc-2620	220	18	:	:	PUNCT
dpc-2620	220	19	a	a	DET
dpc-2620	220	20	 	 	SPACE
dpc-2620	220	21	systematic	systematic	ADJ
dpc-2620	220	22	review	review	NOUN
dpc-2620	220	23	and	and	CCONJ
dpc-2620	220	24	meta	meta	NOUN
dpc-2620	220	25	-	-	PUNCT
dpc-2620	220	26	analysis	analysis	NOUN
dpc-2620	220	27	of	of	ADP
dpc-2620	220	28	observational	observational	ADJ
dpc-2620	220	29	studies	study	NOUN
dpc-2620	220	30	.	.	PUNCT
dpc-2620	221	1	br	br	PROPN
dpc-2620	221	2	j	j	PROPN
dpc-2620	221	3	dermatol	dermatol	NOUN
dpc-2620	221	4	.	.	PUNCT
dpc-2620	222	1	2017;177(3):708–718.doi	2017;177(3):708–718.doi	NUM
dpc-2620	222	2	:	:	PUNCT
dpc-2620	222	3	10.1111	10.1111	NUM
dpc-2620	222	4	/	/	SYM
dpc-2620	222	5	bjd.15199	bjd.15199	NOUN
dpc-2620	222	6	.	.	PUNCT
dpc-2620	223	1	pmid	pmid	NOUN
dpc-2620	223	2	:	:	PUNCT
dpc-2620	223	3	27878819	27878819	NUM
dpc-2620	223	4	.	.	PUNCT
dpc-2620	224	1	7	7	X
dpc-2620	224	2	.	.	X
dpc-2620	224	3	lotti	lotti	PROPN
dpc-2620	224	4	tm	tm	PROPN
dpc-2620	224	5	,	,	PUNCT
dpc-2620	224	6	berti	berti	PROPN
dpc-2620	224	7	sf	sf	PROPN
dpc-2620	224	8	,	,	PUNCT
dpc-2620	224	9	hercogova	hercogova	PROPN
dpc-2620	224	10	j	j	PROPN
dpc-2620	224	11	,	,	PUNCT
dpc-2620	224	12	et	et	PROPN
dpc-2620	224	13	al	al	PROPN
dpc-2620	224	14	.	.	PROPN
dpc-2620	224	15	vitiligo	vitiligo	PROPN
dpc-2620	224	16	:	:	PUNCT
dpc-2620	224	17	recent	recent	ADJ
dpc-2620	224	18	insights	insight	NOUN
dpc-2620	224	19	and	and	CCONJ
dpc-2620	224	20	new	new	ADJ
dpc-2620	224	21	therapeutic	therapeutic	ADJ
dpc-2620	224	22	approaches	approach	NOUN
dpc-2620	224	23	.	.	PUNCT
dpc-2620	225	1	g	g	ADP
dpc-2620	225	2	ital	ital	ADJ
dpc-2620	225	3	dermatol	dermatol	NOUN
dpc-2620	225	4	venereol	venereol	NOUN
dpc-2620	225	5	.	.	PUNCT
dpc-2620	226	1	2012	2012	NUM
dpc-2620	226	2	dec;147(6):637	dec;147(6):637	NOUN
dpc-2620	226	3	-	-	PUNCT
dpc-2620	226	4	647	647	NUM
dpc-2620	226	5	.	.	PUNCT
dpc-2620	227	1	pmid	pmid	NOUN
dpc-2620	227	2	:	:	PUNCT
dpc-2620	227	3	23149710	23149710	NUM
dpc-2620	227	4	.	.	PUNCT
dpc-2620	228	1	8	8	X
dpc-2620	228	2	.	.	X
dpc-2620	228	3	goldstein	goldstein	PROPN
dpc-2620	228	4	nb	nb	PROPN
dpc-2620	228	5	,	,	PUNCT
dpc-2620	228	6	koster	koster	PROPN
dpc-2620	228	7	mi	mi	PROPN
dpc-2620	228	8	,	,	PUNCT
dpc-2620	228	9	hoaglin	hoaglin	PROPN
dpc-2620	228	10	lg	lg	PROPN
dpc-2620	228	11	,	,	PUNCT
dpc-2620	228	12	et	et	PROPN
dpc-2620	228	13	al	al	PROPN
dpc-2620	228	14	.	.	PROPN
dpc-2620	228	15	narrow	narrow	ADJ
dpc-2620	228	16	band	band	NOUN
dpc-2620	228	17	ultraviolet	ultraviolet	PROPN
dpc-2620	228	18	b	b	PROPN
dpc-2620	228	19	treatment	treatment	NOUN
dpc-2620	228	20	for	for	ADP
dpc-2620	228	21	human	human	ADJ
dpc-2620	228	22	vitiligo	vitiligo	NOUN
dpc-2620	228	23	is	be	AUX
dpc-2620	228	24	associated	associate	VERB
dpc-2620	228	25	with	with	ADP
dpc-2620	228	26	proliferation	proliferation	NOUN
dpc-2620	228	27	,	,	PUNCT
dpc-2620	228	28	migration	migration	NOUN
dpc-2620	228	29	,	,	PUNCT
dpc-2620	228	30	and	and	CCONJ
dpc-2620	228	31	differentiation	differentiation	NOUN
dpc-2620	228	32	of	of	ADP
dpc-2620	228	33	melanocyte	melanocyte	NOUN
dpc-2620	228	34	precursors	precursor	NOUN
dpc-2620	228	35	.	.	PUNCT
dpc-2620	229	1	j	j	PROPN
dpc-2620	229	2	invest	invest	VERB
dpc-2620	229	3	dermatol	dermatol	NOUN
dpc-2620	229	4	.	.	PUNCT
dpc-2620	230	1	2015;135(8):2068–2076	2015;135(8):2068–2076	NUM
dpc-2620	230	2	.	.	PUNCT
dpc-2620	230	3	doi	doi	NOUN
dpc-2620	230	4	:	:	PUNCT
dpc-2620	230	5	10.1038	10.1038	NUM
dpc-2620	230	6	/jid.2015.126.pmid	/jid.2015.126.pmid	SYM
dpc-2620	230	7	:	:	PUNCT
dpc-2620	230	8	25822579	25822579	NUM
dpc-2620	230	9	.	.	PUNCT
dpc-2620	231	1	pmcid	pmcid	NOUN
dpc-2620	231	2	:	:	PUNCT
dpc-2620	231	3	pmc4683025	pmc4683025	ADJ
dpc-2620	231	4	.	.	PUNCT
dpc-2620	232	1	9	9	X
dpc-2620	232	2	.	.	X
dpc-2620	232	3	milrod	milrod	PROPN
dpc-2620	232	4	cj	cj	PROPN
dpc-2620	232	5	,	,	PUNCT
dpc-2620	232	6	blevins	blevins	PROPN
dpc-2620	232	7	f	f	PROPN
dpc-2620	232	8	,	,	PUNCT
dpc-2620	232	9	hughes	hughes	PROPN
dpc-2620	232	10	d	d	PROPN
dpc-2620	232	11	,	,	PUNCT
dpc-2620	232	12	et	et	PROPN
dpc-2620	232	13	al	al	PROPN
dpc-2620	232	14	.	.	PROPN
dpc-2620	232	15	incidence	incidence	NOUN
dpc-2620	232	16	of	of	ADP
dpc-2620	232	17	skin	skin	NOUN
dpc-2620	232	18	hyperpigmentation	hyperpigmentation	NOUN
dpc-2620	232	19	in	in	ADP
dpc-2620	232	20	black	black	ADJ
dpc-2620	232	21	patients	patient	NOUN
dpc-2620	232	22	receiving	receive	VERB
dpc-2620	232	23	treatment	treatment	NOUN
dpc-2620	232	24	with	with	ADP
dpc-2620	232	25	immunomodulatory	immunomodulatory	ADJ
dpc-2620	232	26	drugs	drug	NOUN
dpc-2620	232	27	.	.	PUNCT
dpc-2620	232	28	  	  	SPACE
dpc-2620	232	29	blood	blood	NOUN
dpc-2620	232	30	.	.	PUNCT
dpc-2620	233	1	2021;137(21):2987–2989	2021;137(21):2987–2989	NUM
dpc-2620	233	2	.	.	PUNCT
dpc-2620	234	1	doi	doi	NOUN
dpc-2620	234	2	:	:	PUNCT
dpc-2620	234	3	10.1182	10.1182	NUM
dpc-2620	234	4	/	/	SYM
dpc-2620	234	5	blood.2021010853	blood.2021010853	PROPN
dpc-2620	234	6	.	.	PUNCT
dpc-2620	235	1	pmid	pmid	NOUN
dpc-2620	235	2	:	:	PUNCT
dpc-2620	235	3	33728443	33728443	NUM
dpc-2620	235	4	.	.	PUNCT
dpc-2620	236	1	10	10	NUM
dpc-2620	236	2	.	.	X
dpc-2620	236	3	dasanu	dasanu	NOUN
dpc-2620	236	4	ca	can	AUX
dpc-2620	236	5	,	,	PUNCT
dpc-2620	236	6	mitsis	mitsis	NOUN
dpc-2620	236	7	d	d	PROPN
dpc-2620	236	8	,	,	PUNCT
dpc-2620	237	1	alexandrescu	alexandrescu	PROPN
dpc-2620	237	2	dt	dt	PROPN
dpc-2620	237	3	.	.	PUNCT
dpc-2620	237	4	hair	hair	NOUN
dpc-2620	237	5	repigmentation	repigmentation	NOUN
dpc-2620	237	6	associated	associate	VERB
dpc-2620	237	7	with	with	ADP
dpc-2620	237	8	the	the	DET
dpc-2620	237	9	use	use	NOUN
dpc-2620	237	10	of	of	ADP
dpc-2620	237	11	lenalidomide	lenalidomide	NOUN
dpc-2620	237	12	:	:	PUNCT
dpc-2620	237	13	graying	graying	NOUN
dpc-2620	237	14	may	may	AUX
dpc-2620	237	15	not	not	PART
dpc-2620	237	16	be	be	AUX
dpc-2620	237	17	an	an	DET
dpc-2620	237	18	irreversible	irreversible	ADJ
dpc-2620	237	19	process	process	NOUN
dpc-2620	237	20	.	.	PUNCT
dpc-2620	238	1	j	j	PROPN
dpc-2620	238	2	oncol	oncol	ADJ
dpc-2620	238	3	pharma	pharma	PROPN
dpc-2620	238	4	pract	pract	NOUN
dpc-2620	238	5	.	.	PUNCT
dpc-2620	239	1	20119(2):165	20119(2):165	NUM
dpc-2620	239	2	-	-	SYM
dpc-2620	239	3	169	169	NUM
dpc-2620	239	4	.	.	PUNCT
dpc-2620	240	1	doi	doi	NOUN
dpc-2620	240	2	:	:	PUNCT
dpc-2620	240	3	10.1177/1078155212442561	10.1177/1078155212442561	NUM
dpc-2620	240	4	.	.	PUNCT
dpc-2620	241	1	pmid	pmid	NOUN
dpc-2620	241	2	:	:	PUNCT
dpc-2620	241	3	22440400	22440400	NUM
dpc-2620	241	4	.	.	PUNCT
dpc-2620	242	1	11	11	NUM
dpc-2620	242	2	.	.	X
dpc-2620	242	3	pervaiz	pervaiz	PROPN
dpc-2620	242	4	n	n	CCONJ
dpc-2620	242	5	,	,	PUNCT
dpc-2620	242	6	kaur	kaur	PROPN
dpc-2620	242	7	h	h	PROPN
dpc-2620	242	8	,	,	PUNCT
dpc-2620	242	9	parsad	parsad	PROPN
dpc-2620	242	10	d	d	PROPN
dpc-2620	242	11	,	,	PUNCT
dpc-2620	242	12	et	et	PROPN
dpc-2620	242	13	al	al	PROPN
dpc-2620	242	14	.	.	PUNCT
dpc-2620	243	1	immune‐modulatory	immune‐modulatory	ADJ
dpc-2620	243	2	effects	effect	NOUN
dpc-2620	243	3	of	of	ADP
dpc-2620	243	4	lenalidomide	lenalidomide	NOUN
dpc-2620	243	5	inhibited	inhibit	VERB
dpc-2620	243	6	the	the	DET
dpc-2620	243	7	progression	progression	NOUN
dpc-2620	243	8	of	of	ADP
dpc-2620	243	9	lesions	lesion	NOUN
dpc-2620	243	10	in	in	ADP
dpc-2620	243	11	a	a	DET
dpc-2620	243	12	vitiligo	vitiligo	NOUN
dpc-2620	243	13	mouse	mouse	NOUN
dpc-2620	243	14	model	model	NOUN
dpc-2620	243	15	.	.	PUNCT
dpc-2620	244	1	pigment	pigment	ADJ
dpc-2620	244	2	cell	cell	NOUN
dpc-2620	244	3	melanoma	melanoma	NOUN
dpc-2620	244	4	res	re	NOUN
dpc-2620	244	5	.	.	PUNCT
dpc-2620	245	1	2021;34(5	2021;34(5	NUM
dpc-2620	245	2	):	):	PUNCT
dpc-2620	245	3	918-927.doi	918-927.doi	NUM
dpc-2620	245	4	:	:	PUNCT
dpc-2620	245	5	10.1111	10.1111	NUM
dpc-2620	245	6	/	/	SYM
dpc-2620	245	7	pcmr.12962	pcmr.12962	PROPN
dpc-2620	245	8	.	.	PUNCT
dpc-2620	246	1	pmid	pmid	NOUN
dpc-2620	246	2	:	:	PUNCT
dpc-2620	246	3	33522688	33522688	NUM
dpc-2620	246	4	.	.	PUNCT
dpc-2620	247	1	12	12	NUM
dpc-2620	247	2	.	.	PUNCT
dpc-2620	248	1	gilanchi	gilanchi	PROPN
dpc-2620	248	2	s	s	PROPN
dpc-2620	248	3	,	,	PUNCT
dpc-2620	248	4	esmaeilzade	esmaeilzade	PROPN
dpc-2620	248	5	b	b	PROPN
dpc-2620	248	6	,	,	PUNCT
dpc-2620	248	7	eidi	eidi	PROPN
dpc-2620	248	8	a	a	PROPN
dpc-2620	248	9	,	,	PUNCT
dpc-2620	248	10	et	et	PROPN
dpc-2620	248	11	al	al	PROPN
dpc-2620	248	12	.	.	PUNCT
dpc-2620	248	13	neuronal	neuronal	ADJ
dpc-2620	248	14	differentiation	differentiation	NOUN
dpc-2620	248	15	of	of	ADP
dpc-2620	248	16	rat	rat	NOUN
dpc-2620	248	17	hair	hair	NOUN
dpc-2620	248	18	follicle	follicle	NOUN
dpc-2620	248	19	stem	stem	NOUN
dpc-2620	248	20	cells	cell	NOUN
dpc-2620	248	21	:	:	PUNCT
dpc-2620	248	22	the	the	DET
dpc-2620	248	23	involvement	involvement	NOUN
dpc-2620	248	24	of	of	ADP
dpc-2620	248	25	the	the	DET
dpc-2620	248	26	neuroprotective	neuroprotective	ADJ
dpc-2620	248	27	factor	factor	NOUN
dpc-2620	248	28	seladin-1	seladin-1	NUM
dpc-2620	248	29	(	(	PUNCT
dpc-2620	248	30	dhcr24	dhcr24	PROPN
dpc-2620	248	31	)	)	PUNCT
dpc-2620	248	32	.	.	PUNCT
dpc-2620	249	1	iran	iran	PROPN
dpc-2620	249	2	biomed	biome	VERB
dpc-2620	249	3	j.	j.	PROPN
dpc-2620	249	4	2014;18(3):136	2014;18(3):136	PROPN
dpc-2620	249	5	.	.	PUNCT
dpc-2620	250	1	doi	doi	NOUN
dpc-2620	250	2	:	:	PUNCT
dpc-2620	250	3	10.6091	10.6091	NUM
dpc-2620	250	4	/	/	SYM
dpc-2620	250	5	ibj.1284.2014	ibj.1284.2014	PART
dpc-2620	250	6	.	.	PUNCT
dpc-2620	251	1	pmid	pmid	NOUN
dpc-2620	251	2	:	:	PUNCT
dpc-2620	251	3	24842139	24842139	NUM
dpc-2620	251	4	.	.	PUNCT
dpc-2620	252	1	pmcid	pmcid	ADJ
dpc-2620	252	2	:	:	PUNCT
dpc-2620	252	3	pmc4048477	pmc4048477	NOUN
dpc-2620	252	4	.	.	PUNCT
dpc-2620	253	1	13	13	NUM
dpc-2620	253	2	.	.	PUNCT
dpc-2620	253	3	li	li	PROPN
dpc-2620	253	4	l	l	PROPN
dpc-2620	253	5	,	,	PUNCT
dpc-2620	253	6	fukunaga	fukunaga	NOUN
dpc-2620	253	7	-	-	PUNCT
dpc-2620	253	8	kalabis	kalabis	PROPN
dpc-2620	253	9	m	m	PROPN
dpc-2620	253	10	,	,	PUNCT
dpc-2620	253	11	yu	yu	PROPN
dpc-2620	253	12	h	h	NOUN
dpc-2620	253	13	,	,	PUNCT
dpc-2620	253	14	et	et	PROPN
dpc-2620	253	15	al	al	PROPN
dpc-2620	253	16	.	.	PUNCT
dpc-2620	254	1	human	human	ADJ
dpc-2620	254	2	dermal	dermal	NOUN
dpc-2620	254	3	stem	stem	NOUN
dpc-2620	254	4	cells	cell	NOUN
dpc-2620	254	5	differentiate	differentiate	VERB
dpc-2620	254	6	into	into	ADP
dpc-2620	254	7	functional	functional	ADJ
dpc-2620	254	8	epidermal	epidermal	ADJ
dpc-2620	254	9	melanocytes	melanocyte	NOUN
dpc-2620	254	10	.	.	PUNCT
dpc-2620	255	1	j	j	PROPN
dpc-2620	255	2	cell	cell	PROPN
dpc-2620	255	3	sci	sci	PROPN
dpc-2620	255	4	.	.	PUNCT
dpc-2620	256	1	2010;123(pt	2010;123(pt	NUM
dpc-2620	256	2	6):853	6):853	NUM
dpc-2620	256	3	-	-	PUNCT
dpc-2620	256	4	860.doi	860.doi	NUM
dpc-2620	256	5	:	:	PUNCT
dpc-2620	256	6	10.1242	10.1242	NUM
dpc-2620	256	7	/	/	SYM
dpc-2620	256	8	jcs.061598.pmid	jcs.061598.pmid	NOUN
dpc-2620	256	9	:	:	PUNCT
dpc-2620	256	10	20159965	20159965	NUM
dpc-2620	256	11	.	.	PUNCT
dpc-2620	257	1	pmcid	pmcid	NOUN
dpc-2620	257	2	:	:	PUNCT
dpc-2620	257	3	pmc2831759	pmc2831759	ADJ
dpc-2620	257	4	.	.	PUNCT
dpc-2620	258	1	14	14	NUM
dpc-2620	258	2	.	.	X
dpc-2620	259	1	osada	osada	PROPN
dpc-2620	259	2	a	a	PROPN
dpc-2620	259	3	,	,	PUNCT
dpc-2620	259	4	iwabuchi	iwabuchi	PROPN
dpc-2620	259	5	t	t	PROPN
dpc-2620	259	6	,	,	PUNCT
dpc-2620	259	7	kishimoto	kishimoto	PROPN
dpc-2620	259	8	j	j	PROPN
dpc-2620	259	9	,	,	PUNCT
dpc-2620	259	10	hamazaki	hamazaki	PROPN
dpc-2620	259	11	ts	ts	PROPN
dpc-2620	259	12	,	,	PUNCT
dpc-2620	259	13	okochi	okochi	PROPN
dpc-2620	259	14	h.	h.	PROPN
dpc-2620	259	15	long	long	ADJ
dpc-2620	259	16	-	-	PUNCT
dpc-2620	259	17	term	term	NOUN
dpc-2620	259	18	culture	culture	NOUN
dpc-2620	259	19	of	of	ADP
dpc-2620	259	20	mouse	mouse	NOUN
dpc-2620	259	21	vibrissal	vibrissal	ADJ
dpc-2620	259	22	dermal	dermal	NOUN
dpc-2620	259	23	papilla	papilla	NOUN
dpc-2620	259	24	cells	cell	NOUN
dpc-2620	259	25	and	and	CCONJ
dpc-2620	259	26	de	de	X
dpc-2620	259	27	from	from	ADP
dpc-2620	259	28	hair	hair	NOUN
dpc-2620	259	29	follicle	follicle	NOUN
dpc-2620	259	30	are	be	AUX
dpc-2620	259	31	primed	prime	VERB
dpc-2620	259	32	for	for	ADP
dpc-2620	259	33	melanocyte	melanocyte	NOUN
dpc-2620	259	34	differentiation	differentiation	NOUN
dpc-2620	259	35	[	[	X
dpc-2620	259	36	23	23	NUM
dpc-2620	259	37	]	]	PUNCT
dpc-2620	259	38	.	.	PUNCT
dpc-2620	260	1	as	as	SCONJ
dpc-2620	260	2	these	these	DET
dpc-2620	260	3	sphere	sphere	NOUN
dpc-2620	260	4	derived	derive	VERB
dpc-2620	260	5	cells	cell	NOUN
dpc-2620	260	6	were	be	AUX
dpc-2620	260	7	negative	negative	ADJ
dpc-2620	260	8	for	for	ADP
dpc-2620	260	9	functional	functional	ADJ
dpc-2620	260	10	melanocyte	melanocyte	NOUN
dpc-2620	260	11	marker	marker	NOUN
dpc-2620	260	12	tyrosinase	tyrosinase	NOUN
dpc-2620	260	13	and	and	CCONJ
dpc-2620	260	14	dopa	dopa	NOUN
dpc-2620	260	15	,	,	PUNCT
dpc-2620	260	16	it	it	PRON
dpc-2620	260	17	confirmed	confirm	VERB
dpc-2620	260	18	that	that	SCONJ
dpc-2620	260	19	these	these	DET
dpc-2620	260	20	cells	cell	NOUN
dpc-2620	260	21	were	be	AUX
dpc-2620	260	22	not	not	PART
dpc-2620	260	23	functional	functional	ADJ
dpc-2620	260	24	melanocytes	melanocyte	NOUN
dpc-2620	260	25	.	.	PUNCT
dpc-2620	261	1	melanocytes	melanocyte	NOUN
dpc-2620	261	2	are	be	AUX
dpc-2620	261	3	also	also	ADV
dpc-2620	261	4	derived	derive	VERB
dpc-2620	261	5	from	from	ADP
dpc-2620	261	6	the	the	DET
dpc-2620	261	7	neural	neural	ADJ
dpc-2620	261	8	tube	tube	NOUN
dpc-2620	261	9	and	and	CCONJ
dpc-2620	261	10	neural	neural	ADJ
dpc-2620	261	11	-	-	PUNCT
dpc-2620	261	12	crest	crest	NOUN
dpc-2620	261	13	,	,	PUNCT
dpc-2620	261	14	and	and	CCONJ
dpc-2620	261	15	then	then	ADV
dpc-2620	261	16	play	play	VERB
dpc-2620	261	17	an	an	DET
dpc-2620	261	18	important	important	ADJ
dpc-2620	261	19	role	role	NOUN
dpc-2620	261	20	in	in	ADP
dpc-2620	261	21	pigmentation	pigmentation	NOUN
dpc-2620	261	22	[	[	X
dpc-2620	261	23	24	24	NUM
dpc-2620	261	24	]	]	PUNCT
dpc-2620	261	25	.	.	PUNCT
dpc-2620	262	1	for	for	ADP
dpc-2620	262	2	repigmentation	repigmentation	NOUN
dpc-2620	262	3	process	process	NOUN
dpc-2620	262	4	,	,	PUNCT
dpc-2620	262	5	the	the	DET
dpc-2620	262	6	most	most	ADV
dpc-2620	262	7	important	important	ADJ
dpc-2620	262	8	step	step	NOUN
dpc-2620	262	9	is	be	AUX
dpc-2620	262	10	the	the	DET
dpc-2620	262	11	proliferation	proliferation	NOUN
dpc-2620	262	12	and	and	CCONJ
dpc-2620	262	13	migration	migration	NOUN
dpc-2620	262	14	of	of	ADP
dpc-2620	262	15	stem	stem	NOUN
dpc-2620	262	16	cells	cell	NOUN
dpc-2620	262	17	from	from	ADP
dpc-2620	262	18	hair	hair	NOUN
dpc-2620	262	19	dermis	dermis	NOUN
dpc-2620	262	20	to	to	ADP
dpc-2620	262	21	the	the	DET
dpc-2620	262	22	lesional	lesional	ADJ
dpc-2620	262	23	areas	area	NOUN
dpc-2620	262	24	[	[	X
dpc-2620	262	25	25	25	NUM
dpc-2620	262	26	]	]	PUNCT
dpc-2620	262	27	.	.	PUNCT
dpc-2620	263	1	recovery	recovery	NOUN
dpc-2620	263	2	from	from	ADP
dpc-2620	263	3	vitiligo	vitiligo	PROPN
dpc-2620	263	4	is	be	AUX
dpc-2620	263	5	initiated	initiate	VERB
dpc-2620	263	6	by	by	ADP
dpc-2620	263	7	the	the	DET
dpc-2620	263	8	subsequent	subsequent	ADJ
dpc-2620	263	9	migration	migration	NOUN
dpc-2620	263	10	of	of	ADP
dpc-2620	263	11	the	the	DET
dpc-2620	263	12	melanocyte	melanocyte	NOUN
dpc-2620	263	13	stem	stem	NOUN
dpc-2620	263	14	cells	cell	NOUN
dpc-2620	263	15	from	from	ADP
dpc-2620	263	16	the	the	DET
dpc-2620	263	17	hair	hair	NOUN
dpc-2620	263	18	matrices	matrix	NOUN
dpc-2620	263	19	to	to	PART
dpc-2620	263	20	produce	produce	VERB
dpc-2620	263	21	melanocytes	melanocyte	NOUN
dpc-2620	263	22	[	[	X
dpc-2620	263	23	26	26	NUM
dpc-2620	263	24	]	]	PUNCT
dpc-2620	263	25	.	.	PUNCT
dpc-2620	264	1	therefore	therefore	ADV
dpc-2620	264	2	,	,	PUNCT
dpc-2620	264	3	we	we	PRON
dpc-2620	264	4	checked	check	VERB
dpc-2620	264	5	the	the	DET
dpc-2620	264	6	effect	effect	NOUN
dpc-2620	264	7	of	of	ADP
dpc-2620	264	8	lenalidomide	lenalidomide	NOUN
dpc-2620	264	9	in	in	ADP
dpc-2620	264	10	proliferation	proliferation	NOUN
dpc-2620	264	11	and	and	CCONJ
dpc-2620	264	12	migration	migration	NOUN
dpc-2620	264	13	of	of	ADP
dpc-2620	264	14	melscs	melsc	NOUN
dpc-2620	264	15	.	.	PUNCT
dpc-2620	265	1	the	the	DET
dpc-2620	265	2	results	result	NOUN
dpc-2620	265	3	revealed	reveal	VERB
dpc-2620	265	4	that	that	SCONJ
dpc-2620	265	5	there	there	PRON
dpc-2620	265	6	was	be	VERB
dpc-2620	265	7	a	a	DET
dpc-2620	265	8	non	non	ADJ
dpc-2620	265	9	-	-	ADJ
dpc-2620	265	10	significant	significant	ADJ
dpc-2620	265	11	rise	rise	NOUN
dpc-2620	265	12	in	in	ADP
dpc-2620	265	13	the	the	DET
dpc-2620	265	14	proliferation	proliferation	NOUN
dpc-2620	265	15	of	of	ADP
dpc-2620	265	16	lenalidomide	lenalidomide	NOUN
dpc-2620	265	17	treated	treat	VERB
dpc-2620	265	18	melscs	melsc	NOUN
dpc-2620	265	19	in	in	ADP
dpc-2620	265	20	comparison	comparison	NOUN
dpc-2620	265	21	to	to	ADP
dpc-2620	265	22	control	control	VERB
dpc-2620	265	23	.	.	PUNCT
dpc-2620	266	1	on	on	ADP
dpc-2620	266	2	the	the	DET
dpc-2620	266	3	other	other	ADJ
dpc-2620	266	4	hand	hand	NOUN
dpc-2620	266	5	,	,	PUNCT
dpc-2620	266	6	very	very	ADV
dpc-2620	266	7	importantly	importantly	ADV
dpc-2620	266	8	a	a	DET
dpc-2620	266	9	significant	significant	ADJ
dpc-2620	266	10	increase	increase	NOUN
dpc-2620	266	11	in	in	ADP
dpc-2620	266	12	migration	migration	NOUN
dpc-2620	266	13	of	of	ADP
dpc-2620	266	14	lenalidomide	lenalidomide	NOUN
dpc-2620	266	15	treated	treat	VERB
dpc-2620	266	16	melscs	melsc	NOUN
dpc-2620	266	17	in	in	ADP
dpc-2620	266	18	comparison	comparison	NOUN
dpc-2620	266	19	to	to	ADP
dpc-2620	266	20	control	control	NOUN
dpc-2620	266	21	was	be	AUX
dpc-2620	266	22	observed	observe	VERB
dpc-2620	266	23	.	.	PUNCT
dpc-2620	267	1	the	the	DET
dpc-2620	267	2	proliferative	proliferative	ADJ
dpc-2620	267	3	role	role	NOUN
dpc-2620	267	4	of	of	ADP
dpc-2620	267	5	lenalidomide	lenalidomide	NOUN
dpc-2620	267	6	has	have	AUX
dpc-2620	267	7	been	be	AUX
dpc-2620	267	8	earlier	early	ADV
dpc-2620	267	9	reported	report	VERB
dpc-2620	267	10	in	in	ADP
dpc-2620	267	11	the	the	DET
dpc-2620	267	12	hematopoietic	hematopoietic	ADJ
dpc-2620	267	13	progenitor	progenitor	NOUN
dpc-2620	267	14	cells	cell	NOUN
dpc-2620	267	15	by	by	ADP
dpc-2620	267	16	verhelle	verhelle	NOUN
dpc-2620	267	17	et	et	X
dpc-2620	267	18	al	al	PROPN
dpc-2620	268	1	[	[	X
dpc-2620	268	2	27	27	NUM
dpc-2620	268	3	]	]	PUNCT
dpc-2620	268	4	.	.	PUNCT
dpc-2620	269	1	role	role	NOUN
dpc-2620	269	2	of	of	ADP
dpc-2620	269	3	lenalidomide	lenalidomide	NOUN
dpc-2620	269	4	in	in	ADP
dpc-2620	269	5	the	the	DET
dpc-2620	269	6	differentiation	differentiation	NOUN
dpc-2620	269	7	of	of	ADP
dpc-2620	269	8	melscs	melsc	NOUN
dpc-2620	269	9	into	into	ADP
dpc-2620	269	10	functional	functional	ADJ
dpc-2620	269	11	melanocytes	melanocyte	NOUN
dpc-2620	269	12	was	be	AUX
dpc-2620	269	13	further	far	ADV
dpc-2620	269	14	analyzed	analyze	VERB
dpc-2620	269	15	.	.	PUNCT
dpc-2620	270	1	differentiation	differentiation	NOUN
dpc-2620	270	2	of	of	ADP
dpc-2620	270	3	melscs	melsc	NOUN
dpc-2620	270	4	into	into	ADP
dpc-2620	270	5	functional	functional	ADJ
dpc-2620	270	6	melanocytes	melanocyte	NOUN
dpc-2620	270	7	was	be	AUX
dpc-2620	270	8	investigated	investigate	VERB
dpc-2620	270	9	through	through	ADP
dpc-2620	270	10	gene	gene	NOUN
dpc-2620	270	11	expression	expression	NOUN
dpc-2620	270	12	and	and	CCONJ
dpc-2620	270	13	immunocytochemical	immunocytochemical	ADJ
dpc-2620	270	14	studies	study	NOUN
dpc-2620	270	15	,	,	PUNCT
dpc-2620	270	16	which	which	PRON
dpc-2620	270	17	indicated	indicate	VERB
dpc-2620	270	18	that	that	SCONJ
dpc-2620	270	19	lenalidomide	lenalidomide	NOUN
dpc-2620	270	20	treatment	treatment	NOUN
dpc-2620	270	21	enhanced	enhance	VERB
dpc-2620	270	22	the	the	DET
dpc-2620	270	23	differentiation	differentiation	NOUN
dpc-2620	270	24	of	of	ADP
dpc-2620	270	25	melscs	melsc	NOUN
dpc-2620	270	26	into	into	ADP
dpc-2620	270	27	melanocytes	melanocyte	NOUN
dpc-2620	270	28	confirmed	confirm	VERB
dpc-2620	270	29	by	by	ADP
dpc-2620	270	30	their	their	PRON
dpc-2620	270	31	increased	increase	VERB
dpc-2620	270	32	expression	expression	NOUN
dpc-2620	270	33	of	of	ADP
dpc-2620	270	34	tyr	tyr	PROPN
dpc-2620	270	35	,	,	PUNCT
dpc-2620	270	36	dct	dct	PROPN
dpc-2620	270	37	,	,	PUNCT
dpc-2620	270	38	mitf	mitf	NOUN
dpc-2620	270	39	,	,	PUNCT
dpc-2620	270	40	sox10	sox10	PROPN
dpc-2620	270	41	,	,	PUNCT
dpc-2620	270	42	sox9	sox9	PROPN
dpc-2620	270	43	genes	gene	NOUN
dpc-2620	270	44	.	.	PUNCT
dpc-2620	271	1	mitf	mitf	PROPN
dpc-2620	271	2	is	be	AUX
dpc-2620	271	3	the	the	DET
dpc-2620	271	4	master	master	NOUN
dpc-2620	271	5	gene	gene	NOUN
dpc-2620	271	6	that	that	PRON
dpc-2620	271	7	regulates	regulate	VERB
dpc-2620	271	8	the	the	DET
dpc-2620	271	9	pigmentation	pigmentation	NOUN
dpc-2620	271	10	through	through	ADP
dpc-2620	271	11	activation	activation	NOUN
dpc-2620	271	12	of	of	ADP
dpc-2620	271	13	downstream	downstream	ADJ
dpc-2620	271	14	genes	gene	NOUN
dpc-2620	271	15	like	like	ADP
dpc-2620	271	16	tyr	tyr	PROPN
dpc-2620	271	17	which	which	PRON
dpc-2620	271	18	ultimately	ultimately	ADV
dpc-2620	271	19	determines	determine	VERB
dpc-2620	271	20	pigmentation	pigmentation	NOUN
dpc-2620	271	21	of	of	ADP
dpc-2620	271	22	skin	skin	NOUN
dpc-2620	271	23	as	as	ADV
dpc-2620	271	24	well	well	ADV
dpc-2620	271	25	as	as	ADP
dpc-2620	271	26	hair	hair	NOUN
dpc-2620	271	27	[	[	X
dpc-2620	271	28	28,29	28,29	NUM
dpc-2620	271	29	]	]	PUNCT
dpc-2620	271	30	.	.	PUNCT
dpc-2620	272	1	sox10	sox10	NOUN
dpc-2620	272	2	is	be	AUX
dpc-2620	272	3	one	one	NUM
dpc-2620	272	4	of	of	ADP
dpc-2620	272	5	the	the	DET
dpc-2620	272	6	key	key	ADJ
dpc-2620	272	7	genes	gene	NOUN
dpc-2620	272	8	which	which	PRON
dpc-2620	272	9	play	play	VERB
dpc-2620	272	10	its	its	PRON
dpc-2620	272	11	role	role	NOUN
dpc-2620	272	12	in	in	ADP
dpc-2620	272	13	coordinating	coordinate	VERB
dpc-2620	272	14	melanocyte	melanocyte	NOUN
dpc-2620	272	15	differentiation	differentiation	NOUN
dpc-2620	272	16	by	by	ADP
dpc-2620	272	17	upregulating	upregulating	ADJ
dpc-2620	272	18	expression	expression	NOUN
dpc-2620	272	19	of	of	ADP
dpc-2620	272	20	genes	gene	NOUN
dpc-2620	272	21	required	require	VERB
dpc-2620	272	22	for	for	ADP
dpc-2620	272	23	melanogenesis	melanogenesis	NOUN
dpc-2620	272	24	[	[	X
dpc-2620	272	25	30	30	NUM
dpc-2620	272	26	]	]	PUNCT
dpc-2620	272	27	.	.	PUNCT
dpc-2620	273	1	tyr	tyr	PROPN
dpc-2620	273	2	initiates	initiate	VERB
dpc-2620	273	3	the	the	DET
dpc-2620	273	4	melanogenesis	melanogenesis	NOUN
dpc-2620	273	5	by	by	ADP
dpc-2620	273	6	oxidizing	oxidize	VERB
dpc-2620	273	7	tyrosine	tyrosine	NOUN
dpc-2620	273	8	to	to	ADP
dpc-2620	273	9	l	l	NOUN
dpc-2620	273	10	-	-	NOUN
dpc-2620	273	11	dopa	dopa	NOUN
dpc-2620	273	12	while	while	SCONJ
dpc-2620	273	13	dct	dct	PROPN
dpc-2620	273	14	is	be	AUX
dpc-2620	273	15	required	require	VERB
dpc-2620	273	16	down	down	ADP
dpc-2620	273	17	the	the	DET
dpc-2620	273	18	pathway	pathway	NOUN
dpc-2620	273	19	in	in	ADP
dpc-2620	273	20	synthesis	synthesis	NOUN
dpc-2620	273	21	of	of	ADP
dpc-2620	273	22	melanin	melanin	NOUN
dpc-2620	273	23	[	[	X
dpc-2620	273	24	31,32	31,32	NUM
dpc-2620	273	25	]	]	PUNCT
dpc-2620	273	26	.	.	PUNCT
dpc-2620	274	1	the	the	DET
dpc-2620	274	2	increased	increase	VERB
dpc-2620	274	3	expression	expression	NOUN
dpc-2620	274	4	of	of	ADP
dpc-2620	274	5	dct	dct	PROPN
dpc-2620	274	6	and	and	CCONJ
dpc-2620	274	7	tyr	tyr	PROPN
dpc-2620	274	8	by	by	ADP
dpc-2620	274	9	lenalidomide	lenalidomide	NOUN
dpc-2620	274	10	treatment	treatment	NOUN
dpc-2620	274	11	was	be	AUX
dpc-2620	274	12	also	also	ADV
dpc-2620	274	13	observed	observe	VERB
dpc-2620	274	14	at	at	ADP
dpc-2620	274	15	protein	protein	NOUN
dpc-2620	274	16	level	level	NOUN
dpc-2620	274	17	,	,	PUNCT
dpc-2620	274	18	which	which	PRON
dpc-2620	274	19	further	far	ADV
dpc-2620	274	20	verified	verify	VERB
dpc-2620	274	21	the	the	DET
dpc-2620	274	22	differentiating	differentiate	VERB
dpc-2620	274	23	effect	effect	NOUN
dpc-2620	274	24	of	of	ADP
dpc-2620	274	25	lenalidomide	lenalidomide	NOUN
dpc-2620	274	26	in	in	ADP
dpc-2620	274	27	the	the	DET
dpc-2620	274	28	melscs	melscs	NOUN
dpc-2620	274	29	into	into	ADP
dpc-2620	274	30	pigment	pigment	NOUN
dpc-2620	274	31	producing	produce	VERB
dpc-2620	274	32	melanocytes	melanocyte	NOUN
dpc-2620	274	33	.	.	PUNCT
dpc-2620	275	1	in	in	ADP
dpc-2620	275	2	conclusion	conclusion	NOUN
dpc-2620	275	3	,	,	PUNCT
dpc-2620	275	4	our	our	PRON
dpc-2620	275	5	data	datum	NOUN
dpc-2620	275	6	indicated	indicate	VERB
dpc-2620	275	7	that	that	SCONJ
dpc-2620	275	8	lenalidomide	lenalidomide	NOUN
dpc-2620	275	9	had	have	VERB
dpc-2620	275	10	very	very	ADV
dpc-2620	275	11	encouraging	encouraging	ADJ
dpc-2620	275	12	effects	effect	NOUN
dpc-2620	275	13	on	on	ADP
dpc-2620	275	14	the	the	DET
dpc-2620	275	15	in	in	X
dpc-2620	275	16	vitro	vitro	X
dpc-2620	275	17	differentiation	differentiation	NOUN
dpc-2620	275	18	of	of	ADP
dpc-2620	275	19	melscs	melsc	NOUN
dpc-2620	275	20	.	.	PUNCT
dpc-2620	276	1	it	it	PRON
dpc-2620	276	2	enhanced	enhance	VERB
dpc-2620	276	3	the	the	DET
dpc-2620	276	4	proliferation	proliferation	NOUN
dpc-2620	276	5	and	and	CCONJ
dpc-2620	276	6	migration	migration	NOUN
dpc-2620	276	7	of	of	ADP
dpc-2620	276	8	cultured	cultured	ADJ
dpc-2620	276	9	melscs	melsc	NOUN
dpc-2620	276	10	.	.	PUNCT
dpc-2620	277	1	further	far	ADV
dpc-2620	277	2	,	,	PUNCT
dpc-2620	277	3	it	it	PRON
dpc-2620	277	4	augmented	augment	VERB
dpc-2620	277	5	the	the	DET
dpc-2620	277	6	differentiation	differentiation	NOUN
dpc-2620	277	7	of	of	ADP
dpc-2620	277	8	hair	hair	NOUN
dpc-2620	277	9	follicle	follicle	VERB
dpc-2620	277	10	derived	derive	VERB
dpc-2620	277	11	melscs	melsc	NOUN
dpc-2620	277	12	into	into	ADP
dpc-2620	277	13	functional	functional	ADJ
dpc-2620	277	14	melanocytes	melanocyte	NOUN
dpc-2620	277	15	that	that	PRON
dpc-2620	277	16	endorses	endorse	VERB
dpc-2620	277	17	its	its	PRON
dpc-2620	277	18	therapeutic	therapeutic	ADJ
dpc-2620	277	19	use	use	NOUN
dpc-2620	277	20	in	in	ADP
dpc-2620	277	21	the	the	DET
dpc-2620	277	22	repigmentation	repigmentation	NOUN
dpc-2620	277	23	process	process	NOUN
dpc-2620	277	24	of	of	ADP
dpc-2620	277	25	vitiligo	vitiligo	NOUN
dpc-2620	277	26	.	.	PUNCT
dpc-2620	278	1	acknowledgements	acknowledgement	NOUN
dpc-2620	278	2	we	we	PRON
dpc-2620	278	3	acknowledge	acknowledge	VERB
dpc-2620	278	4	the	the	DET
dpc-2620	278	5	science	science	NOUN
dpc-2620	278	6	and	and	CCONJ
dpc-2620	278	7	engineering	engineering	NOUN
dpc-2620	278	8	research	research	NOUN
dpc-2620	278	9	board	board	NOUN
dpc-2620	278	10	,	,	PUNCT
dpc-2620	278	11	department	department	NOUN
dpc-2620	278	12	of	of	ADP
dpc-2620	278	13	science	science	NOUN
dpc-2620	278	14	and	and	CCONJ
dpc-2620	278	15	technology	technology	NOUN
dpc-2620	278	16	,	,	PUNCT
dpc-2620	278	17	new	new	ADJ
dpc-2620	278	18	delhi	delhi	PROPN
dpc-2620	278	19	,	,	PUNCT
dpc-2620	278	20	india	india	PROPN
dpc-2620	278	21	for	for	ADP
dpc-2620	278	22	financial	financial	ADJ
dpc-2620	278	23	support	support	NOUN
dpc-2620	278	24	(	(	PUNCT
dpc-2620	278	25	ecr/2016/000671	ecr/2016/000671	PROPN
dpc-2620	278	26	)	)	PUNCT
dpc-2620	278	27	to	to	PART
dpc-2620	278	28	ravinder	ravinder	VERB
dpc-2620	278	29	original	original	ADJ
dpc-2620	278	30	article	article	NOUN
dpc-2620	278	31	|	|	ADV
dpc-2620	278	32	dermatol	dermatol	ADJ
dpc-2620	278	33	pract	pract	NOUN
dpc-2620	278	34	concept	concept	NOUN
dpc-2620	278	35	.	.	PUNCT
dpc-2620	279	1	2023;13(2):e2023077	2023;13(2):e2023077	NUM
dpc-2620	279	2	9	9	NUM
dpc-2620	279	3	24	24	NUM
dpc-2620	279	4	.	.	PUNCT
dpc-2620	280	1	colombo	colombo	PROPN
dpc-2620	280	2	s	s	PROPN
dpc-2620	280	3	,	,	PUNCT
dpc-2620	280	4	berlin	berlin	PROPN
dpc-2620	280	5	i	i	PROPN
dpc-2620	280	6	,	,	PUNCT
dpc-2620	280	7	delmas	delmas	PROPN
dpc-2620	280	8	v	v	PROPN
dpc-2620	280	9	,	,	PUNCT
dpc-2620	280	10	et	et	PROPN
dpc-2620	280	11	al	al	PROPN
dpc-2620	280	12	.	.	PROPN
dpc-2620	281	1	classical	classical	ADJ
dpc-2620	281	2	and	and	CCONJ
dpc-2620	281	3	nonclassical	nonclassical	ADJ
dpc-2620	281	4	melanocytes	melanocyte	NOUN
dpc-2620	281	5	in	in	ADP
dpc-2620	281	6	vertebrates	vertebrate	NOUN
dpc-2620	281	7	)	)	PUNCT
dpc-2620	281	8	.	.	PUNCT
dpc-2620	282	1	weinheim	weinheim	PROPN
dpc-2620	282	2	,	,	PUNCT
dpc-2620	282	3	germany	germany	PROPN
dpc-2620	282	4	:	:	PUNCT
dpc-2620	282	5	wiley	wiley	PROPN
dpc-2620	282	6	-	-	PUNCT
dpc-2620	282	7	blackwell	blackwell	PROPN
dpc-2620	282	8	.	.	PUNCT
dpc-2620	283	1	2011:21	2011:21	NOUN
dpc-2620	283	2	-	-	SYM
dpc-2620	283	3	61	61	NUM
dpc-2620	283	4	.	.	PUNCT
dpc-2620	284	1	25	25	NUM
dpc-2620	284	2	.	.	PUNCT
dpc-2620	285	1	qiu	qiu	PROPN
dpc-2620	285	2	w	w	PROPN
dpc-2620	285	3	,	,	PUNCT
dpc-2620	285	4	yang	yang	PROPN
dpc-2620	285	5	k	k	PROPN
dpc-2620	285	6	,	,	PUNCT
dpc-2620	285	7	lei	lei	PROPN
dpc-2620	285	8	m	m	PROPN
dpc-2620	285	9	,	,	PUNCT
dpc-2620	285	10	et	et	PROPN
dpc-2620	285	11	al	al	PROPN
dpc-2620	285	12	.	.	PUNCT
dpc-2620	285	13	scf	scf	PROPN
dpc-2620	285	14	/	/	SYM
dpc-2620	285	15	c	c	NOUN
dpc-2620	285	16	-	-	PUNCT
dpc-2620	285	17	kit	kit	NOUN
dpc-2620	285	18	signaling	signaling	NOUN
dpc-2620	285	19	is	be	AUX
dpc-2620	285	20	required	require	VERB
dpc-2620	285	21	in	in	ADP
dpc-2620	285	22	12	12	NUM
dpc-2620	285	23	-	-	PUNCT
dpc-2620	285	24	o	o	NOUN
dpc-2620	285	25	-	-	PUNCT
dpc-2620	285	26	tetradecanoylphorbol-13	tetradecanoylphorbol-13	PROPN
dpc-2620	285	27	-	-	PUNCT
dpc-2620	285	28	acetate	acetate	NOUN
dpc-2620	285	29	-	-	PUNCT
dpc-2620	285	30	induced	induce	VERB
dpc-2620	285	31	migration	migration	NOUN
dpc-2620	285	32	and	and	CCONJ
dpc-2620	285	33	differentiation	differentiation	NOUN
dpc-2620	285	34	of	of	ADP
dpc-2620	285	35	hair	hair	NOUN
dpc-2620	285	36	follicle	follicle	NOUN
dpc-2620	285	37	melanocytes	melanocyte	NOUN
dpc-2620	285	38	for	for	ADP
dpc-2620	285	39	epidermal	epidermal	ADJ
dpc-2620	285	40	pigmentation	pigmentation	NOUN
dpc-2620	285	41	.	.	PUNCT
dpc-2620	286	1	cell	cell	NOUN
dpc-2620	286	2	tissue	tissue	NOUN
dpc-2620	286	3	res	re	NOUN
dpc-2620	286	4	.	.	PUNCT
dpc-2620	287	1	2015;360(2):333	2015;360(2):333	NOUN
dpc-2620	287	2	-	-	SYM
dpc-2620	287	3	346.doi	346.doi	NUM
dpc-2620	287	4	:	:	PUNCT
dpc-2620	287	5	10.1007	10.1007	NUM
dpc-2620	287	6	/s00441	/s00441	ADJ
dpc-2620	287	7	-	-	PUNCT
dpc-2620	287	8	014	014	NUM
dpc-2620	287	9	-	-	PUNCT
dpc-2620	287	10	2101	2101	NUM
dpc-2620	287	11	-	-	PUNCT
dpc-2620	287	12	8	8	NUM
dpc-2620	287	13	.	.	PUNCT
dpc-2620	288	1	pmid	pmid	NOUN
dpc-2620	288	2	:	:	PUNCT
dpc-2620	288	3	25727244	25727244	NUM
dpc-2620	288	4	.	.	PUNCT
dpc-2620	289	1	26	26	NUM
dpc-2620	289	2	.	.	PUNCT
dpc-2620	290	1	cui	cui	PROPN
dpc-2620	290	2	j	j	PROPN
dpc-2620	290	3	,	,	PUNCT
dpc-2620	290	4	shen	shen	PROPN
dpc-2620	290	5	ly	ly	PROPN
dpc-2620	290	6	,	,	PUNCT
dpc-2620	290	7	wang	wang	PROPN
dpc-2620	290	8	gc	gc	PROPN
dpc-2620	290	9	.	.	PROPN
dpc-2620	290	10	role	role	NOUN
dpc-2620	290	11	of	of	ADP
dpc-2620	290	12	hair	hair	NOUN
dpc-2620	290	13	follicles	follicle	NOUN
dpc-2620	290	14	in	in	ADP
dpc-2620	290	15	the	the	DET
dpc-2620	290	16	repigmentation	repigmentation	NOUN
dpc-2620	290	17	of	of	ADP
dpc-2620	290	18	vitiligo	vitiligo	NOUN
dpc-2620	290	19	.	.	PUNCT
dpc-2620	291	1	j	j	PROPN
dpc-2620	291	2	invest	invest	VERB
dpc-2620	291	3	dermatol	dermatol	NOUN
dpc-2620	291	4	.	.	PUNCT
dpc-2620	292	1	1991;97(3):410	1991;97(3):410	PROPN
dpc-2620	292	2	-	-	PUNCT
dpc-2620	292	3	416.doi	416.doi	NUM
dpc-2620	292	4	:	:	PUNCT
dpc-2620	292	5	10.1111/1523	10.1111/1523	NUM
dpc-2620	292	6	-	-	NOUN
dpc-2620	292	7	1747.ep12480997	1747.ep12480997	NOUN
dpc-2620	292	8	.	.	PUNCT
dpc-2620	293	1	pmid	pmid	NOUN
dpc-2620	293	2	:	:	PUNCT
dpc-2620	293	3	1714927	1714927	NUM
dpc-2620	293	4	.	.	PUNCT
dpc-2620	294	1	27	27	NUM
dpc-2620	294	2	.	.	X
dpc-2620	295	1	verhelle	verhelle	PROPN
dpc-2620	295	2	d	d	NOUN
dpc-2620	295	3	,	,	PUNCT
dpc-2620	295	4	corral	corral	ADJ
dpc-2620	295	5	lg	lg	NOUN
dpc-2620	295	6	,	,	PUNCT
dpc-2620	295	7	wong	wong	PROPN
dpc-2620	295	8	k	k	PROPN
dpc-2620	295	9	,	,	PUNCT
dpc-2620	295	10	et	et	PROPN
dpc-2620	295	11	al	al	PROPN
dpc-2620	295	12	.	.	PROPN
dpc-2620	295	13	lenalidomide	lenalidomide	PROPN
dpc-2620	295	14	and	and	CCONJ
dpc-2620	295	15	cc-4047	cc-4047	PROPN
dpc-2620	295	16	inhibit	inhibit	VERB
dpc-2620	295	17	the	the	DET
dpc-2620	295	18	proliferation	proliferation	NOUN
dpc-2620	295	19	of	of	ADP
dpc-2620	295	20	malignant	malignant	ADJ
dpc-2620	295	21	b	b	NOUN
dpc-2620	295	22	cells	cell	NOUN
dpc-2620	295	23	while	while	SCONJ
dpc-2620	295	24	expanding	expand	VERB
dpc-2620	295	25	normal	normal	ADJ
dpc-2620	295	26	cd34	cd34	PROPN
dpc-2620	295	27	+	+	ADJ
dpc-2620	295	28	progenitor	progenitor	NOUN
dpc-2620	295	29	cells	cell	NOUN
dpc-2620	295	30	.	.	PUNCT
dpc-2620	296	1	cancer	cancer	NOUN
dpc-2620	296	2	res	re	NOUN
dpc-2620	296	3	.	.	PUNCT
dpc-2620	297	1	2007;67(2):746	2007;67(2):746	PROPN
dpc-2620	297	2	-	-	PUNCT
dpc-2620	297	3	755	755	NUM
dpc-2620	297	4	.	.	PUNCT
dpc-2620	297	5	doi	doi	NOUN
dpc-2620	297	6	:	:	PUNCT
dpc-2620	297	7	10.1158/0008	10.1158/0008	NUM
dpc-2620	297	8	-	-	PUNCT
dpc-2620	297	9	5472.can-06	5472.can-06	NUM
dpc-2620	297	10	-	-	PUNCT
dpc-2620	297	11	2317	2317	NUM
dpc-2620	297	12	.	.	PUNCT
dpc-2620	298	1	pmid	pmid	NOUN
dpc-2620	298	2	:	:	PUNCT
dpc-2620	298	3	17234786	17234786	NUM
dpc-2620	298	4	.	.	PUNCT
dpc-2620	299	1	28	28	NUM
dpc-2620	299	2	.	.	PUNCT
dpc-2620	300	1	kawakami	kawakami	PROPN
dpc-2620	300	2	a	a	PROPN
dpc-2620	300	3	,	,	PUNCT
dpc-2620	300	4	fisher	fisher	PROPN
dpc-2620	300	5	de	de	PROPN
dpc-2620	300	6	.	.	PUNCT
dpc-2620	301	1	the	the	DET
dpc-2620	301	2	master	master	NOUN
dpc-2620	301	3	role	role	NOUN
dpc-2620	301	4	of	of	ADP
dpc-2620	301	5	microphthalmia	microphthalmia	NOUN
dpc-2620	301	6	associated	associate	VERB
dpc-2620	301	7	transcription	transcription	NOUN
dpc-2620	301	8	factor	factor	NOUN
dpc-2620	301	9	in	in	ADP
dpc-2620	301	10	melanocyte	melanocyte	NOUN
dpc-2620	301	11	and	and	CCONJ
dpc-2620	301	12	melanoma	melanoma	NOUN
dpc-2620	301	13	biology	biology	NOUN
dpc-2620	301	14	.	.	PUNCT
dpc-2620	302	1	lab	lab	NOUN
dpc-2620	302	2	invest.2017;97(6):649	invest.2017;97(6):649	PROPN
dpc-2620	302	3	-	-	PUNCT
dpc-2620	302	4	656.doi	656.doi	NUM
dpc-2620	302	5	:	:	PUNCT
dpc-2620	302	6	  	  	SPACE
dpc-2620	302	7	10.1038/	10.1038/	NUM
dpc-2620	302	8	labinvest.2017.9	labinvest.2017.9	PROPN
dpc-2620	302	9	.	.	PUNCT
dpc-2620	303	1	pmid	pmid	NOUN
dpc-2620	303	2	:	:	PUNCT
dpc-2620	303	3	28263292	28263292	NUM
dpc-2620	303	4	.	.	PUNCT
dpc-2620	304	1	29	29	NUM
dpc-2620	304	2	.	.	PUNCT
dpc-2620	305	1	wu	wu	PROPN
dpc-2620	305	2	m	m	PROPN
dpc-2620	305	3	,	,	PUNCT
dpc-2620	305	4	chen	chen	PROPN
dpc-2620	305	5	x	x	PROPN
dpc-2620	305	6	,	,	PUNCT
dpc-2620	305	7	cui	cui	PROPN
dpc-2620	305	8	k	k	PROPN
dpc-2620	305	9	,	,	PUNCT
dpc-2620	305	10	li	li	PROPN
dpc-2620	305	11	h	h	PROPN
dpc-2620	305	12	,	,	PUNCT
dpc-2620	305	13	jiang	jiang	PROPN
dpc-2620	305	14	y.	y.	PROPN
dpc-2620	305	15	pigmentation	pigmentation	PROPN
dpc-2620	305	16	formation	formation	NOUN
dpc-2620	305	17	and	and	CCONJ
dpc-2620	305	18	expression	expression	NOUN
dpc-2620	305	19	analysis	analysis	NOUN
dpc-2620	305	20	of	of	ADP
dpc-2620	305	21	tyrosinase	tyrosinase	NOUN
dpc-2620	305	22	in	in	ADP
dpc-2620	305	23	siniperca	siniperca	PROPN
dpc-2620	305	24	chuatsi	chuatsi	PROPN
dpc-2620	305	25	.	.	PUNCT
dpc-2620	306	1	fish	fish	PROPN
dpc-2620	306	2	physiol	physiol	PROPN
dpc-2620	306	3	biochem	biochem	PROPN
dpc-2620	306	4	.	.	PUNCT
dpc-2620	307	1	2020;46(4):1279	2020;46(4):1279	NUM
dpc-2620	307	2	-	-	SYM
dpc-2620	307	3	1293	1293	NUM
dpc-2620	307	4	.	.	PUNCT
dpc-2620	308	1	doi	doi	NOUN
dpc-2620	308	2	:	:	PUNCT
dpc-2620	308	3	10.1007	10.1007	NUM
dpc-2620	308	4	/s10695	/s10695	SYM
dpc-2620	308	5	-	-	PUNCT
dpc-2620	308	6	020	020	NUM
dpc-2620	308	7	-	-	PUNCT
dpc-2620	308	8	00788	00788	NUM
dpc-2620	308	9	-	-	SYM
dpc-2620	308	10	7	7	NUM
dpc-2620	308	11	.	.	PUNCT
dpc-2620	309	1	pmid	pmid	NOUN
dpc-2620	309	2	:	:	PUNCT
dpc-2620	309	3	32185567	32185567	NUM
dpc-2620	309	4	.	.	PUNCT
dpc-2620	310	1	30	30	NUM
dpc-2620	310	2	.	.	PUNCT
dpc-2620	311	1	wegner	wegner	PROPN
dpc-2620	311	2	m.	m.	NOUN
dpc-2620	311	3	secrets	secret	NOUN
dpc-2620	311	4	to	to	ADP
dpc-2620	311	5	a	a	DET
dpc-2620	311	6	healthy	healthy	ADJ
dpc-2620	311	7	sox	sox	PROPN
dpc-2620	311	8	life	life	NOUN
dpc-2620	311	9	:	:	PUNCT
dpc-2620	311	10	lessons	lesson	NOUN
dpc-2620	311	11	for	for	ADP
dpc-2620	311	12	melanocytes	melanocyte	NOUN
dpc-2620	311	13	.	.	PUNCT
dpc-2620	312	1	pigment	pigment	NOUN
dpc-2620	312	2	cell	cell	NOUN
dpc-2620	312	3	res	re	NOUN
dpc-2620	312	4	.	.	PUNCT
dpc-2620	313	1	2005;18(2):74–85.doi	2005;18(2):74–85.doi	NOUN
dpc-2620	313	2	:	:	PUNCT
dpc-2620	313	3	 	 	SPACE
dpc-2620	313	4	10.1111	10.1111	NUM
dpc-2620	313	5	/	/	SYM
dpc-2620	313	6	j.1600	j.1600	PROPN
dpc-2620	313	7	-0749.2005.00218.x	-0749.2005.00218.x	PROPN
dpc-2620	313	8	.	.	PUNCT
dpc-2620	314	1	pmid	pmid	NOUN
dpc-2620	314	2	:	:	PUNCT
dpc-2620	314	3	15760336	15760336	NUM
dpc-2620	314	4	.	.	PUNCT
dpc-2620	315	1	31	31	NUM
dpc-2620	315	2	.	.	PUNCT
dpc-2620	316	1	yasumoto	yasumoto	PROPN
dpc-2620	316	2	ki	ki	PROPN
dpc-2620	316	3	,	,	PUNCT
dpc-2620	316	4	yokoyama	yokoyama	PROPN
dpc-2620	316	5	k	k	PROPN
dpc-2620	316	6	,	,	PUNCT
dpc-2620	316	7	shibata	shibata	PROPN
dpc-2620	316	8	k	k	PROPN
dpc-2620	316	9	,	,	PUNCT
dpc-2620	316	10	tomita	tomita	PROPN
dpc-2620	316	11	y	y	PROPN
dpc-2620	316	12	,	,	PUNCT
dpc-2620	316	13	shibahara	shibahara	ADJ
dpc-2620	316	14	s.	s.	PROPN
dpc-2620	316	15	microphthalmia	microphthalmia	PROPN
dpc-2620	316	16	-	-	PUNCT
dpc-2620	316	17	associated	associate	VERB
dpc-2620	316	18	transcription	transcription	NOUN
dpc-2620	316	19	factor	factor	NOUN
dpc-2620	316	20	as	as	ADP
dpc-2620	316	21	a	a	DET
dpc-2620	316	22	regulator	regulator	NOUN
dpc-2620	316	23	for	for	ADP
dpc-2620	316	24	melanocyte	melanocyte	NOUN
dpc-2620	316	25	-	-	PUNCT
dpc-2620	316	26	specific	specific	ADJ
dpc-2620	316	27	transcription	transcription	NOUN
dpc-2620	316	28	of	of	ADP
dpc-2620	316	29	the	the	DET
dpc-2620	316	30	human	human	ADJ
dpc-2620	316	31	tyrosinase	tyrosinase	NOUN
dpc-2620	316	32	gene	gene	NOUN
dpc-2620	316	33	.	.	PUNCT
dpc-2620	317	1	mol	mol	ADP
dpc-2620	317	2	cell	cell	NOUN
dpc-2620	317	3	biol	biol	NOUN
dpc-2620	317	4	.	.	PUNCT
dpc-2620	318	1	1994;14(12):8058	1994;14(12):8058	NUM
dpc-2620	318	2	-	-	SYM
dpc-2620	318	3	8070	8070	NUM
dpc-2620	318	4	.	.	PUNCT
dpc-2620	319	1	doi	doi	NOUN
dpc-2620	319	2	:	:	PUNCT
dpc-2620	319	3	10.1128	10.1128	NUM
dpc-2620	319	4	/	/	SYM
dpc-2620	319	5	mcb.14.12.80588070.1994	mcb.14.12.80588070.1994	NOUN
dpc-2620	319	6	.	.	PUNCT
dpc-2620	320	1	pmid	pmid	NOUN
dpc-2620	320	2	:	:	PUNCT
dpc-2620	320	3	7969144	7969144	NUM
dpc-2620	320	4	.	.	PUNCT
dpc-2620	321	1	pmcid	pmcid	NOUN
dpc-2620	321	2	:	:	PUNCT
dpc-2620	321	3	pmc359344	pmc359344	NOUN
dpc-2620	321	4	.	.	PUNCT
dpc-2620	322	1	32	32	NUM
dpc-2620	322	2	.	.	PUNCT
dpc-2620	323	1	bertolotto	bertolotto	PROPN
dpc-2620	323	2	c	c	NOUN
dpc-2620	323	3	,	,	PUNCT
dpc-2620	323	4	abbe	abbe	X
dpc-2620	323	5	p	p	X
dpc-2620	323	6	,	,	PUNCT
dpc-2620	323	7	bille	bille	NOUN
dpc-2620	323	8	k	k	PROPN
dpc-2620	323	9	,	,	PUNCT
dpc-2620	323	10	et	et	PROPN
dpc-2620	323	11	al	al	PROPN
dpc-2620	323	12	.	.	PUNCT
dpc-2620	324	1	different	different	ADJ
dpc-2620	324	2	cis	cis	NOUN
dpc-2620	324	3	-	-	PUNCT
dpc-2620	324	4	acting	act	VERB
dpc-2620	324	5	elements	element	NOUN
dpc-2620	324	6	are	be	AUX
dpc-2620	324	7	involved	involve	VERB
dpc-2620	324	8	in	in	ADP
dpc-2620	324	9	the	the	DET
dpc-2620	324	10	regulation	regulation	NOUN
dpc-2620	324	11	of	of	ADP
dpc-2620	324	12	trp1	trp1	NOUN
dpc-2620	324	13	and	and	CCONJ
dpc-2620	324	14	trp2promoter	trp2promoter	PROPN
dpc-2620	324	15	activities	activity	NOUN
dpc-2620	324	16	bycyclic	bycyclic	ADJ
dpc-2620	324	17	amp	amp	PROPN
dpc-2620	324	18	:	:	PUNCT
dpc-2620	324	19	pivotal	pivotal	ADJ
dpc-2620	324	20	role	role	NOUN
dpc-2620	324	21	of	of	ADP
dpc-2620	324	22	m	m	PROPN
dpc-2620	324	23	boxes	box	NOUN
dpc-2620	324	24	(	(	PUNCT
dpc-2620	324	25	gtcatgtgct)and	gtcatgtgct)and	NOUN
dpc-2620	324	26	of	of	ADP
dpc-2620	324	27	microphthalmia	microphthalmia	NOUN
dpc-2620	324	28	.	.	PUNCT
dpc-2620	325	1	mol	mol	PROPN
dpc-2620	325	2	cel	cel	PROPN
dpc-2620	325	3	.	.	PUNCT
dpc-2620	325	4	biol	biol	PROPN
dpc-2620	325	5	.	.	PUNCT
dpc-2620	326	1	1998;18(2	1998;18(2	NUM
dpc-2620	326	2	):	):	PUNCT
dpc-2620	326	3	694-702.doi	694-702.doi	NUM
dpc-2620	326	4	:	:	PUNCT
dpc-2620	326	5	10.1128	10.1128	NUM
dpc-2620	326	6	/	/	SYM
dpc-2620	326	7	mcb.18.2.694	mcb.18.2.694	NOUN
dpc-2620	326	8	.	.	PUNCT
dpc-2620	327	1	pmid	pmid	NOUN
dpc-2620	327	2	:	:	PUNCT
dpc-2620	327	3	9447965	9447965	NUM
dpc-2620	327	4	.	.	PUNCT
dpc-2620	328	1	pmcid	pmcid	NOUN
dpc-2620	328	2	:	:	PUNCT
dpc-2620	328	3	pmc108780	pmc108780	ADJ
dpc-2620	328	4	.	.	PUNCT
dpc-2620	329	1	novo	novo	PROPN
dpc-2620	329	2	hair	hair	NOUN
dpc-2620	329	3	follicle	follicle	NOUN
dpc-2620	329	4	induction	induction	NOUN
dpc-2620	329	5	.	.	PUNCT
dpc-2620	330	1	j	j	PROPN
dpc-2620	330	2	tissue	tissue	NOUN
dpc-2620	330	3	eng	eng	PROPN
dpc-2620	330	4	.	.	PUNCT
dpc-2620	331	1	2007;13(5):975	2007;13(5):975	NUM
dpc-2620	331	2	-	-	SYM
dpc-2620	331	3	982	982	NUM
dpc-2620	331	4	.	.	PUNCT
dpc-2620	331	5	doi	doi	NOUN
dpc-2620	331	6	:	:	PUNCT
dpc-2620	331	7	10.1089	10.1089	NUM
dpc-2620	331	8	/	/	SYM
dpc-2620	331	9	ten.2006.0304	ten.2006.0304	NUM
dpc-2620	331	10	.	.	PUNCT
dpc-2620	332	1	pmid	pmid	NOUN
dpc-2620	332	2	:	:	PUNCT
dpc-2620	332	3	17341162	17341162	NUM
dpc-2620	332	4	.	.	PUNCT
dpc-2620	333	1	15	15	NUM
dpc-2620	333	2	.	.	PUNCT
dpc-2620	334	1	mosmann	mosmann	PROPN
dpc-2620	334	2	t.	t.	PROPN
dpc-2620	334	3	rapid	rapid	ADJ
dpc-2620	334	4	colorimetric	colorimetric	ADJ
dpc-2620	334	5	assay	assay	NOUN
dpc-2620	334	6	for	for	ADP
dpc-2620	334	7	cellular	cellular	ADJ
dpc-2620	334	8	growth	growth	NOUN
dpc-2620	334	9	and	and	CCONJ
dpc-2620	334	10	survival	survival	NOUN
dpc-2620	334	11	:	:	PUNCT
dpc-2620	334	12	application	application	NOUN
dpc-2620	334	13	to	to	ADP
dpc-2620	334	14	proliferation	proliferation	NOUN
dpc-2620	334	15	and	and	CCONJ
dpc-2620	334	16	cytotoxicity	cytotoxicity	NOUN
dpc-2620	334	17	assays	assay	NOUN
dpc-2620	334	18	.	.	PUNCT
dpc-2620	335	1	j	j	PROPN
dpc-2620	335	2	immunol	immunol	NOUN
dpc-2620	335	3	methods	method	NOUN
dpc-2620	335	4	.	.	PUNCT
dpc-2620	336	1	1983;65(1	1983;65(1	NUM
dpc-2620	336	2	-	-	SYM
dpc-2620	336	3	2):55	2):55	NUM
dpc-2620	336	4	-	-	PUNCT
dpc-2620	336	5	63.doi	63.doi	PROPN
dpc-2620	336	6	:	:	PUNCT
dpc-2620	336	7	10.1016/0022	10.1016/0022	NUM
dpc-2620	336	8	-1759(83)90303	-1759(83)90303	NOUN
dpc-2620	336	9	-	-	PUNCT
dpc-2620	336	10	4	4	NUM
dpc-2620	336	11	.	.	PUNCT
dpc-2620	337	1	pmid	pmid	NOUN
dpc-2620	337	2	:	:	PUNCT
dpc-2620	337	3	6606682	6606682	NUM
dpc-2620	337	4	.	.	PUNCT
dpc-2620	338	1	16	16	NUM
dpc-2620	338	2	.	.	PUNCT
dpc-2620	339	1	livak	livak	PROPN
dpc-2620	339	2	kj	kj	PROPN
dpc-2620	339	3	,	,	PUNCT
dpc-2620	339	4	schmittgen	schmittgen	PROPN
dpc-2620	339	5	td	td	NOUN
dpc-2620	339	6	.	.	PUNCT
dpc-2620	339	7	analysis	analysis	NOUN
dpc-2620	339	8	of	of	ADP
dpc-2620	339	9	relative	relative	ADJ
dpc-2620	339	10	gene	gene	NOUN
dpc-2620	339	11	expression	expression	NOUN
dpc-2620	339	12	data	datum	NOUN
dpc-2620	339	13	using	use	VERB
dpc-2620	339	14	real	real	ADJ
dpc-2620	339	15	-	-	PUNCT
dpc-2620	339	16	time	time	NOUN
dpc-2620	339	17	quantitative	quantitative	ADJ
dpc-2620	339	18	pcr	pcr	NOUN
dpc-2620	339	19	and	and	CCONJ
dpc-2620	339	20	the	the	DET
dpc-2620	339	21	2−	2−	NUM
dpc-2620	339	22	δδct	δδct	NOUN
dpc-2620	339	23	method	method	NOUN
dpc-2620	339	24	.	.	PUNCT
dpc-2620	340	1	methods.2001;25(4):402	methods.2001;25(4):402	PROPN
dpc-2620	340	2	-	-	PUNCT
dpc-2620	340	3	408.doi	408.doi	NUM
dpc-2620	340	4	:	:	PUNCT
dpc-2620	340	5	10.1006	10.1006	NUM
dpc-2620	340	6	/	/	SYM
dpc-2620	340	7	meth.2001.1262	meth.2001.1262	PROPN
dpc-2620	340	8	.	.	PUNCT
dpc-2620	341	1	pmid	pmid	NOUN
dpc-2620	341	2	:	:	PUNCT
dpc-2620	341	3	11846609	11846609	NUM
dpc-2620	341	4	.	.	PUNCT
dpc-2620	342	1	17	17	NUM
dpc-2620	342	2	.	.	PUNCT
dpc-2620	343	1	ortonne	ortonne	NOUN
dpc-2620	343	2	jp	jp	PROPN
dpc-2620	343	3	,	,	PUNCT
dpc-2620	343	4	schmitt	schmitt	PROPN
dpc-2620	343	5	d	d	NOUN
dpc-2620	343	6	,	,	PUNCT
dpc-2620	343	7	thivolet	thivolet	PROPN
dpc-2620	343	8	j.	j.	PROPN
dpc-2620	343	9	puva	puva	PROPN
dpc-2620	343	10	-	-	PUNCT
dpc-2620	343	11	induced	induce	VERB
dpc-2620	343	12	repigmentation	repigmentation	NOUN
dpc-2620	343	13	of	of	ADP
dpc-2620	343	14	vitiligo	vitiligo	NOUN
dpc-2620	343	15	:	:	PUNCT
dpc-2620	343	16	scanning	scan	VERB
dpc-2620	343	17	electron	electron	NOUN
dpc-2620	343	18	microscopy	microscopy	NOUN
dpc-2620	343	19	of	of	ADP
dpc-2620	343	20	hair	hair	NOUN
dpc-2620	343	21	follicles	follicle	NOUN
dpc-2620	343	22	.	.	PUNCT
dpc-2620	343	23	 	 	SPACE
dpc-2620	344	1	j	j	PROPN
dpc-2620	344	2	invest	invest	VERB
dpc-2620	344	3	dermatol	dermatol	NOUN
dpc-2620	344	4	.	.	PUNCT
dpc-2620	344	5	 	 	SPACE
dpc-2620	344	6	1980;74:40–42.doi	1980;74:40–42.doi	NUM
dpc-2620	344	7	:	:	PUNCT
dpc-2620	344	8	10.1006	10.1006	NUM
dpc-2620	344	9	/	/	SYM
dpc-2620	344	10	meth.2001.1262	meth.2001.1262	PROPN
dpc-2620	344	11	.	.	PUNCT
dpc-2620	345	1	pmid	pmid	NOUN
dpc-2620	345	2	:	:	PUNCT
dpc-2620	345	3	7351492	7351492	NUM
dpc-2620	345	4	.	.	PUNCT
dpc-2620	346	1	18	18	NUM
dpc-2620	346	2	.	.	PUNCT
dpc-2620	346	3	buffoli	buffoli	PROPN
dpc-2620	346	4	b	b	PROPN
dpc-2620	346	5	,	,	PUNCT
dpc-2620	346	6	rinaldi	rinaldi	PROPN
dpc-2620	346	7	f	f	PROPN
dpc-2620	346	8	,	,	PUNCT
dpc-2620	346	9	labanca	labanca	PROPN
dpc-2620	346	10	m	m	PROPN
dpc-2620	346	11	,	,	PUNCT
dpc-2620	346	12	et	et	PROPN
dpc-2620	346	13	al	al	PROPN
dpc-2620	346	14	.	.	PUNCT
dpc-2620	347	1	the	the	DET
dpc-2620	347	2	human	human	ADJ
dpc-2620	347	3	hair	hair	NOUN
dpc-2620	347	4	:	:	PUNCT
dpc-2620	347	5	from	from	ADP
dpc-2620	347	6	anatomy	anatomy	NOUN
dpc-2620	347	7	to	to	ADP
dpc-2620	347	8	physiology	physiology	NOUN
dpc-2620	347	9	.	.	PUNCT
dpc-2620	347	10	  	  	SPACE
dpc-2620	348	1	int	int	PROPN
dpc-2620	348	2	j	j	PROPN
dpc-2620	348	3	dermatol	dermatol	NOUN
dpc-2620	348	4	.	.	PUNCT
dpc-2620	348	5	  	  	SPACE
dpc-2620	349	1	2014;53(3):331–341	2014;53(3):331–341	NUM
dpc-2620	349	2	.	.	PUNCT
dpc-2620	349	3	doi	doi	NOUN
dpc-2620	349	4	:	:	PUNCT
dpc-2620	349	5	10.1111	10.1111	NUM
dpc-2620	349	6	/	/	SYM
dpc-2620	349	7	ijd.12362.pmid	ijd.12362.pmid	NOUN
dpc-2620	349	8	:	:	PUNCT
dpc-2620	349	9	24372228	24372228	NUM
dpc-2620	349	10	.	.	PUNCT
dpc-2620	350	1	19	19	NUM
dpc-2620	350	2	.	.	PUNCT
dpc-2620	350	3	zeuner	zeuner	PROPN
dpc-2620	350	4	mt	mt	PROPN
dpc-2620	350	5	,	,	PUNCT
dpc-2620	350	6	didenko	didenko	PROPN
dpc-2620	350	7	nn	nn	PROPN
dpc-2620	350	8	,	,	PUNCT
dpc-2620	350	9	humphries	humphries	PROPN
dpc-2620	350	10	d	d	PROPN
dpc-2620	350	11	,	,	PUNCT
dpc-2620	350	12	et	et	PROPN
dpc-2620	350	13	al	al	PROPN
dpc-2620	350	14	.	.	PUNCT
dpc-2620	350	15	isolation	isolation	NOUN
dpc-2620	350	16	and	and	CCONJ
dpc-2620	350	17	characterization	characterization	NOUN
dpc-2620	350	18	of	of	ADP
dpc-2620	350	19	neural	neural	ADJ
dpc-2620	350	20	crest	crest	NOUN
dpc-2620	350	21	-	-	PUNCT
dpc-2620	350	22	derived	derive	VERB
dpc-2620	350	23	stem	stem	NOUN
dpc-2620	350	24	cells	cell	NOUN
dpc-2620	350	25	from	from	ADP
dpc-2620	350	26	adult	adult	NOUN
dpc-2620	350	27	ovine	ovine	ADJ
dpc-2620	350	28	palatal	palatal	ADJ
dpc-2620	350	29	tissue	tissue	NOUN
dpc-2620	350	30	.	.	PUNCT
dpc-2620	350	31	  	  	SPACE
dpc-2620	351	1	front	front	ADJ
dpc-2620	351	2	cell	cell	NOUN
dpc-2620	351	3	dev	dev	PROPN
dpc-2620	351	4	biol	biol	NOUN
dpc-2620	351	5	.	.	PUNCT
dpc-2620	352	1	2018;6:39.doi	2018;6:39.doi	NUM
dpc-2620	352	2	:	:	PUNCT
dpc-2620	352	3	10.3389	10.3389	NUM
dpc-2620	352	4	/fcell.2018.00039.pmid	/fcell.2018.00039.pmid	NOUN
dpc-2620	352	5	:	:	PUNCT
dpc-2620	352	6	29696142	29696142	NUM
dpc-2620	352	7	.	.	PUNCT
dpc-2620	353	1	pmcid	pmcid	NOUN
dpc-2620	353	2	:	:	PUNCT
dpc-2620	353	3	pmc5904732	pmc5904732	ADJ
dpc-2620	353	4	.	.	PUNCT
dpc-2620	354	1	20	20	NUM
dpc-2620	354	2	.	.	PUNCT
dpc-2620	355	1	amoh	amoh	PROPN
dpc-2620	355	2	y	y	PROPN
dpc-2620	355	3	,	,	PUNCT
dpc-2620	355	4	li	li	PROPN
dpc-2620	355	5	l	l	PROPN
dpc-2620	355	6	,	,	PUNCT
dpc-2620	355	7	yang	yang	PROPN
dpc-2620	355	8	m	m	PROPN
dpc-2620	355	9	,	,	PUNCT
dpc-2620	355	10	et	et	PROPN
dpc-2620	355	11	al	al	PROPN
dpc-2620	355	12	.	.	PUNCT
dpc-2620	356	1	nascent	nascent	ADJ
dpc-2620	356	2	blood	blood	NOUN
dpc-2620	356	3	vessels	vessel	NOUN
dpc-2620	356	4	in	in	ADP
dpc-2620	356	5	the	the	DET
dpc-2620	356	6	skin	skin	NOUN
dpc-2620	356	7	arise	arise	NOUN
dpc-2620	356	8	from	from	ADP
dpc-2620	356	9	nestin	nestin	NOUN
dpc-2620	356	10	-	-	PUNCT
dpc-2620	356	11	expressing	express	VERB
dpc-2620	356	12	hair	hair	NOUN
dpc-2620	356	13	follicle	follicle	NOUN
dpc-2620	356	14	cells	cell	NOUN
dpc-2620	356	15	.	.	PUNCT
dpc-2620	357	1	proc	proc	PROPN
dpc-2620	357	2	natl	natl	PROPN
dpc-2620	357	3	acad	acad	PROPN
dpc-2620	357	4	sci	sci	PROPN
dpc-2620	357	5	usa	usa	PROPN
dpc-2620	357	6	.	.	PROPN
dpc-2620	358	1	2004;101(36):13291	2004;101(36):13291	NUM
dpc-2620	358	2	-	-	PUNCT
dpc-2620	358	3	5.doi	5.doi	ADJ
dpc-2620	358	4	:	:	PUNCT
dpc-2620	358	5	10.1073	10.1073	NUM
dpc-2620	358	6	/	/	SYM
dpc-2620	358	7	pnas.0405250101	pnas.0405250101	PROPN
dpc-2620	358	8	.	.	PUNCT
dpc-2620	359	1	pmid	pmid	NOUN
dpc-2620	359	2	:	:	PUNCT
dpc-2620	359	3	15331785	15331785	NUM
dpc-2620	359	4	.	.	PUNCT
dpc-2620	360	1	pmcid	pmcid	NOUN
dpc-2620	360	2	:	:	PUNCT
dpc-2620	360	3	pmc516562	pmc516562	ADV
dpc-2620	360	4	.	.	PUNCT
dpc-2620	361	1	21	21	NUM
dpc-2620	361	2	.	.	PUNCT
dpc-2620	361	3	li	li	PROPN
dpc-2620	361	4	l	l	PROPN
dpc-2620	361	5	,	,	PUNCT
dpc-2620	361	6	mignone	mignone	PROPN
dpc-2620	361	7	j	j	PROPN
dpc-2620	361	8	,	,	PUNCT
dpc-2620	361	9	yang	yang	PROPN
dpc-2620	361	10	m	m	PROPN
dpc-2620	361	11	,	,	PUNCT
dpc-2620	361	12	matic	matic	PROPN
dpc-2620	361	13	et	et	PROPN
dpc-2620	361	14	al	al	PROPN
dpc-2620	361	15	.	.	PROPN
dpc-2620	361	16	nestin	nestin	PROPN
dpc-2620	361	17	expression	expression	NOUN
dpc-2620	361	18	in	in	ADP
dpc-2620	361	19	hair	hair	NOUN
dpc-2620	361	20	follicle	follicle	NOUN
dpc-2620	361	21	sheath	sheath	NOUN
dpc-2620	361	22	progenitor	progenitor	NOUN
dpc-2620	361	23	cells	cell	NOUN
dpc-2620	361	24	.	.	PUNCT
dpc-2620	361	25	  	  	SPACE
dpc-2620	361	26	procnatl	procnatl	NOUN
dpc-2620	361	27	acad	acad	NOUN
dpc-2620	361	28	sci	sci	PROPN
dpc-2620	361	29	usa.2003;100:9958–9961.doi	usa.2003;100:9958–9961.doi	PROPN
dpc-2620	361	30	:	:	PUNCT
dpc-2620	361	31	10.1073	10.1073	NUM
dpc-2620	361	32	/	/	SYM
dpc-2620	361	33	pnas.1733025100	pnas.1733025100	PROPN
dpc-2620	361	34	.	.	PUNCT
dpc-2620	361	35	pmid	pmid	NOUN
dpc-2620	361	36	:	:	PUNCT
dpc-2620	361	37	12904579	12904579	NUM
dpc-2620	361	38	.	.	PUNCT
dpc-2620	362	1	pmcid	pmcid	ADJ
dpc-2620	362	2	:	:	PUNCT
dpc-2620	362	3	pmc187900	pmc187900	NOUN
dpc-2620	362	4	.	.	PUNCT
dpc-2620	363	1	22	22	NUM
dpc-2620	363	2	.	.	PUNCT
dpc-2620	364	1	osawa	osawa	PROPN
dpc-2620	364	2	m	m	PROPN
dpc-2620	364	3	,	,	PUNCT
dpc-2620	364	4	egawa	egawa	PROPN
dpc-2620	364	5	g	g	PROPN
dpc-2620	364	6	,	,	PUNCT
dpc-2620	364	7	mak	mak	PROPN
dpc-2620	364	8	ss	ss	PROPN
dpc-2620	364	9	,	,	PUNCT
dpc-2620	364	10	et	et	PROPN
dpc-2620	364	11	al	al	PROPN
dpc-2620	364	12	.	.	PUNCT
dpc-2620	365	1	molecular	molecular	ADJ
dpc-2620	365	2	characterization	characterization	NOUN
dpc-2620	365	3	of	of	ADP
dpc-2620	365	4	melanocyte	melanocyte	NOUN
dpc-2620	365	5	stem	stem	NOUN
dpc-2620	365	6	cells	cell	NOUN
dpc-2620	365	7	in	in	ADP
dpc-2620	365	8	their	their	PRON
dpc-2620	365	9	niche	niche	NOUN
dpc-2620	365	10	.	.	PUNCT
dpc-2620	366	1	development	development	NOUN
dpc-2620	366	2	.	.	PUNCT
dpc-2620	367	1	2005;132(24):5589–5599	2005;132(24):5589–5599	NUM
dpc-2620	367	2	.	.	X
dpc-2620	367	3	doi	doi	NOUN
dpc-2620	367	4	:	:	PUNCT
dpc-2620	367	5	10.1242	10.1242	NUM
dpc-2620	367	6	/	/	SYM
dpc-2620	367	7	dev.02161.pmid	dev.02161.pmid	NOUN
dpc-2620	367	8	:	:	PUNCT
dpc-2620	367	9	16314490	16314490	NUM
dpc-2620	367	10	.	.	PUNCT
dpc-2620	368	1	23	23	NUM
dpc-2620	368	2	.	.	PUNCT
dpc-2620	369	1	joshi	joshi	PROPN
dpc-2620	369	2	ss	ss	PROPN
dpc-2620	369	3	,	,	PUNCT
dpc-2620	369	4	tandukar	tandukar	PROPN
dpc-2620	369	5	b	b	NUM
dpc-2620	369	6	,	,	PUNCT
dpc-2620	369	7	pan	pan	PROPN
dpc-2620	369	8	l	l	PROPN
dpc-2620	369	9	,	,	PUNCT
dpc-2620	369	10	et	et	PROPN
dpc-2620	369	11	al	al	PROPN
dpc-2620	369	12	.	.	PUNCT
dpc-2620	370	1	cd34	cd34	PROPN
dpc-2620	370	2	defines	define	VERB
dpc-2620	370	3	melanocyte	melanocyte	NOUN
dpc-2620	370	4	stem	stem	NOUN
dpc-2620	370	5	cell	cell	NOUN
dpc-2620	370	6	subpopulations	subpopulation	NOUN
dpc-2620	370	7	with	with	ADP
dpc-2620	370	8	distinct	distinct	ADJ
dpc-2620	370	9	regenerative	regenerative	ADJ
dpc-2620	370	10	properties	property	NOUN
dpc-2620	370	11	.	.	PUNCT
dpc-2620	370	12	  	  	SPACE
dpc-2620	371	1	plos	plos	PROPN
dpc-2620	371	2	genet	genet	PROPN
dpc-2620	371	3	.	.	PUNCT
dpc-2620	372	1	2019;15(4):1008034	2019;15(4):1008034	NUM
dpc-2620	372	2	.	.	PUNCT
dpc-2620	373	1	doi	doi	NOUN
dpc-2620	373	2	:	:	PUNCT
dpc-2620	373	3	10.1371	10.1371	NUM
dpc-2620	373	4	/	/	SYM
dpc-2620	373	5	journal	journal	NOUN
dpc-2620	373	6	.pgen.1008034	.pgen.1008034	NOUN
dpc-2620	373	7	.	.	PUNCT
dpc-2620	374	1	pmid	pmid	NOUN
dpc-2620	374	2	:	:	PUNCT
dpc-2620	374	3	31017901	31017901	NUM
dpc-2620	374	4	.	.	PUNCT
dpc-2620	375	1	pmcid	pmcid	ADJ
dpc-2620	375	2	:	:	PUNCT
dpc-2620	375	3	pmc6481766	pmc6481766	NOUN
dpc-2620	375	4	.	.	PUNCT